Annual Report • Apr 3, 2020
Annual Report
Open in ViewerOpens in native device viewer
Nolato AB
Nolato Beijing
SE-269 04 Torekov, Sweden Street address: Nolatovägen Phone: +46 431 442290 Email: [email protected]
Nolato Gota
Nolato Hungary Jánossomorjai utca 3
UK
UK
Phone: +36 96 578770 Negoiesti, Romania DIBO Industrial Park, H13 Negoiesti, Prahova Romania, 107086 Nolato Jaycare Portsmouth, UK Walton Road, Farlington Portsmouth Hampshire, PO6 1TS
Phone: +44 2392 370102 Newcastle, UK
Phone: +44 191 296 0303 Lövepac Converting Beijing, China 4th Floor, Building 3, No. 21 Xingsheng Road BDA, Beijing, 100176, China Phone: +86 10 6780 5580 Shenzhen, China
New York Way, New York Ind. Park Newcastle upon Tyne NE27 0QF
Lövepac technology (Shenzhen) Co., Ltd 1st. Floor, No. 3 building, No.1 Lirong Rd.
Lorong Perindustrian Bukit Minyak 21,
Changyi Industrial Area, Xinshi Community, Dalang St. Longhua District Shenzhen 518109, China Phone: +86 755 8610 6065 Penang, Malaysia Nolato EMC Production Center
Penang Science Park, 14100 Simpang Ampat Penang, Malaysia Phone: +604 50 57 830
Plot 368,
Box 29, SE-533 21 Götene, Sweden Street address: Alsborgsgatan 2 Phone: +46 511 342100
Nolato Lövepac Ringvägen 5
Nolato MediTor
Sweden
SE-269 04 Torekov, Sweden Street address: Nolatovägen Phone: +46 431 442260 Nolato Plastteknik
Sweden
SE-286 73 Skånes Fagerhult,
Nolato Silikonteknik
East Rongchang Road, Beijing Development Area Beijing 100176, China Phone: +86 10 6787 2200 Suzhou, China
Box 62, SE-694 22 Hallsberg, Sweden Street address: Bergsmansvägen 4 Phone: + 46 582 88900 Beijing, China
Nolato Silikonteknik (Beijing) Co., Ltd Room 207, 2nd Floor, Building 208, 7#
Nolato Electronic Technology Co., Ltd Plant E, No. 46 Chunxing Road Caohu Street, Xiangchen Suzhou 215100, China Phone: +86 51 2693 90380 New Jersey, USA Nolato Jabar P.O. Box 1249 Andover, NJ 07821, USA Street address: 252 Brighton Road Phone: +1 973 786 5000 Penang, Malaysia
Nolato EMC Production Center Sdn. Bhd.
Lorong Perindustrian Bukit Minyak 21,
Plot 368,
Penang Science Park, 14100 Simpang Ampat Penang, Malaysia Phone: +604 50 57 830 Gyõr, Hungary Nolato EMC Production Center Limited Liability Company
Bükkfa utca 10 HU-9027, Gyõr, Hungary Nolato Stargard ul. Uslogowa 1 73-110 Stargard Poland
Nolato Treff
Switzerland
Phone: +48 91 573 6362
Phone: +41 71 372 55 55
www.nolato.com
Taastrasse 16, 9113 Degersheim
Box 93, SE-242 21 Hörby, Sweden Street address: Medicingatan 4 Phone: +46 415 19700 Lomma, Sweden
Box 28, SE-234 21 Lomma, Sweden Street address: Koppargatan 13 Phone: +46 415 19700
Box 4123, SE-422 04 Hisings Backa,
Street address: Exportgatan 59 Phone: +46 31 588400 Nolato Polymer
SE-269 04 Torekov, Sweden Street address: Nolatovägen Phone: +46 431 442200 Ängelholm, Sweden Framtidsgatan 6
SE-262 73 Ängelholm, Sweden Phone: +46 431 442200
Phone: +46 433 32300 Nolato MediTech
HU-9200 Mosonmagyaróvár, Hungary
402 Longsheng Industrial Park 7 Rong Chang Road East Beijing Development Area Beijing 100176, China Phone: +86 10 6787 2200 Suzhou, China
Nolato Electronic Technology (Suzhou) Co. Ltd.
Nolato AB 2022:210 Stridsvagnsvägen 14 SE-291 39 Kristianstad, Sweden Phone: +46 708-74 41 70 San Diego, USA 16208 Palomino Mesa Ct San Diego, CA 92127, USA Phone: +1 858 859 5270
Nolato Cerbo
Nolato Contour 660 VandeBerg Street Baldwin, WI 54002, USA Phone: +1 715 684 4614
Box 905, SE-461 29 Trollhättan, Sweden Street address: Verkmästarevägen 1–3 Phone: +46 520 409900 Paris, France 15 Rue Vignon FR-75008 Paris, France Phone: +33 1 47 975284
Building E Pingqian Industrial Park No. 46 Chunxing Road Xiangcheng District Suzhou 215100, China Phone: +86 512 6939 0380 Nolato Beijing Medical 402 Longsheng Industrial Park 7 Rong Chang Road East Beijing Development Area Beijing 100176, China Phone: +86 10 6787 2200 Kristianstad, Sweden Krinova Incubator & Science Park
Global expansion
Nolato Annual Report 2019



"As a profitable, sustainable and innovative company at the cutting edge of technology, we are well positioned to take advantage of the many opportunities that the future holds, with continued healthy profitability and growth."

Nolato's history
Nordiska Latexfabriken i Torekov is
First medical device component is
The Group changes its name to Nolato, a contraction of the original name.
Nolato shares are listed on the Stockholm Stock Exchange OTC list.
The Group achieves sales of SEK 650 million. Acquisition of companies in Lomma, Sunne, Hallsberg, Gothenburg
Nolato doubles its sales through the acquisition of Ericsson's plastics factory in Kristianstad, Sweden (mobile phone
The first Group company achieves certification under the ISO 14001 environmental
Production starts in Hungary through an
and Ängelholm in Sweden.
1938
founded.
1957
1982
1984
1994
1997
division).
1998
2000
acquisition.
management system.
manufactured.
The Nolato Annual Report was produced by Bysted AB.
and the printing process is FSC and environmentally certified.
Photography: Jüri Soomägi, Anders Eliasson and others. Illustrations: Björn Nilsson.
2001
2005
Hungary.
2006
2007
2008
China.
2010
Plastics.
2011
Romania.
2012
2013
Allman Jaycare.
to China begins.
Relocation of the mobile phone division
2014
2016
2018
2019
Integrated Solutions establishes own
Treff AG in Switzerland and Grizzly Medical
Integrated Solutions acquires US-based
production in Malaysia.
in Poland are acquired.
Sweden-based Hertila is sold.
Ja-Bar Silicone Corporation.
Medical Solutions starts production in
Sweden-based Medical Rubber is acquired.
Sweden-based Cerbo Group is acquired.
Medical Solutions starts production in
Medical Solutions starts production in the US through the acquisition of Contour
Industrial Solutions starts production in
Medical Solutions starts production in the UK through the acquisition of Cope
Sweden-based Nolato Sunne is sold.
Repro & printing TMG Öresund. Translation by Hilltop Language Ltd. Production has been carried out in line with Nolato's corporate responsibility principles, with a sustainability focus, social responsibility and low environmental impact. The paper comes from responsible, certified sources
Nolato's customer offering comprises most technologies in the field of polymers and spans the entire value chain, from solutions-oriented development to product delivery.
One Nolato means customers benefit from end-to-end solutions using technologies and products that leverage the skills and resources of all three business areas.

| Nolato in brief | 3 |
|---|---|
| 2019 in brief | 4 |
| CEO's comments | 6 |
| Nolato's strategic focus | 8 |
| Operating environment | 9 |
| Vision | 10 |
| Values | 11 |
| Targets | 12 |
| Strategy | 13 |
| Mission and business model | 14 |
| Production technologies | 16 |
| Sustainable development | 18 |
| Nolato's three business areas | 26 |
| Shareholder information | 40 |
| Corporate governance | 42 |
| Board of Directors | 44 |
| Group management | 46 |
| Directors' report and financial statements* | 47 |
www.nolato.com
The Investor Relations section of www.nolato.com provides information focused on investors and Nolato shares. The printed annual report is sent by post to those shareholders who have notified the company that they wish to receive a copy. It can also be ordered at www.nolato.com, where a digital version is also available. New shareholders are offered the opportunity in a welcome letter to receive future annual reports as long as they own shares in the company. The annual report is also available in Swedish.
Nolato was listed on the stock exchange in 1984 and its B shares, STO:NOLA B, are listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector.

*The information on pages 47–92 has been audited.
Nolato is a Swedish publicly listed group with operations in Europe, Asia and North America. Nolato's three business areas develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading, often global, companies.

Three basic principles that comprise Nolato's group-wide values and are key to our long-standing tradition of responsible business and sustainable development strategy.




| Financial highlights: | 2019 | 2018 |
|---|---|---|
| Sales, SEKm | 2,484 | 2,270 |
| Operating profit (EBITA), SEKm | 320 | 295 |
| EBITA margin, % | 12.9 | 13.0 |
| Average no. of employees | 1,624 | 1,497 |
Development and manufacture of complex product systems and components within medical technology and advanced packaging solutions for pharmaceuticals and dietary supplements.
| Financial highlights: | 2019 | 2018 |
|---|---|---|
| Sales, SEKm | 3,292 | 3,720 |
| Operating profit (EBITA), SEKm | 427 | 473 |
| EBITA margin, % | 13.0 | 12.7 |
| Average no. of employees | 3,201 | 3,868 |
Integrated
Solutions
Design, development and manufacture of advanced components, subsystems and ready-packaged products for consumer electronics. EMC & Thermal develops and manufactures shielding and heat dissipation products and systems for electronics.
| Financial highlights: | 2019 | 2018 |
|---|---|---|
| Sales, SEKm | 2,159 | 2,119 |
| Operating profit (EBITA), SEKm | 181 | 186 |
| EBITA margin, % | 8.4 | 8.8 |
| Average no. of employees | 1,109 | 1,078 |
Industrial
Solutions
Development and manufacture of products and product systems for customers in the automotive, hygiene, packaging, gardening/forestry, domestic appliance and furniture sectors, and other selected industrial segments.


Q1/18 Q2/18 Q3/18 Q4/18 Q1/19 Q2/19 Q3/19 Q4/19

Excluding acquisitions and disposals


Basic

| SEKm (unless otherwise specified) | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Net sales | 7,919 | 8,102 | 6,720 | 4,447 | 4,726 |
| Operating profit (EBITDA) | 1,263 | 1,189 | 980 | 636 | 737 |
| Operating profit (EBITA) | 895 | 949 | 763 | 457 | 570 |
| EBITA margin, % | 11.3 | 11.7 | 11.4 | 10.3 | 12.1 |
| Profit after financial income and expenses | 857 | 921 | 731 | 438 | 555 |
| Profit after tax | 703 | 722 | 572 | 336 | 420 |
| Basic earnings per share, SEK | 26.60 | 27.44 | 21.74 | 12.77 | 15.97 |
| Adjusted basic earnings per share, SEK | 26.82 | 27.67 | 22.16 | 13.19 | 16.35 |
| Cash flow after investment, excl. acquisitions and disposals | 800 | 593 | 496 | 245 | 288 |
| Net investment, affecting cash flow, excl. acquisitions and disposals | 360 | 452 | 277 | 221 | 244 |
| Cash conversion, % | 88 | 60 | 66 | 55 | 52 |
| Return on capital employed, % | 23.1 | 29.7 | 26.6 | 20.6 | 29.6 |
| Return on shareholders' equity, % | 25.5 | 30.4 | 29.4 | 19.0 | 25.3 |
| Equity/assets ratio, % | 48 | 50 | 45 | 47 | 54 |
| Net financial assets (+)/net financial liabilities (–) | 666 | 341 | 31 | –206 | 249 |
| Dividend per share (2019 proposal), SEK | 14.50 | 14.00 | 12.50 | 10.50 | 10.00 |
| Average no. of employees | 5,941 | 6,449 | 7,249 | 6,418 | 7,759 |
See definitions of IFRS measures and alternative performance measures on page 85.
Nolato posted good earnings for 2019, owing in particular to a strong end to the year. What's your view on the year?
Overall I'm pleased with performance in 2019. During the year we advanced our market positions further, including by establishing Industrial Solutions and Integrated Solutions production in the US and the Group maintaining a healthy margin and continued robust cash flow. It was a great finish to the year with a very strong fourth quarter, which helped generate a 22% rise in sales, adjusted for currency. This was largely led by our Integrated Solutions business area, which, adjusted for currency, increased sales by a remarkable 45%. A key factor in this success is the sterling work by all of Nolato's employees, who are now based across three continents. Our employees are our most important asset, and it's their commitment and expertise that have enabled our gradual progression to the role of strategic solutions provider for our customers. I also think our combination of responsible business and in-depth know-how in polymer materials and alternatives based on fossil-free raw materials is right for today's world. It's one of the reasons why we are gaining an increasingly strong position among our customers, by being an important part of their transition towards more sustainable development.
For Integrated Solutions, the inventory adjustments in vaporiser heating products (VHP) that carried over into 2019 resulted in low volumes in the first quarter, but it then performed fully in line with our hopes of a normalisation in the inventory situation. The margin was boosted mainly by healthy volumes of older VHP products with high production efficiency, together with the market launch of new product variants.
Medical Solutions increased sales in both Medical Devices and Pharma Packaging, along with healthy growth across most product areas. The business area's growth in the second half of the year was affected by strong comparative figures, which contained very high development sales and billing of production equipment.
Industrial Solutions sales were essentially unchanged. The year began with inventory adjustments in the area of hygiene and ended with the start of a number of new customer projects within general industry, which boosted sales.
We're generally getting better and better at leveraging the synergies between our three business areas to create the greatest possible benefit for customers by offering 'One Nolato'. I view the synergies that we can generate by drawing on our in-depth expertise in polymer materials, technologies and manufacturing processes across a range of sectors as a unique customer offering and a genuine advantage for our business and our comprehensive offering.
Acquisitions have long been an important part of our growth strategy and efforts to boost shareholder value by identifying highquality companies that complement our offering with solid market positions and a high level of technical expertise. EMC production has traditionally taken place in Asia, but the trade war has led to a geographical shift. We've responded by establishing a business in Hungary, and Ja-Bar reinforces our presence in North America while bringing additional production technologies and expanding our customer base. I believe the acquisition will generate longterm market and customer synergies that will make Nolato's customer offering even stronger.
Nolato has now been a signatory to the Global Compact for 10 years, and our sustainability efforts continue to be guided by this network's 10 principles. The key indicators we publish for performance on environmental responsibility, social responsibility and business benefit are a good reflection of our priorities. We also incorporate a number of the UN Sustainable Development Goals that have a clear bearing on our business.
Nolato has been taking proactive sustainability measures regarding our own direct emissions, waste management and energy usage for many years now. Where we can gradually reduce the impact of our own operations, this also contributes to our customers' sustainability efforts as we are a part of their value chain. Key elements of this include innovations such as greater use of bio-based and recycled plastic, investment in new technology and switching to renewable energy.
What is the scope of Nolato's responsibility? Nolato believes in extensive responsible business, which encompasses the products that we're involved in helping bring to
market, as that's where the long-term environmental impact mainly occurs. We also want to make a sustainable transition together with our customers by offering them opportunities to phase out fossil plastics in favour of bioplastics, alongside adapting and designing products that can easily link into a circular approach. This is part of an essential transition, and helping our customers be more sustainable is a primary issue for us.
I believe we are well positioned to continue our successful journey. As a profitable, sustainable and innovative company at the cutting edge of technology, we are well equipped to respond to the opportunities and needs of the future with continued sustainable, profitable growth. I think our best years are ahead of us.
Torekov, March 2020
Christer Wahlquist
President and CEO

"Our combination of responsible business and in-depth know-how in polymer materials and alternatives based on fossil-free raw materials is right for today's world. It's one of the reasons why we are gaining an increasingly strong position among our customers, by being an important part of their transition towards more sustainable development."
PAGE 10 Values PAGE 11
Vision
Financial targets PAGE 12
Strategy PAGE 13
Mission PAGE 14
Business model PAGE 14
Nolato's production technologies PAGE 16
Globalisation, digitalisation, corporate responsibility requirements and 'more for less' are some of the main trends constantly changing the landscape for Nolato's customers.


Nolato's customers operate in a world in which powerful trends and drivers are presenting both challenges and business opportunities for innovative companies. As a high-tech solutions provider, Nolato's task alongside customers is to develop and adapt products as circumstances change and turn each challenge into a competitive, sustainable business opportunity.
Speed-to-market needs are increasing in step with rapid technological developments and constantly changing consumer behaviour. Ever shorter product life cycles have to be addressed through both parallel development projects and efficient production processes.
This rapid pace is resulting in customers increasingly needing to focus on their own core business. Outsourcing parts of the business to subcontractors and partners companies is a way of responding to this challenge.
As electronics and the Internet of Things (IoT) are rapidly integrated into products, the need for both shielding and heat dissipation is also growing in entirely new areas.
General pricing pressure combined with the constant emergence of new operators on the market underscores the need for competitive, differentiated products to strengthen market position.
Increasingly high expectations of proactive sustainability work involving responsible business practices regarding environmental issues, social issues and business ethics.
As a global business with a local presence, Nolato is well positioned to understand customers' needs to deliver integrated solutions that meet their demand for short lead times and efficient time to market for new products.
In-depth technical expertise, close involvement in and an understanding of customers' businesses provide Nolato with a unique ability to identify development needs at an early stage in order to raise the level of innovation and streamline customers' production processes and logistics chains. This is in addition to an aim of increasing the level of renewable/recycled materials, along with designs that make it easier for products to become part of a sustainable loop and contribute to a circular economy.
Sustainable, responsible business is the basis for everything that Nolato does and is at the heart of its long-term strategy to generate sustainable growth and value for customers. Proactive measures are also taken to manage Nolato's primary sustainability issues, while business opportunities offered by greener products and solutions are constantly being created.
Nolato's vision is to be the natural choice when customers need a high-tech cooperation partner and provider. Being the customer's first choice is defined as customers experiencing the delivery of high quality in all aspects of projects. Nolato aims to be a highly credible partner by delivering what we promise, on schedule. Nolato targets long-term cooperation and values transparent, close customer relationships. Nolato is constantly looking for new ways of always exceeding customer expectations.
The key factors in achieving our vision are:


More and more customers are using fewer suppliers, prioritising those that have the resources and expertise to be involved from concept to delivery. That's why our broad customer offering in developing and producing polymer-based products comprises everything from concept development, product design and process optimisation to high-volume production, post-processing, assembly and logistics.

We have strong core values based on the view that efficient and profitable business operations must be ethical and sustainable. Issues relating to ethics, social responsibility, environmental matters and work environment are therefore integral elements of our business.

Long-term, close cooperation is the objective for all Nolato's customer relationships. Better understanding and knowledge of their processes and needs allow key values to be generated.

The things that create value for customers and that are important to them in the long term also create value for Nolato. So high productivity and a continual focus on costs are core elements of our business. Lean manufacturing maximises the business benefit for Nolato and its customers, while it also helps streamline processes, reduce scrap, cut lead times and develop innovative solutions.

Nolato's customers constantly challenge us with new requests and tougher requirements. We therefore enhance our customer offering by continually raising the skill levels of employees and investing in cutting-edge technologies. One Nolato creates positive synergies between the three business areas to increase value for Nolato's customers.

Proximity to customers and their markets is crucial. It's about achieving the most efficient logistics possible, along with short lines of command and the ability to make quick decisions.

provides us with a stable foundation and is essential for our business. Nolato is a reliable supplier and cooperation partner and ensures that it has solid finances, including in more challenging economic times.
Nolato's Basic Principles comprise its group-wide values, which are central components of a long-standing tradition of responsible business and sustainable development strategy. Values that provide Nolato employees with important guidance in their day-to-day work.
WELL ORGANISED
Nolato's financial targets ensure the Group is managed with the aim of achieving healthy earnings, generating adequate cash flow and maintaining a healthy level of financial risk. These financial targets reflect Nolato's strategic focus on a well-balanced Group structure with three business areas and advanced market positions, which provides financial flexibility to make new acquisitions and/or provide good potential dividends for shareholders.
Nolato's dividend policy is to propose a dividend that exceeds 50% of profit after tax, taking account of Nolato's long-term development opportunities, financial position and investment needs. The 2019 Annual General Meeting (AGM) approved a dividend corresponding to 51% of profit after tax. The Board's proposed dividend ahead of the 2020 AGM is 55%.

The target for the EBITA margin is for it to exceed 10% over a business cycle.
The outcome for 2019 was a strong 11.3% (11.7). Medical Solutions and Integrated Solutions had margins of approximately 13%, significantly exceeding the Group target. Industrial Solutions had a margin of 8.4%, which was below the Group target.
Over the past five years, the EBITA margin has averaged 11.4%.

The target is to achieve cash conversion of more than 75% of EBIT over a business cycle, measured as the ratio of cash flow after investment and EBIT.
The outcome for 2019 was 88% (60), which exceeded the target. The improvement on the previous year was achieved as a result of lower investment, lower working capital and continued good earnings.
Over the past five years, cash conversion has averaged 64%.

The target for the equity/assets ratio is for it to exceed 35% over a business cycle.
Nolato has a sustained strong financial position. The equity/ assets ratio at year-end 2019 was 48% (50).
Over the last five years, the equity/assets ratio has averaged 49%.
Nolato aims to achieve growth that exceeds the level of growth within each market segment.
Medical Solutions' sales in 2019 grew by 5% compared with the previous year, adjusted for currency. Long-term volume growth for this business area's market segments and applications is assessed to remain around 4–5%. Sales increased in both Medical Devices and Pharma Packaging. Growth was affected by strong comparative figures, which contained very high development sales and billing of production equipment.
5% –18% 0%
Integrated Solutions sales decreased by 18% in 2019, adjusted for currency. The year began with inventory adjustments in the area of VHP. After normalisation of the inventory situation, sales gradually increased each quarter. Volumes in the EMC area were stable, while mobile phones were initially weak but performed well in the second half of the year.
Industrial Solutions sales in 2019 were unchanged after adjusting for currency. Inventory adjustments in the hygiene area had a negative effect in the first half of the year. A new general industry customer project was started, increasing sales at the end of the year. Volumes were stable in other product areas.
The following overarching strategy has been established in order to achieve Nolato's growth targets.

Nolato aims to be a high-tech cooperation partner with a global presence, with the objective of long-term growth and stable returns for shareholders.
We invest in employees and a high level of expertise and development of cutting-edge technology, together with global competitive lean manufacturing. This helps us offer end-to-end solutions in which sustainability is a key element.
A corporate culture based on a decentralised business model. This gives the companies of the business areas the authority to develop and adapt their offerings based on the specific needs and demands of customers. The similarity of the technologies used by the three business areas generates synergies and cooperation that provide additional customer value.
A customer-oriented strategy means Nolato looks for large customers in product areas with organic growth, providing opportunities to grow and develop alongside their market offerings.
Nolato's expansion is achieved both by accompanying customers into new markets and by acquiring companies with a corporate culture that matches Nolato's culture and that complement the existing customer base, in addition to expertise that further broadens Nolato's offering.
Nolato's continued progression is aimed at gaining a position as an advanced high-tech cooperation partner for customers.
| Past | Present | Future |
|---|---|---|
| Mobile phones, manufacturing, medical technology |
A well-balanced group with three business areas; Medical, Industrial and Integrated Solutions |
Continued sustainable growth |
| Supplier | Cooperation partner and provider of technically advanced products |
Global high-tech strategic cooperation partner |
| Leading position in Sweden Growing market in Asia and Central Europe |
Global presence Strong position in Asia and Europe Production established in North America |
Strong position and presence on three continents; Asia, Europe and North America |

Nolato's mission is the company's reason for being, the basis for the business and provides a clear picture of how its customers' needs can be met:
Nolato is a global, advanced high-tech solutions provider and manufacturer of polymer products and systems for leading customers in specific market areas.
With its many years of experience, in-depth expertise in materials and processes, early involvement in customer projects, advanced project management and detailed knowledge of each customer's specific requirements, Nolato is an effective and innovative partner.
Nolato's business model is based on three decentralised business areas, which with their own decision-making and shared ambitions endeavour to achieve its vision and financial targets. This creates secure jobs for employees and generates value for shareholders.
Extensive experience and wide-ranging expertise allow us to develop close, long-term and innovative cooperation with customers.
Added value is created for both customers and owners through progressive, leading technology, extensive expertise in development and design, advanced project management, and highly efficient production.
Our shared values of being professional, well organised and responsible are reflected in all aspects of the business.
Nolato's revenue is mainly generated from customer production assignments. Manufacturing and supply of products take place in accordance with customer orders and other preferences and are then billed. Manufacturing is based on short production and turnaround times, resulting in low risk exposure for warehousing and obsolescence.
An important part of Nolato's value creation for customers and owners is the ability to provide in-depth expertise in leading technologies, design and advanced project management at an early stage of product development.
Nolato's business consists of developing and manufacturing customer-specific products, primarily in polymer materials such as plastic, silicone and TPE. It also produces standardised products within some areas. Nolato's customers can be found in the medical technology, pharmaceutical, consumer electronics, telecom, automotive, hygiene and other selected industrial sectors.
Customer needs and requirements form the basis for all of Nolato's development work. Customer-specific products and solutions are created by leveraging our expertise in advanced technologies and cost-effective manufacturing. Nolato supports customers from concept development to high-volume production.
and lean manufacturing. Products include interior details for vehicles and components for strimmers and chainsaws.
The standard range of own products that Nolato develops and manufactures includes pharmaceutical packaging, laboratory products, process and materials solutions for shielding and heat dissipation for electronics.

Concept development Nolato supports customers from the concept stage and is involved in discussions about production options.
We create technical solutions that give products unique haptic and cosmetic features, make them waterresistant, reduce the weight of products and/or minimise their environmental impact.

Nolato optimises design in order to create the most efficient and effective production solutions in terms of function, quality and price.

Nolato visualises the future product by producing prototypes and materials samples.

Production tools Nolato specifies and manufactures, or buys in, moulds and related production equipment.
We work with most production technologies, primarily in the field of polymers.
Nolato continually ensures correct quality through the use of automated vision systems, professional operators and effective systems for continuous improvements.

Technology for manufacturing components from plastic, silicone, TPE and ceramics to highly precise dimensions and stringent quality requirements.
Our most common production technology.
Technology for manufacturing plastic containers and bottles.
We use this method for the manufacture of pharmaceutical packaging.
Technology for the production of tubing and other tubular products.
This technique is used to manufacture surgical instruments and urine catheters, as well as EMC shielding gaskets.
Technology for the production of flexible, airtight liquid latex products.
This is used to manufacture products such as catheter balloons and breathing bags.

Technology for producing flat products from one or more materials and for providing effective joining of components and electronics.
We use die-cutting for manufacturing adhesive, gaskets, seals and cosmetic details for customers in the telecom, automotive, medical technology and electronics industries.
Techniques and materials developed to achieve electromagnetic compatibility, i.e. to prevent disruption from electromagnetic radiation between electronic components. Radio base stations are an example of a customer product that uses EMC shielding.
Assembly of components to create a complete product or subsystem. This may take place on a fully automated, semi-automated or fully manual basis. Automated assembly is mainly carried out for medical devices such as autoinjectors, for which assembly is performed on a fully automated basis at high volumes.
We provide components with the desired finish through painting, decoration and metallisation of components for products like mobile phones and medical devices.
A proactive approach, new business opportunities, responsibility and transparency are core elements of Nolato's long-term strategy to create growth and value for stakeholders.
Nolato has established a long-term sustainable development strategy. The strategy encompasses activities within social responsibility, business ethics/financial responsibility and the environment. We can demonstrate progress within these areas, but the challenge of improving products' environmental attributes requires cooperation with raw material suppliers and customers. An important aspect of the strategy is taking a systematic approach to developing resource-efficient production methods and products with a small carbon footprint.
This is what we mean by responsible business:
Responsibility and transparency – Nolato complies with international conventions and principles for sustainable development, including via being a signatory to the Global Compact. The long-term targets set out the road map for our sustainability work and we openly report on both our progress and setbacks encountered, according to international standards for sustainability reporting.
Our sustainable development strategy is part and parcel of our mission and business model. By creating safe and stimulating workplaces, minimising environmental impact and generating lasting value for our shareholders and stakeholders, Nolato is benefitting both business and society. In short, we aim to be customers' first choice for sustainable development.
For detailed information about how Nolato manages and monitors work concerning sustainable development, please see Our Sustainability Work 2019, www.nolato.com/sustainability
Interest in sustainable development grew in many of the countries in which Nolato operates. Climate change and the role of plastics in society were just two of the issues that engaged Nolato's stakeholders. We continued to work on reducing the Group's carbon footprint, and during the year we implemented several projects that could mean greater use of bio-based plastics and recycled plastic raw material in the long term. Positive results were also achieved in other strategically important areas such as energy, waste, health and safety, social responsibility and business ethics.
"Sustainability issues are a key component of Nolato's longterm business strategy. Expectations of specific results are clear and by taking a responsible and innovative approach I see significant opportunities for us to generate good business through resource-efficient production and environmentally sustainable products."
Christer Wahlquist President and CEO
| 2019 | 2018 | 2017 |
|---|---|---|
| 0.023 | 0.022 | 0.028 |
| 75 | 62 | 53 |
| 4.3 | 4.5 | 7.3 |
| 2 | 2 | 2 |
| 2 | 0 | 2 |
| 4.9 | 4.1 | 3.7 |
| 26 | 24 | 47 |
| 25 | 22 | 22 |
| 0 | 0 | 0 |
| 7,592 | 7,993 | 6,530 |

Customer expectations of Nolato regarding sustainable development have increased over the years. Requirements on environmental management systems, phasing out of hazardous substances and a code of conduct have long been in place. Recent years have seen a greater requirement for active responsibility within the supply chain. In 2019 we noted increased interest among many customers in bio-based and recycled raw materials.
At the production plant in Beijing, China the Employee Care Programme is a way of creating an interesting and stimulating workplace. The programme includes social activities such as a day trip to central Beijing, sport, access to libraries and family days. It also comprises training courses, including about lean production, quality management, leadership, technology and languages. E-learning is an important tool, and 22 new courses were developed over the year. A total of 491 employees attended training courses, comprising more than 19,000 hours.
Certified environmental management systems are a key component of Nolato's sustainability work. All production facilities are certified, and 129 internal and 28 external environmental audits were conducted during the year.

ISO 14001
Nolato has introduced long-term group-wide goals covering the environment, people and society. Several of these goals are linked to Agenda 2030 and the UN Sustainable Development Goals (SDGs). A number of the production plants also have local goals, particularly as part of ISO 14001 and other management systems. Below is a summary of these goals and how work developed in 2019.
The Code of Conduct (The Nolato Spirit) is applied uniformly around the world and these values help attract, retain and develop committed, talented employees. Our long-term goals on social responsibility include initiatives that contribute to good health and safety, employee training and respect for human rights. Engagement with society is being further developed in those countries in which the Group operates.
| Area | Goals for sustainable development | SDGs | Outcome |
|---|---|---|---|
| Safe workplaces |
The number of workplace accidents should be minimised with the long-term targeting of zero occurrences. All units must have a functioning system for registering and addressing near misses. This work should be conducted systematically, for example using certified management systems relating to health and safety (ISO 45001). |
There were 4.9 accidents (4.1) resulting in absence per million hours worked in 2019. Systems for recording near misses have been introduced and there are certified management systems in place at six (five) units. Continued technical and organisational initiatives are required to ultimately eliminate all accidents. |
|
| Human rights and gender equality |
There should be no cases of infringements of human rights, discrimination or forced labour. Active information shall continue to be provided to employees and new staff. |
During the year, employee training was held on The Nolato Spirit. No cases of infringements of human rights were recorded. Recruitment of people with disabilities continued. Local management teams are made up of approximately 25% (22) women. |


Climate change concerns Nolato in a number of ways, with the transition to a society with a smaller carbon footprint creating risks and opportunities for the Group. Boosting energy efficiency and phasing out fossil fuels is reducing Nolato's carbon footprint. These measures also create preparedness for higher fees and taxes on carbon-emitting operations. Greater use of recycled and bio-based raw materials are other initiatives that are positive with regard to carbon emissions and may create business opportunities. So environmentally sustainable product development is a priority area, in which Nolato's expertise and technology can contribute to customers' environmental and carbon reduction efforts. Nolato has a number of long-term targets relating to the environment.
| Area | Goals for sustainable development | SDGs | Outcome |
|---|---|---|---|
| Energy | More efficient energy use, and up until 2020 usage should decrease by 20% compared with the average for 2011–2012. The group-wide key performance indicator (KPI) is GWh/net sales and production units use locally adapted targets and KPIs. |
Measures included investments in more energy-efficient production equipment (electric injection moulding machines), infrastructure and lighting (LED bulbs). Energy consumption was also affected by production changes at the plant in Beijing. Since 2011–2012, GWh/net sales has decreased by roughly 50 percentage points. |
|
| Carbon emissions |
A 20% reduction in emissions of the greenhouse gas carbon dioxide (CO2 ) up to the year 2020 compared with the average for 2011–2012. The target relates to CO2 emissions from energy consumption. The group-wide KPI is tonnes of CO2 /net sales and there are also different types of local targets. |
Climate-related measures include more efficient use of energy, installation of heat pumps, purchase of fossil free electricity and HVO (hydrotreated vegetable oil) for heating. The changes in production at the Beijing plant are also contributing to a reduction in emissions. For Scope 1 and 2 emissions (GHG Protocol), the KPI has declined by around 75 percentage points. |
|
| Chemicals and raw materials |
Hazardous chemical substances should be identified and, where possible, phased out. |
Some 20 hazardous substances were phased out. A handful of chemical substances have been identified as candidates for risk reduction. |
|
| Waste | The amount of waste should continually decrease in rela tion to net sales. The percentage of recycled waste should increase. The Group's units often use detailed tar gets regarding scrap and waste management. |
We are seeing a clear trend over the long term, with the percentage of waste disposed of in landfill declin ing and the percentage that is recycled rising. This target is part of the Group's continual improvement measures and has no specific deadline. The KPI indi cates a downward trend. |
|
| Environmental management systems |
All units to be ISO 14001-certified. Acquired companies should be certified within two years. |
All production units are certified in accordance with ISO 14001. |
|
| Environmentally sustainable products |
The percentage of bio-based and recycled raw materials should increase. Nolato will take part in projects with customers and other stakeholders aimed at reducing the environmental impact of existing or new products. |
During the year we used 43 tonnes of bioplastics and 626 tonnes of recycled plastics, which is an increase compared with the previous year. Interest is growing among our customers, but it will take time before these raw materials make up a significant proportion of the product portfolio. |


*Scope 1 (1,940 tonnes) and Scope 2 (31,990 tonnes)
under GHG Protocol.

Nolato business principles are characterised by integrity, responsibility and good ethics – basic principles that we share with suppliers, customers and others affected by our business operations. Prevention of corruption is a high priority. In this respect the Global Compact provides an ethical guide for employees and generates business benefits in the interaction with customers and other stakeholders.
| Area | Goals for sustainable development | SDGs | Outcome |
|---|---|---|---|
| Anti-corruption | There should be no cases of bribery, corruption or cartel formation. Continued active information to employees. |
Training, information and discussions are tools being used in anti-corruption work. The Group has introduced a whistleblowing system and no events relating to corruption or inadequate business ethics were recorded during the year. |
|
| Customers | Customer requirements regarding the environment and social responsibility shall be met by a comfortable margin. |
Many customers imposed sustainable development requirements and several expressed interest in bio based or recycled raw materials. During the year, customers carried out a significant number of evalua tions. On the whole, Nolato received excellent feed back from these evaluations. |
|
| Suppliers | Improved evaluation of suppliers' sustainability work. | In 2019, roughly 200 (250) evaluations of suppliers' sustainability work were conducted. The suppliers satisfied Nolato's requirements at an acceptable or good level. |
|
| Society, investors and analysts |
Reporting must be in accordance with GRI and CDP gui delines. Nolato will continue to endorse the Global Com pact. We aim to achieve good results in evaluations by analysts and independent institutions through transpa rent information in the field of sustainability. |
Sustainability work was reported in accordance with international standards. In daily business paper Dagens Industri's ranking 'Sustainable com panies 2019', the Group came in at number five in the capital goods category. |
With biomaterial as a raw material, the packaging of the future is here already. Only green electricity is used where possible in production, and there is an emphasis on recycling.
Nolato has worked on this basis for many years and is constantly looking ahead to the next stage on the path to a sustainable society.
"Plastic is an amazing material with a good product life, for the right application. According to the motto 'Design for Environment', our objective is to contribute towards sustainable development with effective and smart plastic packaging for pharmaceuticals. In a second generation of packaging we've also succeeded in reducing the amount of material used by 25%, without compromising on properties," explains Glenn Svedberg, Managing Director of Nolato Cerbo AB.
With sustainability in focus, the Nolato Group has switched over to green electricity at all plants that have access to it, that is everywhere except in China and the US.
"Besides switching to green electricity we are also
optimising our transport by maximising the number of products in each transport unit to avoid unnecessary emissions. Naturally we are also cutting the use of chemicals and continually trying to make our processes that bit cleaner. There's always room for improvement."
Designing for sustainability means always considering the recycling stage right from the start.
"For example, we need to try and avoid combining different plastics and refrain from using composite materials, as they are difficult to recycle."
"Nolato would love to use more recycled plastics, but at the moment there are restrictions due to regulatory requirements."
"In purely technical terms we could switch to using a large proportion of recycled material now, but we're not able to do so at present because regulatory authorities require us to have traceability all the way back to the raw materials. But if in the long term our suppliers are able to classify recycled material in the same group as virgin material, then we'll be ready," explains Glenn Svedberg.
Biomaterial, however, satisfies all the requirements, and Nolato is already using polyethylene (PE) from sugarcane for some of its packaging.
"The material essentially has the same properties as PE from fossil raw material, so we can use our existing machinery and tools, and with some minor adjustments to the manufacturing process make products based on bioplastic that offer the same technical performance as traditional fossil plastic. In 2020, a large portion of our standard range will be validated for bioplastics."
"Plastic as a material will continue to have a role in modern society. So it's vital to use all means to minimise plastic's footprint and contribute to a sustainable transition by increasing the use of recycled plastic and bioplastics."
Interview – Christer Wahlquist, Nolato President and CEO
The discussion on the role of plastic in our society is intensifying. What is Nolato's view on this? On the whole I think the debate on plastic is both relevant and important, provided it is balanced. Plastic has both positive and negative effects from an environmental perspective, so it's not that simple. You have to have a degree of pragmatism and understand that in many ways plastic will continue to have an important role to play in society. For example, when plastic is used to replace metals and other heavy materials in the automotive and aviation industries, it helps reduce weight and fuel consumption, and thus carbon dioxide emissions. In the construction industry, plastics are used as an insulation material, which is positive from an energy perspective. Plastics as packaging material in retail reduce both weight and fuel consumption. At the same time, plastic is based on fossil crude oil, and single-use plastic or plastic used in consumer products with a short lifespan tends to end up in the natural environment and oceans, where it can take hundreds of years to break down.
We use somewhere in the region of 40,000 tonnes of plastic a year and we make products that have both a long and a short lifespan. Long-lasting products are used as components in items such as vehicles, mobile phones, household appliances and medical devices. Most of the time there are efficient systems in place for collecting and recycling the plastic in products such as these. Short-lived products include pharmaceutical packaging and single-use products within health care. Many of these products are recycled, but we cannot rule out the possibility of some of them ending up littering the environment.
Being a high-tech developer of polymer products is key for us. The customer approaches us with a concept or an initial outline of a product, which they plan to launch on their markets. By working alongside the customer at an early stage, we can contribute towards the development of a functional, cost-effective and environmentally sustainable product. Success factors include experience, in-depth knowledge of the materials and processes, involvement early on in the project, expert project management and a sound knowledge of customers and markets.
In environmentally sustainable product development, we focus specifically on reducing the
product's fossil raw material content and increasing recyclability. We have good examples within pharmaceuticals and consumer packaging where we are reducing the product's weight and thus its carbon footprint. It's also possible to increase the content of fossil-free filler material in the plastic, which is something that we're doing with breathing bags, for example.
We're currently using just over 625 tonnes of recycled plastic in products that are mainly for the automotive industry, and we're confident that usage will increase. The same applies to bioplastics, which we've been successfully testing as a raw material in Nolato's production technologies. Our offering therefore includes the possibility for customers to make an active choice and opt for an environmentally sustainable solution.
It varies hugely between different sectors. But overall I'd say that demand for materials that are more sustainable is growing. A key driver is the general transition to fossil-free alternatives that companies are having to go through. Increasing the proportion of products based on bioplastic or recycled plastic for example is often a strategic decision that can help strengthen a company's position in the market and generate new commercial value. For example, we know that one of our customers in the automotive industry has a strategic target of all new vehicles containing 25% recycled plastic by the year 2025.
Medical Solutions launched a product made from bioplastic derived from sugarcane during the year. It's an excellent material and we're now introducing it as an alternative in a number of ongoing customer projects. Other customers are increasingly interested in using more recycled plastic in their products. Whatever our customers choose, here at Nolato we have the expertise and capacity needed to guide companies, based on needs and opportunities, through the sustainability transition of phasing out of fossil raw materials.


It's 10 years since Nolato became a member of the UN Global Compact and the then Secretary-General Ban Ki-moon approved our application. Over the ensuing years, the network has grown to become the world's largest sustainable development network. Around 13,000 organisations have signed up to the Global Compact, 300 of which are in Sweden.
"The clear requirements for active measures by members sets the Global Compact apart from other sustainability initiatives. It's not enough to just sign a document and carry on as usual. As a member Nolato has committed to supporting 10 fundamental principles concerning human rights, labour law, the environment and anti-corruption. The Group also aims to contribute to the UN Sustainable Development Goals. In practice this means that each year Nolato has to report to the UN on what has been done. If a company fails to submit its
reporting, it is quickly excluded from the network.
The Global Compact is a global initiative focused on issues of importance for the whole of society. It is consequently an important element of Nolato's sustainable development strategy. The network also provides the Group with access to guidance and relevant reports, along with the opportunity to meet other companies and exchange experience. The annual report to the UN is part of Our Sustainability Work 2019 (www.nolato. com/sustainability).


Based on the same core values and technologies, Nolato's three business areas all work towards the same objective of being the customer's solutions provider. The potential for the greatest possible customer value can be found in the meeting point between the business areas' local presence, close customer relationships and the Group's combined expertise.
Nolato is made up of a number of stand-alone companies organised into three business areas. All of them develop their business based on expertise, market conditions and the differing needs of customer segments. The decentralised business model is also one of Nolato's many strengths, providing each company with considerable freedom to tailor its offerings to the specific needs of each customer. A high degree of decentralisation also provides the basis for an organisation that's close to decisions, with significant opportunities for flexibility in customer relationships, and generates employee engagement and motivation.
The beneficial effects of this can be seen in the business areas' financial results and growth exceeding the level of each market segment.
Collaboration between the business areas is becoming increasingly common as synergies generate real benefit for customers. Nolato's combined expertise is available to customers that wish to benefit from it. Comprehensive customer-specific solutions can be delivered in the form of subsystems or complete products by sharing production units, expertise in technologies, materials and processes. This simplifies and cuts
customer time to market and helps generate additional business value.
Examples include Industrial Solutions' establishment of operations at Medical Solutions' Wisconsin-based production unit in the US, enabling effective expansion together with an existing customer. In addition, the other two business areas can benefit from Industrial Solutions' in-depth experience of lean manufacturing, and as electronics and the Internet of Things are integrated into products, Integrated Solutions can assist through its expertise in both EMC shielding and heat dissipation for electronics.

Integrated Solutions 2005–2019 Expansion into new market segments

Industrial Solutions 2005–2019 Technological and geographical expansion


Express aim of growing on the American, European and Asian markets. Operates in a sector with stable growth driven mainly by population growth, an aging population and lifestyle diseases. Growing demand for outsourcing services and medical devices that make life easier for patients. Acquisition opportunities are continually considered.
Continued focus on the American, European and Asian markets. Continual demand for advanced components and subsystems for consumer electronics products, in addition to a growing need for shielding and heat dissipation for electronics.
Continued emphasis on the industrial sector on the Nordic market and selected Central European markets, with the possibility of bolt-on acquisitions. The establishment of production in the US brings a valuable increase in capacity and new business opportunities. The ability to supply high-quality cost-effective products with short lead times based on customer requirements is a key growth driver.
An end-to-end solution offering that generates increased customer value. The local team of experts with a dedicated customer team that takes overall responsibility for projects and delivery in close cooperation with the customer. Access to the entire Group's expertise and resources + combination of close cooperation and an efficient decision-making structure with the local customer team. Nolato's combined expertise Nolato's local customer team Putting the customer front and centre
The business areas' share of net sales


Medical Solutions develops and manufactures complex product systems and components within medical technology, as well as advanced packaging solutions for pharmaceuticals and dietary supplements.
Continued sales growth of 5%, with both Medical Devices and Pharma Packaging contributing healthy growth across most product areas. High project activity and gradually increasing production capacity as the investments made in production units were realised. Launch of a new bioplastic packaging product based on fossil-free polymers.
| Financial highlights: | 2019 | 2018 |
|---|---|---|
| Sales, SEKm | 2,484 | 2,270 |
| Operating profit (EBITA), SEKm | 320 | 295 |
| EBITA margin, % | 12.9 | 13.0 |
| Average no. of employees | 1,624 | 1,497 |

Low. Steady market growth. Long-term growth potential.
Long product life cycles.


Abbott, Becton Dickinson, Boston Scientific, Coloplast, Hamilton, Medtronic, Novo Nordisk, Pfizer, Roche, Sanofi, Takeda.
Bespak/Consort, Carclo, Gerresheimer, Nemera, Phillips-Medisize, West Pharmaceuticals.
The Medical Solutions business area comprises two business sectors:
The expected global volume growth for medical devices remains stable at around 4–5%. The main drivers are global population growth, increased access to medication in developing countries, an aging population, and more people being affected by lifestyle diseases. This is resulting in a greater need for health care, much of which will have to take place in the form of self-care at home using medical devices that patients can easily handle themselves. The need for more precise diagnostics of clinical samples is also a key driver for in vitro diagnostics (IVD).
Medical Solutions' market is characterised by companies that:
One effect of these market trends is continued consolidation among both customers and competitors. On the one hand this means that small providers with limited offerings and a restricted geographical presence are at risk of being eliminated or bought up. On the other hand, established end-to-end providers with a global presence have good opportunities to grow faster than the market.
Medical Solutions is well positioned to respond to the changes taking place on the market. This is primarily thanks to its indepth medical understanding that puts the patient front and centre with wide-ranging expertise to develop and manufacture both customer-specific solutions and platform solutions for a global market. It has good capabilities to meet the growing demand for green materials, i.e. to lead development towards a lower proportion of fossil raw materials in packaging solutions. And to respond to rapid technological development, particularly in the area of the Internet of Things (IoT).
Over the past decade, Medical Solutions has progressed from being a local component manufacturer to being a global end-to-end provider with the resources and capabilities to support customers throughout the process; from concept and design to validation and full-scale production. The offering consists of a broad technological base, advanced support in the development process and a global presence with production units in Europe, Asia and North America.
Pharma Packaging's leading market position in Scandinavia and the UK is complemented by significant global exports. The strong customer offering is based on in-depth understanding of regulatory management and applicable quality requirements for both individual components and entire packaging solutions. Pharma Packaging's forte is being one of only a few packaging system suppliers that is focused solely on the pharmaceutical and dietary supplements sector.
The favourable development for Medical Devices and Pharma Packaging was further bolstered during the year through a combination of earlier projects resulting in production at the same time as new projects were initiated and progressed according to plan.
Medical Solutions' vision is to be the acknowledged best systems solution development and production partner for medical technology and pharmaceutical companies.
This strategic focus is based on growing faster than the market in all segments. The aim is to do this both organically and through acquisitions, enabling rapid global expansion. The strategy is also based on growing alongside customers' businesses, and ensuring offerings comprising global production, design optimisation, product development and integrated electronics. This is combined with the sale of standard products via own channels and distribution networks.
Medical Solutions' aim is to continue growing faster than expected market growth of 4–5%. Strong growth is expected in particular on
markets for autoinjectors, insulin products, diagnostics and incontinence products. Greater interest in reducing the proportion of fossil raw materials in the design optimisation of packaging solutions can also be anticipated to increase, offering Medical Solutions a number of business opportunities. The expanded production capacity that is being rolled out globally is also key to ensuring capacity in line with the many customer projects that are already up and running, as well as forthcoming development projects.
Sustained intensive active marketing to existing markets will take place in order to gain new customers while advancing Nolato's positions with existing customers.


Net sales, quarter






Examples of therapy areas and products: asthma (inhalers, check valves), diabetes (insulin pens, infusion sets), hearing aids (seals, earpieces), heart rhythm treatment (seals for pacemakers, cardiac anchors), dialysis (seals, connectors), urology (catheter balloons, uridomes), surgery (catheter balloons, complete blood purification equipment), diagnostics (allergy tests, pregnancy tests).




Standard or customer-specific primary plastic packaging that meets pharmaceutical and dietary supplement industry requirements.

Medical Devices: Nolato Beijing Medical Beijing, China MD Thomas Hofflander (from 1 Feb. 2019) Nolato Contour Baldwin, Wisconsin, US MD Russell Steele Nolato Hungary Mosonmagyaróvár, Hungary Negoiesti, Romania MD Johan Arvidsson Nolato MediTech Hörby and Lomma, Sweden MD Torkel Skoglösa Nolato MediTor Torekov, Sweden MD Michael Holmström Nolato Stargard Stargard, Poland MD Wojciech Orlowski Nolato Treff Degersheim, Switzerland MD Guido Vollrath

Integrated Solutions designs, develops and produces advanced components, subsystems and ready-packaged products for consumer electronics. EMC & Thermal develops and manufactures shielding and heat dissipation products and systems for electronics.
Solid performance in both business sectors, along with the successful transfer of production from Beijing to Shenzhen and Suzhou. Significant move into the US market with the acquisition of Ja-Bar Silicone. In addition, the inventory situation in vaporiser heating products (VHP) gradually normalised in the spring, followed by the start of deliveries of new product variants in the second half of the year.
| Financial highlights: | 2019 | 2018 |
|---|---|---|
| Sales, SEKm | 3,292 | 3,720 |
| Operating profit (EBITA), SEKm | 427 | 473 |
| EBITA margin, % | 13.0 | 12.7 |
| Average no. of employees | 3,201 | 3,868 |

High. Project-based operations.
Product life cycle Short.


Ericsson, Fitbit, Huawei, Motorola Solutions, Google, Nokia, Sonos, Sony, Xioami, ZTE.
Some of Integrated Solutions' competitors Chiyoda, Chomerics, Jabil Green Point, Laird, Marian, BYD.
The Integrated Solutions business area comprises two business sectors:
A volatile market driven by technological developments and customer requirements The consumer electronics market is vast, agile and fast-changing. The mobile phone market, for instance, is highly volatile, having gone from being a growth industry to being regarded as a sector with relatively low overall growth expectations.
For Integrated Solutions the rapid growth of VHP products is positive, and the major regulatory changes occurring in the tobacco industry are a major driver, along with a general trend of healthier lifestyles.
This business area is adopting a strategic approach of introducing new offerings to gradually expand the customer base. This includes product areas such as Laser Applications and Ceramics, aimed at companies developing fitness trackers, loudspeaker systems, thermostats and webcams.
Growth on EMC's market is chiefly fuelled by growing needs for applications and products that can be tailored to 4G and 5G networks as the number of new connected products grows. Increased network traffic is in turn leading to greater requirement for process and materials solutions for shielding (EMC) and heat dissipation (Thermal). The business area is also well positioned to meet a rising need for materials that are used for demanding cooling of electronics in sectors such as telecom, automotive, home electronics, IT and medtech. These are known as thermal interface materials (TIM).
Integrated Solutions is largely a niche operator in consumer electronics product areas, based on in-depth in-house expertise in development, design and production.
Its role is well established in the VHP
product area as a close strategic partner to one of the market's larger operators.
The business area has a strong position in EMC & Thermal mainly as a supplier of technically advanced products, such as shielding solutions for mobile phone network base stations and applications such as TIM in the automotive and other industries.
Integrated Solutions is aimed at being a partner and provider of technically advanced products mainly for high-end segments of the electronics and telecom industry. This strategic focus is based on growing faster than the market in all segments. This is being achieved through organic growth, with success factors including continued close relationships with existing customers and an expanded customer offering providing access to new customers and markets. In areas such as injection moulding, die-cutting, painting, decoration, assembly, testing and packaging of electronic products the business area aims to offer a one-stop shop, including advanced project management and rapid time to market.
The VHP area remains focused on developing its position as a strategic partner for one of the market's leading operators. The aim is to grow alongside the customer's business and launches on new markets by providing product development, production and assembly of complete products, delivered direct to the customer's distributors.
In addition, it will be intensifying development of electrically conductive material solutions for the shielding of electronics, along with the development of TIM products. The aim is to reach new markets and customer segments, both through direct sales channels and licensed partners.
The overall objective to grow faster than the market in all segments continues to apply. The long-term growth potential for most consumer electronics areas are assessed as good. The same is true for the VHP product area, which with a normalised inventory situation and the introduction of new product variants is expected to perform in line with the performance of the customer's business and product launches on new markets.
Intensive product development in EMC & Thermal is continuing, with the aim of being at the cutting edge for the 5G network roll-out. In addition to this is the development of new products and expansion of production to respond to the rapid advance of electronics in the automotive industry.
The acquisition of US-based Ja-Bar Silicone, offering additional production technologies and a large customer base, provides a basis for increasing value for both the business and customers.


Net sales, quarter





Subsystems for VHPs, mobile phones and home electronics products, which contain injectionmoulded, painted and decorated components, in certain cases integrated with electronics in the form of 'mechanical modules', which are sometimes water resistant. Creative material and surface design with significant cosmetic and haptic content. Small, designed adhesivebased components with mechanical and/or cosmetic functions, such as logos, speaker grilles and three-dimensional design elements.


Process and material solutions for the shielding of electronics to achieve electromagnetic compatibility (EMC), and for heat dissipation.
Beijing & Suzhou, China MD Thomas Hofflander (from 1 Feb. 2019)
Lövepac Converting Beijing, China Shenzhen, China Penang, Malaysia MD Dan Wong
Nolato Silikonteknik Hallsberg, Sweden Beijing, China Suzhou, China Penang, Malaysia Gyõr, Hungary New Jersey, US MD Anders Ericsson





Industrial Solutions develops and manufactures products and product systems, primarily in polymer materials, for customers in the automotive industry, hygiene, packaging, gardening/forestry, domestic appliances, furniture and other selected industrial segments.
Establishment and successful start of production in Wisconsin, US. Production began in a number of large customer projects. Efficiency measures resulted in gradual improvements in the margin.
| Financial highlights: | 2019 | 2018 |
|---|---|---|
| Sales, SEKm | 2,159 | 2,119 |
| Operating profit (EBITA), SEKm | 181 | 186 |
| EBITA margin, % | 8.4 | 8.8 |
| Average no. of employees | 1,109 | 1,078 |

Medium. Follows the Northern European industrial business cycle.
Medium/long.

A fragmented and differentiated market with good access to both customers and suppliers.

Development, production and sales in Sweden, Hungary, Switzerland, Romania and the US.
Atlas Copco, Brose, Geberit, Husqvarna, Jaguar/ Land Rover, MCT Brattberg, Scania, SKF, Volvo and Volvo Cars.
Some of Industrial Solutions' competitors Euroform, KB Components, Kunststoff Schwanden, Plastal, Rosti (Nordstiernan).
Industrial Solutions business is strongly customer oriented and mainly aimed at two customer sectors:
Both of these customer sectors feature continual and extensive purchasing of large volumes and long product series.
Industrial Solutions is active on markets that are competitive, fragmented and constantly under significant pricing pressure. In addition, fluctuations in industrial activity have an impact on market performance.
The European market for the manufacture of polymer products consists of around 50,000 companies with combined sales of
over SEK 500 billion. The majority are family-owned companies with a strong local connection and annual sales of SEK 20–35 million. Establishing a local presence is, in many respects, key for a global operator, both in building long-term, close customer relationships and because transporting large volumes of bulky products is expensive.
The Nordic market is similarly fragmented and highly competitive. In Sweden alone, where Industrial Solutions has its largest presence, there are over 700 manufacturers of polymer products, many of which are small with fewer than five employees. In view of Industrial Solutions' capacity and expertise as an end-to-end provider and high-tech cooperation partner, however, there are only a small number on the Swedish market that can be regarded as competitors.
The main driver for the business area's customers is being able to offer cost-effective high-quality products on their respective markets. There is a demand for end-to-end suppliers that offer capacity and expertise in integrated production processes, enabling higher added value for customers. Performance of the automotive industry on the Swedish market has been particularly favourable for Industrial Solutions, with customers like Scania and Volvo Cars, whose investment in new models is driving increased volumes.
Thanks to its in-depth expertise and experience, the business area has grown and adjusted its offering to the changing needs of the export industry. This means the market position reflects the needs and demands of customers, which Industrial Solutions encounters by being everything from a high-volume manufacturer of components to a high-tech solutions provider involved from development to delivery of a finished product to market.
Industrial Solutions has a leading position on the Swedish market. All eight of the business area's units have strong and often leading positions on their respective markets. In Central Europe, Industrial Solutions also has a strong position as a quality supplier of products in the hygiene sector and precision components for domestic appliances. The establishment of production in the US during the year also provides good opportunities to start building a position on a new market for Industrial Solutions.
Industrial Solutions' objective is to be a leading high-tech supplier, providing development and production of products and product systems in polymer materials for customers in the automotive and general industry sectors. The business area's strategic focus is based on growing faster than the market in all segments.
With the Nordic market as its base, Industrial Solutions aims to grow by developing existing customers and taking market share in these segments. Acquisition opportunities are continually considered as a complement to organic growth.
A key part of its strategy is also to establish Industrial Solutions as a high-tech partner to customers, which requires continued investment in advanced technology that contributes high added value and increased productivity for customers.
Lean manufacturing provides the basis for everything the Group does and helps it achieve its strategic objectives. For Industrial Solutions this involves ensuring things are well organised, that employees are enthusiastic and engaged, an increasingly high degree of integrated processes and automation, minimal warehousing and an aim to eliminate production defects.
The investment made in Sweden and Central Europe alongside establishing a presence in the US is already providing a valuable increase in capacity and offers a sound basis for business and expansion opportunities on new markets.
Industrial Solutions intends to continue growing alongside customers, in terms of volumes and geographically, as well as in terms of technology. It still aims to do so while growing at a faster rate than the market.
Efficiency improvements have been implemented to boost profitability, and they remain a priority.


Net sales, quarter





Ball retainers and storage seals for ball bearings, armrests etc. for office chairs and fireproof cable ducts. Components for microwave ovens, components for strimmers and chainsaws (recoil housing, filler caps, air filter holders, etc.), flushing mechanisms for toilets and brew units for coffee machines.


Exterior details, engine components, gaskets for engines and exhaust systems, interior details, battery casings, etc.




Nolato Gota Götene, Sweden MD Olof Pettersson (from 1 Sept. 2019)
Nolato Hungary
Mosonmagyaróvár, Hungary MD Johan Arvidsson Nolato Lövepac Skånes Fagerhult, Sweden MD Henrik Enoksson
Nolato Plastteknik Gothenburg, Sweden MD Magnus Hettne
MD Anders Willman Nolato Romania
Negoiesti, Romania MD Johan Arvidsson
Nolato Treff Degersheim, Switzerland MD Guido Vollrath
Nolato Contour Baldwin, Wisconsin, US MD Russell Steele
Nolato AB was listed on the Stockholm Stock Exchange in 1984 and its class B shares are currently listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector. The share symbol is STO:NOLA B and the ISIN code is SE0000109811.
Nolato's B shares rose by 50% during the year (–32). The share price at the end of 2019 was SEK 550.00 (366.50). The highest closing price on Nasdaq Stockholm in 2019 was SEK 580.00 (03/07/2019) and the lowest closing price was SEK 352.00 (03/01/2019).
The turnover rate, i.e. the degree of liquidity, in open exchange trading in 2019 was 68%. There were 11,592 (12,052) shareholders at 31 December.


Total shareholder return and share price performance 2010–2019

The share capital of Nolato AB totals SEK 133 million, divided into 26,548,008 shares. Of these, 2,759,400 are A shares and 23,788,608 are B shares. Each A share entitles the holder to ten votes, while a B share entitles the holder to one vote. All shares have equal rights to the assets and earnings of the company.
Nolato has two share warrant programmes for management that could result in dilution of the number of shares. For further information, see Note 27 on page 77.
Nolato's dividend policy is to propose a dividend that exceeds 50% of profit after tax, taking accounting of Nolato's longterm development opportunities, financial position and investment needs. The Board of Directors proposes a dividend for 2019 of SEK 14.50 (14.00), corresponding to SEK 385 million (368).
The pay-out ratio, i.e. the dividend in relation to profit after tax, is 55% (51). The dividend yield was 2.6% in relation to the share price at 31 December 2019 . Over the last five years, the average yield from Nolato shares has been 3.3%.
There are no restrictions on the transferability of the shares as a result of legal provisions or the company's Articles of Association.
Nolato's management works continuously to develop and improve financial information, in order to provide the market with good conditions for determining the value of the company as fairly as possible. This includes participating actively when dealing with analysts, shareholders and the media. Information about the current and historical price of Nolato's B shares and monthly updates on Nolato's largest shareholders can be found on our website, www.nolato.com. On the website you will also find all interim reports, annual reports and press releases dating back 10 years.



| 10 years | 1,378% (yearly average 31%) |
|---|---|
| 5 years | 266% (yearly average 29%) |
| 3 years | 128% (yearly average 32%) |
| 2 years | 7% (yearly average 4%) |
Definition of total shareholder return (not IFRS measure): Total shareholder return shows the change in the share price, including reinvested dividends over the period.
Over the course of the year, Nolato's shares were monitored and analysed by analysts including the following:
ABG Sundahl Collier – Oskar Vikström +46 8 5662 8663

| Shareholders | % of capital | % of votes | |||
|---|---|---|---|---|---|
| 31 December 2019 | Change* 31 December 2019 | Change* | |||
| Jorlén family | 9.6 | –0.1 | 24.3 | –0.1 | |
| Boström family | 9.3 | –0.1 | 19.5 | –0.1 | |
| Hamrin family | 8.2 | –0.3 | 18.6 | –0.2 | |
| State Street Bank and Trust | 13.1 | 0.6 | 6.8 | 0.4 | |
| Lannebo funds | 6.9 | 2.1 | 3.5 | 1.0 | |
| Didner & Gerge Fonder Aktiebolag | 3.8 | 1.1 | 2.0 | 0.6 | |
| Handelsbanken funds | 2.4 | 0.1 | 1.2 | 0.0 | |
| JPM Chase NA | 2.2 | –0.1 | 1.1 | –0.1 | |
| Nordea investment funds | 2.1 | 1.7 | 1.1 | 0.9 | |
| CBNY Norges Bank | 1.9 | 0.8 | 1.0 | 0.4 | |
| BNY Mellon NA | 1.5 | –0.6 | 0.8 | –0.2 | |
| BNY Mellon SA/NV | 1.4 | –1.6 | 0.7 | –0.8 | |
| Second Swedish National Pension Fund | 1.2 | 0.0 | 0.6 | 0.0 | |
| Total for largest shareholders | 63.6 | 81.2 | |||
| Other shareholders | 36.4 | 18.8 |
*Change (percentage points) in shareholdings compared with 31 December 2018.
| 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|
| Basic earnings per share after tax (SEK) 1) | 26.60 | 27.44 | 21.74 | 12.77 | 15.97 |
| Shareholders' equity per share, before dilution, SEK 2) | 112 | 99 | 82 | 70 | 67 |
| Cash flow after investing activities excl. acquisitions and | |||||
| disposals per share, before dilution, SEK | 30.19 | 22.54 | 18.85 | 9.31 | 10.95 |
| Share price at 31 December, SEK | 550.00 | 366.50 | 539.00 | 263.00 | 257.50 |
| Price/earnings ratio, times 3) | 21 | 13 | 25 | 21 | 16 |
| Turnover rate, % | 68 | 92 | 66 | 58 | 75 |
| Dividend (2019 proposal), SEK | 14.50 | 14.00 | 12.50 | 10.50 | 10.00 |
| Yield (2019 proposal), % 4) | 2.6 | 3.8 | 2.3 | 4.0 | 3.9 |
| Dividend as a percentage of earnings per share (2019 prop.) | 55 | 51 | 57 | 82 | 63 |
| Average number of shares before dilution, thousand | 26,432 | 26,307 | 26,307 | 26,307 | 26,307 |
| Price/equity ratio per share, times | 4.9 | 3.7 | 6.6 | 3.8 | 3.8 |
| Market capitalisation at 31 December, SEK million | 14,601 | 9,642 | 14,180 | 6,919 | 6,774 |
1) Profit after tax divided by the average number of shares, IFRS measure.
2) Shareholders' equity divided by the number of shares.
3) Quoted share price at 31 December divided by earnings per share after tax.
4) Dividend for the year divided by the market price quoted on 31 December.
Nolato is a Swedish limited company. Its corporate governance is based on Swedish legislation (primarily the Swedish Companies Act), the regulations set out by Nasdaq Stockholm, the Swedish Code of Corporate Governance and the rules and recommendations issued by relevant organisations.
Nolato's formal corporate governance report is available to read on our website at www.nolato.com/corpgov. The report specifies how the assessment of the Board's work is conducted and reported.
Shareholders exercise their power of ownership at annual general meetings. Nolato's A shares entitle holders to ten votes, and the B shares to one vote. There is no restriction on how many votes shareholders may cast at general meetings.
Resolutions at annual general meetings are normally passed by simple majority. On certain issues, the Swedish Companies Act stipulates a specific minimum percentage of the shareholders present and/or a larger majority.
The meeting of the company at which the Board presents the annual accounts and the audit report is called the Annual General Meeting (AGM) and is normally held by Nolato in late April or early May. The AGM also deals with matters relating to subjects such as dividends, discharging the members of the Board and the President and CEO from liability, and electing the Board members, the Chairman of the Board and auditors. The AGM also determines the fees payable to the Board and the auditors, guidelines for the remuneration of senior executives and the principles for appointing the Nomination Committee for the next AGM.
Shareholders have the opportunity to ask questions about the company and its performance at the AGM. Shareholders also have opportunities to request that a particular issue be dealt with by submitting such a request in writing to the Board.
The Swedish Code of Corporate Governance is based on the principle of comply or explain. This means that companies which apply the Code may deviate from specific rules, but must then provide explanations and reasons for each individual deviation.
Nolato deviates from one point of the Code:
Point 2.4 states that the Chairman of the Nomination Committee should not be the Chairman of the Board or another Board member, and that no more than one of the Board members on the Nomination Committee may not be independent of the company's major shareholders. Nolato's largest shareholders are of the opinion that the company's ownership structure, with three families that hold just over 60% of the votes, is best represented within the Nomination Committee by these shareholders together with other major shareholders. Since the representatives of these families have such a large shareholding, they have deemed it to be both natural and necessary that they should also be involved and exercise their shareholders' interests through representation on both the company's Nomination Committee and the Board.
The 2019 Annual General Meeting elected Ernst & Young AB as Nolato's auditors, with authorised public accountant Joakim Falck as the principal auditor.
Joakim Falck, born in 1972. Authorised public accountant, Ernst & Young AB. Auditor of Nolato since 2018. Other clients include Xano Industri AB, Garo AB, Itab Shop Concept AB and Nefab.

The following overall policy documents for the Group have been established by the Board of Directors:
These define the platform of shared values for all Group operations.
This sets out the ethical and compassionate principles that Nolato employees are obliged to follow. Nolato's groupwide policies regarding the environment, working environment, suppliers and quality are integrated into the Code of Conduct.
This governs how financial risk should be managed within the Group.
This governs the Group's IT security structure.
This supplements the rules contained in the EU Market Abuse Regulation and other insider trading legislation with directives on notification obligations and trading in Nolato's shares.
This regulates the restrictions on employees having business relationships with certain individuals, companies, governments and countries according to sanctions, laws and rules issued by various countries at any given time.
This governs the Group's systems and procedures for receiving and handling reports of possible irregularities.
The Nomination Committee is responsible for submitting proposals to the AGM regarding the Chairman of the Board, Board members, directors' fees, remuneration for committee work, how the Nomination Committee should be appointed for the coming year and submitting proposals regarding auditors and auditors' fees.
The right of shareholders to determine Nolato's affairs is exercised at the annual general meeting (AGM), which usually takes place in late April or early May. Among other things, the AGM elects the Board of Directors and takes decisions regarding a dividend, directors' fees and adopts the annual accounts. By registering a matter in writing with the Board within certain timeframes, shareholders have the right to have a matter addressed by the AGM.
The Auditor is elected by the shareholders at the AGM to audit the company's annual report and accounts, and the Board and CEO's management of Nolato. The auditor also reviews the remuneration of senior executives and the corporate governance report.
Reporting takes place to the Board and the Audit Committee. At the AGM, the auditor provides information about the auditing work and observations made in an auditors' report.

Nolato's operations. It appoints, dismisses and oversees the President and CEO.
The President and CEO manages business operations within the framework established by the Board of Directors. In consultation with the Chairman of the Board, the President and CEO draws up the necessary information and documentation for the Board's decision-making, presents items and justifies proposals. The President and CEO is responsible for Nolato's commercial and financial performance, and manages and coordinates dayto-day operations in accordance with the guidelines and decisions of the Board.

Group management is appointed by the President and CEO and, besides the President and CEO, consists of the CFO and the three business area presidents.
The Group's three business areas coordinate the activities in a number of Group companies with a similar focus. Each business area is managed by a business area president with overall responsibility for operations.
Each Group company has a managing director. It has its own board of directors, which approves and makes decisions on the company's long-term strategies and overall structural and organisational changes.
Reporting and control occurs by means of the Board and the Audit Committee analysing and assessing risks and control environments, and overseeing the quality of financial reporting and Nolato's internal control systems. This takes place through, for example, issuing instructions to the President and CEO and establishing requirements for the content of the financial performance reports provided to the Board on an ongoing basis. In addition, the Committee is responsible for making recommendations and proposals for ensuring reporting reliability. The Board reads and checks financial reporting such as monthly reports, forecasts, interim reports and the Annual Report. The committee must inform the Board of the result of the audit, how it contributed to the reliability of reporting and what role the committee had.





| Name | Fredrik Arp | Dag Andersson | Sven Boström-Svensson | Lovisa Hamrin | Åsa Hedin |
|---|---|---|---|---|---|
| Elected | 2009 (also member 1998–1999) |
2014 | 2013 | 2017 | 2014 |
| Position | Chairman of the Board and Chairman of the Remuneration Committee. |
Board member | Board member | Board member | Board member |
| Born | 1953 | 1961 | 1983 | 1973 | 1962 |
| Education | Master of Science (Economics) and Ec. Doctor h.c. |
Master of Science (Economics), Stockholm School of Economics. MBA INSEAD. |
Bachelor of Science (Che mistry) Master of Science (Analytical Chemistry) and Bachelor of Science (Economics). |
Master of Science (Eco nomics and Business), Stockholm School of Economics and Bachelor of Science. |
Master of Science (Bio physics), Bachelor of Science (Physics). |
| Other assignments |
Chairman of Bravida Holding AB. Board member of Vat tenfall and Swedfund International. |
Board member of GHP AB (publ), Terveystalo OY (publ) and XVIVO AB (publ). |
— | Chairman of the Carl-Olof and Jenz Hamrin Foun dation. Board member of JIBS Strategy Board. |
Board member of Tobii AB, Cellavision AB, C-Rad AB, Immunovia AB and Industrifonden AB. |
| Background | CEO of Volvo Cars, Trelleborg, PLM. |
President and CEO of Diaverum AB. Deputy CEO of Mölnlycke Health Care, various positions at SKF. |
— | Owner and President of Herenco AB, owner and Executive Chairman of Herenco Holding AB, senior management positions at Hall Media AB and Schibsted. |
Deputy CEO of Elekta AB. Senior management positions at Siemens Healthcare and Gambro AB. |
| Attendance | 8 out of 8 meetings | 7 out of 8 meetings | 8 out of 8 meetings | 7 out of 8 meetings | 7 out of 8 meetings |
| Remuneration1) | 595,000 | 215,000 | 215,000 | 215,000 | 215,000 |
| Shareholding 2) | 3,000 B (3,000 B) |
5,000 B (10,000 B) |
255,870 B (255,870 B) |
819,200 A + 1,431,743 B (819,200 A + 1,486,743 B) |
0 (0) |
| Dependence | Independent of the com pany and major share holders. |
Independent of the com pany and major share holders. |
Independent of the com pany but not independent of major shareholders. |
Independent of the com pany but not independent of major shareholders. |
Independent of the com pany and major share holders. |
1) For further information about remuneration, see Note 27 on page 77.
2) Shareholding in Nolato at 31/12/2019 (31/12/2018) incl. family and companies, according to Euroclear Sweden. For current information see www.nolato.com

| Name | Henrik Jorlén | Lars-Åke Rydh | Jenny Sjödahl | Björn Jacobsson | Håkan Svensson |
|---|---|---|---|---|---|
| Elected | 1974 | 2005 | 2016 | 2015 (also member 2000–2013) Deputy 2014 |
2014 Deputy 2009–2014 |
| Position | Board member and member of the Audit and Remuneration Com mittees. |
Board member and Chairman of the Audit Committee. |
Board member | Employee representative from LO (the Swedish Trade Union Confederation). |
Employee representative from PTK (Swedish Federa tion of Salaried Employees in Industry and Services). |
| Born | 1948 | 1953 | 1973 | 1971 | 1960 |
| Education | Business school | Master of Science (Engineering) |
Master of Science (Industrial Economics), MBA |
Upper secondary school | Upper secondary school. Completed PTK employee representative course. |
| Other assignments |
— | Chairman of Danfo AB, Olja ek. för., Schuchardt Maskin AB, Chiffonjén AB, CombiQ AB and Prototy pen AB. Board member of Nefab AB, Garo AB, Spectria Invest Fond AB, Söderbergsföretagen AB, Hjo Verktyg AB and Östrand o Hansen AB. |
Board member of Nibe Industrier AB. |
— | — |
| Background | Senior management positions within the Nolato Group. |
President and CEO of Nefab. |
CEO of Westermo Network Technologies AB (ongoing). Senior management positions within ABB. |
Employed at Nolato Gota. |
Employed at Nolato Cerbo. |
| Attendance | 8 out of 8 meetings | 8 out of 8 meetings | 7 out of 8 meetings | 8 out of 8 meetings | 8 out of 8 meetings |
| Remuneration1) | 262,000 | 285,000 | 215,000 | 0 | 0 |
| Shareholding 2) | 294,000 A + 37,950 B (294,000 A + 37,950 B) |
2,000 B (2,000 B) |
0 (0) |
0 (0) |
0 (0) |
| Dependence | Independent of the com pany but not independent of major shareholders. |
Independent of the com pany and major share holders. |
Independent of the com pany and major share holders. |
— | — |
Deputy employee representatives are Arif Mislimi (LO Swedish Trade Union Confederation), Mats Larsson and Reynaldo Mejedo (PTK organisation). 1) For further information about remuneration, see Note 27 on page 77.
2) Shareholding in Nolato at 31/12/2019 (31/12/2018) incl. family and companies, according to Euroclear Sweden. For current information see www.nolato.com





| Name | Christer Wahlquist | Per-Ola Holmström | Johan Iveberg | Jörgen Karlsson | Johan Arvidsson |
|---|---|---|---|---|---|
| Employed | 1996 | 1995 | 2010 | 1995 | 1994 |
| Position | President and CEO since 2016. |
Executive Vice President and CFO since 1995. |
President of Medical Solutions since 2016. |
President of Integrated Solutions since 2009. |
President of Industrial Solutions since 2012 and MD of Nolato Hungary since 2008. |
| Born | 1971 | 1964 | 1969 | 1965 | 1969 |
| Education | Master of Science (Engineering) MBA |
Bachelor of Science (Economics) |
Master of Science (Engineering) |
Polymer Engineering | Master of Science (Engineering) |
| Background | Business Area President. MD in Group companies. |
Authorised Public Accountant. |
Senior positions with Trelleborg, Akzo Nobel and Perstorp. MD in Group companies. |
Marketing manager. MD in Group companies. |
MD in Group companies. |
| Shareholding1) | 17,712 B (15,712 B) |
15,084 B (14,084 B) |
5,500 B (3,000 B) |
2,000 (0) |
10,000 B (5,000 B) |
| Warrants | 38,000 (Series 2017/2020) 38,000 (Series 2018/2021) |
19,000 (Series 2017/2020) 19,000 (Series 2018/2021) |
19,000 (Series 2017/2020) 19,000 (Series 2018/2021) |
19,000 (Series 2017/2020) 19,000 (Series 2018/2021) |
19,000 (Series 2017/2020) 19,000 (Series 2018/2021) |
1) Shareholding in Nolato at 31/12/2019 (31/12/2018) incl. family and companies, according to Euroclear Sweden. For current information see www.nolato.com
| Operations in 2019 and comments on the financial statements 48 | |
|---|---|
| Responsible business 49 | |
| Statutory sustainability report 49 | |
| Environmental issues51 | |
| Employees51 | |
| Zero tolerance on ethical issues51 | |
| Operational risks51 | |
| Management systems51 | |
| Nolato shares 52 | |
| Corporate governance52 | |
| Remuneration guidelines 52 | |
| Parent Company 52 | |
| Proposed appropriation of profits 52 | |
| Future performance 52 | |
| Consolidated income statement and comprehensive income56 |
|---|
| Comments on the consolidated income statement 57 |
| Consolidated balance sheet 58 |
| Comments on the consolidated balance sheet 59 |
| Changes in consolidated shareholders' equity59 |
| Consolidated cash flow statement 60 |
| Comments on the consolidated cash flow statement61 |
| Note 1 General information 62 | |
|---|---|
| Note 2 Accounting and valuation policies 62 | |
| Note 3 Operating segments 63 | |
| Note 4 Revenue 64 | |
| Note 5 Research and development65 | |
| Note 6 Expenses allocated by type of cost 65 | |
| Note 7 Other operating income and operating expenses 65 | |
| Note 8 Financial income and expenses 66 | |
| Note 9 Tax 66 | |
| Note 10 Earnings per share68 | |
| Note 11 Non-current intangible assets68 | |
| Note 12 Property, plant and equipment 69 | |
| Note 13 Leases70 | |
| Note 14 Financial assets71 | |
| Note 15 Inventories73 | |
| Note 16 Other current assets 73 | |
| Note 17 Shareholders' equity73 | |
| Note 18 Other reserves73 | |
| Note 19 Financial liabilities 74 | |
| Note 20 Provisions for pensions and similar obligations 75 | |
| Note 21 Other provisions 76 | |
| Note 22 Other current liabilities76 | |
| Note 23 Pledged assets and contingent liabilities76 | |
| Note 24 Related parties 77 | |
| Note 25 Cash flow 77 | |
|---|---|
| Note 26 Events after the end of the financial year 77 | |
| Note 27 Remuneration of senior executives 77 | |
| Note 28 Information on remuneration of auditors 78 | |
| Note 29 Average number of employees 79 | |
| Note 30 Financial risk management79 | |
| Note 31 Acquisitions 82 | |
| Five-year review | |
| Five-year review key performance indicators 83 | |
| Alternative performance measures 84 | |
| Definitions | |
| Definitions 85 | |
| Glossary | |
| Specialist terms85 | |
| Parent Company financial statements* | |
| Parent Company income statement and comprehensive income 86 | |
| Parent Company balance sheet86 | |
| Parent Company changes in shareholders' equity 87 | |
| Parent Company cash flow statement87 | |
| Notes to the Parent Company financial statements* | |
| Note 1 Accounting and valuation policies 88 | |
| Note 2 Purchasing and sales between Parent Company and subsidiaries 88 | |
| Note 3 Information on remuneration of auditors 88 | |
| Note 4 Other operating income 88 | |
| Note 5 Other operating expenses 88 | |
| Note 6 Personnel 88 | |
| Note 7 Revenue from investments in Group companies89 | |
| Note 8 Financial income89 | |
| Note 9 Financial expenses 89 | |
| Note 10 Appropriations 89 | |
| Note 11 Tax 89 | |
| Note 12 Expenses allocated by type of cost 89 | |
| Note 13 Investments in Group companies 90 | |
| Note 14 Share capital 91 | |
| Note 15 Borrowings 91 | |
| Note 16 Receivables and liabilities, Group companies 91 | |
| Note 17 Other provisions 91 | |
| Note 18 Accrued expenses and deferred income91 | |
| Note 19 Untaxed reserves91 | |
| Note 20 Contingent liabilities 91 |
| Attestation and signatures of the Board 92 | |
|---|---|
| Auditor's report93 |
Note 21 Related parties ................................................................................91 Note 22 Appropriation of profit......................................................................91
*The content of pages 47–92 has been audited.
2015 2016 2017 2018 2019 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 SEKm Sales Operations in 2019


Basic earnings per share

The Board of Directors and President and CEO hereby publish the annual accounts and consolidated accounts for Nolato AB (publ), company registration number 556080-4592, for the 2019 financial year.
Nolato is a Swedish publicly listed group with 5,941 employees in wholly owned subsidiaries in Europe, Asia and North America. The companies in the Group develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive and other selected industrial sectors.
The business model is based on close, long-term and innovative collaboration with customers. Nolato endeavours to create added value for both customers and shareholders through leading technology, wide-ranging capabilities and highly efficient production.
Nolato's shares are listed on Nasdaq Stockholm Exchange in the Large Cap segment, where they are included in the Industrials sector.
Nolato's operational activities are conducted in three customer-focused business areas:
Medical Solutions: Development and manufacture of complex product systems and components within medical technology, diagnostics (IVD) and advanced packaging solutions for pharmaceuticals.
Integrated Solutions: Development and manufacture of advanced components and subsystems for selected consumer electronics products and mobile phones. Within EMC & Thermal, products and systems for shielding.
Industrial Solutions: Development and manufacture of products and product systems for customers in the automotive industry,
hygiene, packaging, gardening/forestry, furniture and other selected industrial segments.
The activities of these three business areas are based on the same core elements of corporate responsibility, wide-ranging technical capabilities and advanced production technology. These business areas all enjoy good opportunities to create their own optimal conditions to succeed as a result of their specialisation in and adaptation to their respective customer sectors.
As all three business areas are affected differently by business cycle fluctuations, events and market patterns, the Group benefits from a healthy balance in its operations. Medical Solutions operates on a market with long product life cycles and low business cycle dependency, while Integrated Solutions is the opposite, with short product lifespans and high project volatility. And between these two is Industrial Solutions.
The operations of these business areas are presented in more detail on pages 28–39.
Consolidated sales declined by 2% in 2019, amounting to SEK 7,919 million (8,102). Adjusted for currency and Group structure, sales decreased by 7%. Operating profit (EBITA) fell to SEK 895 million (949), giving an EBITA margin of 11.3% (11.7).
Operating profit (EBIT) totalled SEK 887 million (941) after an expense of SEK 8 million in amortisation of intangible assets arising in connection with acquisitions. The EBIT margin was 11.2% (11.6). For further financial information, see the fiveyear review on page 83.
Consolidated profit after tax was SEK 703 million (722). Basic earnings per share were SEK 26.60 (27.44). Adjusted basic earnings per share excluding amortisation of intangible assets arising from acquisitions
| Sales | Operating profit EBITA | EBITA margin (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| SEKm | 2019 | 2018 | 2017 | 2019 | 2018 | 2017 | 2019 | 2018 | 2017 |
| Medical Solutions | 2,484 | 2,270 | 1,955 | 320 | 295 | 257 | 12.9 | 13.0 | 13.1 |
| Integrated Solutions | 3,292 | 3,720 | 2,810 | 427 | 473 | 332 | 13.0 | 12.7 | 11.8 |
| Industrial Solutions | 2,159 | 2,119 | 1,968 | 181 | 186 | 195 | 8.4 | 8.8 | 9.9 |
| Intra-Group adj., Parent Co. | – 16 | – 7 | – 13 | – 33 | – 5 | – 21 | — | — | — |
| Group total | 7,919 | 8,102 | 6,720 | 895 | 949 | 763 | 11.3 | 11.7 | 11.4 |
amounted to SEK 26.82 (27.67). The effective tax rate was 18.0% (21.6).
Sales for the Medical Solutions business area amounted to SEK 2,484 million (2,270); adjusted for currency, sales increased by 5%. Sales increased in both Medical Devices and Pharma Packaging, and most product areas experienced good growth. Growth in the second half of the year was affected by strong comparative figures, which contained very high sales from development work and billing of production equipment.
Operating profit (EBITA) rose to SEK 320 million (295). The EBITA margin was 12.9% (13.0).
Integrated Solutions sales amounted to SEK 3,292 million (3,720); adjusted for currency, sales decreased by 18%. Following inventory adjustments in vaporiser heating products (VHP) towards the end of the previous year and in the first quarter of 2019, the inventory situation normalised. The first quarter consequently began with low volumes, but these grew sequentially over the remaining quarters of the year. Heating Devices started delivering new product variants in the third and fourth quarters, which made a positive contribution. Volumes in the EMC area were stable over the period, while mobile phones were initially weak but performed well in the second half of the year.
Operating profit (EBITA) was SEK 427 million (473). The EBITA margin was a strong 13.0% (12.7).
Nolato completed the acquisition of USbased Ja-Bar Silicone Corporation in the fourth quarter. The final purchase price for the company was SEK 93 million (debt free company). The company, which has annual sales equivalent to approximately SEK 150 million with good profitability, strengthens Nolato's offering in process- and materialsbased electronics shielding solutions for electromagnetic compatibility or 'EMC'. The company was consolidated into the Group as of 18 December 2019. The transaction is expected to have a marginal positive effect on Nolato's earnings per share in 2020. The acquisition was financed using existing credit agreements.
Industrial Solutions sales were SEK 2,159 million (2,119); adjusted for currency and Group structure, sales were unchanged. Inventory adjustments in the hygiene area in the first half of the year had a negative effect. New customer projects in general industry were started in the fourth quarter,
boosting sales. A proportion of this invoicing is non-recurring. Volumes were stable during the year in most other product areas.
Operating profit (EBITA) totalled SEK 181 million (186), with an EBITA margin of 8.4% (8.8). The lower margin is due to the unsatisfactory efficiency of a production plant and high start-up costs in the fourth quarter for new general industry customer projects. Implemented and ongoing efficiency improvements are gradually having an effect.
For additional comments on financial performance, see page 57 part of the directors' report.
Nolato has a long tradition of responsible business, and one of our Basic Principles is that efficient and profitable business operations must be combined with sound business ethics, responsibility and environmental awareness. The company's sustainable development strategy is built on the conviction that a forward-looking and responsible approach creates opportunities and business benefits.
According to ÅRL Chapter 6, Section 11, the company has opted to summarise the statutory sustainability report in the annual report, and to provide a more detailed account in a separate Sustainability Report as per the guidelines in the Global Reporting Initiative (GRI). The Sustainability Report is available on our website at www.nolato.com. The table below gives details of where the statutory information can be found in the annual report. The reporting policies are described in the Sustainability Report.
| Annual report (page) |
|---|
| 14–15 |
| 50–51 |
| 20–22 |
| 21, 51 |
| Working conditions and social responsibility 20, 51 |
| 22, 51 |
| 55 |
| Diversity on the Board and in management 51 |
The Nolato Spirit booklet summarises the Group's core values, Code of Conduct and policies and explains how they relate to the business model. Since 2010, Nolato has been a signatory to the UN Global Compact, a framework document that comprises ten principles on the environment, human rights,
Cash flow after investments








labour and anti-corruption. These ten principles are incorporated into The Nolato Spirit. Nolato's long-term goals are linked to the UN Sustainable Development Goals introduced by the UN in 2015. In this way, the Group is contributing to the 2030 Agenda for Sustainable Development. Nolato's sustainability work is reported in accordance with the Swedish Act on Sustainability Reporting by Large Companies, Global Reporting Initiative (GRI) guidelines, the Carbon Disclosure Project (CDP) and the UN Global Compact (Communication on Progress; COP). Nolato's units are certified to the international standards ISO 14001 (environment), ISO 9001 (quality management) and, where applicable, to industryspecific ISO standards. We also work with health and safety and energy management standards. The ISO 26000 social responsibility standard provides guidance for our overarching sustainable development efforts.
The materiality analysis highlights the key issues for Nolato's stakeholders and the Group's business strategy. The analysis forms the basis of our sustainable development priorities and areas deemed to be highly significant include customer requirements within sustainable development, sound business ethics, being an attractive employer and legal requirements. Other prioritised areas are energy, climate, a safe work environment, human rights and plastics in a life cycle perspective. Sustainability issues in developing countries and the supplier chain are also issues that are being taken very seriously. Nolato has established long-term goals and key performance indicators (KPIs) for a number of the significant areas.
Nolato interacts with a number of stakeholder groups (customers, employees, suppliers, shareholders, society), which brings
requirements and expectations in relation to sustainable development. Our understanding of which stakeholders are significant – and what they consider to be important – is based on experience and long-standing commercial relationships, as well as events over the past financial year. Stakeholder engagement is carried out in multiple ways and includes performance reviews with employees, customer satisfaction surveys, analyst meetings and cooperation with customers, suppliers and contractors. An overview of stakeholder engagement can be found in the Sustainability Report.
We manage sustainability issues in a methodical way and have integrated them into strategic planning and our day-to-day operations. We have set Group sustainable development targets (see pages 20–22). Operational responsibility for sustainable development is delegated to the Managing Director of each Group company. These activities are followed up via dialogue with the companies' management and through internal and external audits. Along with the Sustainability Report, we also carry out an in-depth analysis of compliance with legislation, target outcomes and the development of performance and KPIs during the year. One representative on Nolato's Board has special responsibility for sustainability issues. Matters relating to strategy, risks, monitoring, sustainability reporting, sustainability issues associated with acquisitions and dialogues with investors are managed at Group level.
The manufacture of products in polymer materials is associated with a number of significant environmental aspects. Some examples include the use of materials (plastics, silicone rubber, metals), chemicals (solvents, varnish, paints), energy and water. Emissions of greenhouse gases and solvents (VOC), along with the occurrence of various types of waste, are other key environmental issues. Indirect environmental aspects relating to products, packaging and transportation are also significant. In the Group, the ISO 14001 environmental management system is a valuable tool as part of efforts to systematically reduce our environmental impact.
All production units in Sweden apart from one are obliged to provide notifications pursuant to the Swedish Environmental Code. Most of the Group's units outside Sweden require permits or are covered by similar requirements in accordance with
environmental legislation in the country in question. Sales from operations with permit requirements and notification obligations make up the majority of the Group's net sales. Routine updates to the environmental permits will be carried out at four plants in 2020. We do not anticipate any significant legal or financial consequences as a result of the renewal of these environmental permits.
Environmental legislation in the form of EU directives (REACH, RoHS, CLP, WEEE, energy efficiency, sustainability reporting), or other national or international legislation, relate in the main to the Group's operations and products. About two-thirds of the units are covered by legislation concerning producer responsibility for packaging. In most cases, regular reports are submitted to the environmental authorities, and the supervisory authorities carry out inspections. No significant breaches of environmental legislation were registered in 2019.
The average number of employees at Nolato in 2019 was 5,941 (6,449). Of the total number of employees in the Group, 47% (46) were women. Local management teams are made up of approximately 25% (22) women. Of Nolato's Board members, 30% (30) are women, while the corresponding figure for Group management is 0% (0). All units are wholly owned by Nolato and comply fully with the guidelines in Nolato's Basic Principles and Code of Conduct. The practical work relating to personnel issues in the Group is decentralised. This means each individual Group company is responsible for managing issues in a way that complies with both Group guidelines and the legislation and culture of the country in question. All Nolato employees have the right to be represented by trade unions, and to collective agreements. In Sweden and China, the majority of employees are covered by collective agreements. At the units in other countries, there are no unions or collective agreements, and this reflects a normal situation in these countries.
In Beijing, China, where the Group has its largest workplace with around 48% (51) of its employees, an Employee Care Programme was introduced and further developed in 2019. The programme aims to ensure good conditions for employees in the workplace, and to offer training and stimulating leisure activities.
In order to quickly alert the company to breaches of the Group's Code of Conduct or other serious irregularities, employees can sound the alarm regarding any irregularities
without risk of reprisals or pressure (whistleblowing). No such cases were reported in 2019.
The total figure for the average number of employees includes staff in China who are employed through staffing agencies. This form of employment has mainly been chosen to make it easier for the business to recruit a workforce for various projects and consequently avoid creating its own large recruitment organisation. In accordance with the Group's Code of Conduct, these employees are covered according to the same principles as Nolato's other employees in China with regard to the setting of wages, benefits, working hours, work environment, social responsibility, etc.
Nolato has zero tolerance of bribery, corruption and cartel formation. We therefore work continuously on managing and monitoring the methods used by the units within the Group to conduct business, based on Nolato's Basic Principles and Code of Conduct. We pay particular attention to ethical issues in our relationships with our partners. Standard business practice and corporate culture must be observed in each individual country, but if business practice does not comply with the Group's Code of Conduct we must refrain from doing business or take alternative actions. Managers and sales and marketing employees completed training on issues relating to corruption, cartel formation and sound business ethics. Using the Global Compact checklists, annual evaluations are carried out to examine what action is taken by Group companies to prevent corruption. No incidents relating to corruption or inadequate business ethics were recorded in 2019. The guidelines in Nolato's Code of Conduct also apply to suppliers and other business partners. Completed assessments revealed that our suppliers satisfied Nolato's requirements.
An important aspect of Nolato's strategic planning is identifying potential risks in the organisation, assessing their likelihood and any consequences and minimising the negative impact that such risks could have on the Group. Financial risks are managed in accordance with a financial policy established annually by the Board of Directors. An analysis of potential risks in Nolato's operations and how we manage these risks can be found on pages 53–55.
All of Nolato's production units are certified in accordance with requirements in the ISO 9001 quality management system, while 90% of the units are certified to industry-specific ISO standards, for example with a focus on the automotive industry (IATF 16949), medical technology (ISO 13485), food industry (ISO 22000) and pharmaceutical packaging (ISO 15378).
For the environment and work environment, all companies with the exception of the recently acquired Ja-Bar Silicone are certified according to the environmental management standard (ISO 14001), almost 30% according to the health and safety standards (OHSAS 18001/ISO 45001), and roughly 10% according to the energy management standard (ISO 50001). The social responsibility standard (ISO 26000) provides a guideline for Nolato's sustainable development work.
Nolato was registered on the Stockholm Stock Exchange OTC list in 1984. The company's B shares are now listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector. The company's A shares are not listed.
The share capital totals SEK 133 million, divided among 26,548,008 shares. Of these, 2,759,400 are A shares and 23,788,608 are B shares. Each A share entitles the holder to ten votes, while a B share entitles the holder to one vote. All shares have equal rights to the assets and earnings of the company.
At the end of 2019, Nolato had 11,592 (12,052) shareholders. The largest shareholders are the Jorlén family with 10%, the Boström family with 9%, the Hamrin family with 8%, Capital Group and Lannebo Funds with 7% each, Didner & Gerge Funds with 4% and Handelsbanken Funds with 2%.
Nolato does not own any of its own shares. There are no restrictions as a result of legal provisions or the company's Articles of Association that affect the transferability of the shares.
In 2017, 2018 and 2019, Nolato's management were offered the opportunity to acquire warrants for the purchase of shares at a predetermined price.
At the end of the period, the Group had two Incentive Programmes: Incentive Programme 2016/2021 and Incentive Programme 2019/2024. In Incentive Programme 2016/2021, Series 2017/2020 has redemptions from 01/05/2020 to 15/12/2020 and Series 2018/2021 from 01/05/2021 to 15/12/2021.
The subscription price is SEK 485.10 for Series 2017/2020 and SEK 502.00 for Series 2018/2021. In Incentive Programme 2019/2024, Series 2020/2023 has redemptions from 01/05/2023 to 15/12/2023 and Series 2021/2024 from 01/05/2024 to 15/12/2024. The programmes have been taken into account in calculating the number of shares after dilution. Upon full subscription, the programmes provide a maximum of 921,700 new class B shares.
Further information about Nolato's shares can be found on pages 40–41. Up-to-date information about the share price and shareholders is always available at www.nolato.com.
Basic information about the company's governance, Board of Directors and management can be found on pages 42–46. Nolato's formal corporate governance report is available at www.nolato.com/corpgov.
The guidelines for the remuneration of senior executives agreed on at the latest annual general meeting are detailed in Note 27 on page 77. This note also explains what happens if these executives resign or are dismissed by the company. These guidelines are also essentially the same as the Board's proposals for guidelines for the remuneration of senior executives proposed to the 2020 annual general meeting.
The Parent Company Nolato AB, which has no operating activities, is a holding company which carries out joint Group management functions and financial and accounting functions.
Sales totalled SEK 60 million (63). Profit after financial income and expense was SEK 396 million (414).
The profit at the disposal of the annual general meeting is as follows:
| Total | SEK 1,411 million |
|---|---|
| Profit for the year | SEK 563 million |
| Retained earnings | SEK 848 million |
The Board of Directors and the President and CEO propose that these earnings be appropriated as follows:
| Total | SEK 1,411 million |
|---|---|
| To be carried forward | SEK 1,026 million |
| Div. to shareh. of SEK 14.50 per share | SEK 385 million |
The proposed dividend is, in the view of the Board of Directors, justifiable with respect to the demands that the type and size of operations and the risks associated with them place on shareholders' equity and the company's capital requirements, liquidity and financial position.
Nolato's financial position remains very strong, providing flexibility and opportunities to act, while enabling our customers to feel secure in their choice of Nolato as supplier.
Nolato has an excellent platform for its future operations through a high level of technological expertise and professionalism, modern production units, a clear focus on sustainability and a customer-specific geographic presence in Europe, Asia and North America, as well as a strong financial position. For Medical Solutions, we see opportunities for sustained growth by investing in new projects and customer relationships. For Integrated Solutions, we will carry on extending our offering into related products with our integrated solutions. Industrial Solutions will continue expanding into new markets and growing through acquisitions.
We are continuing to explore acquisition opportunities, preferably in North America, but also bolt-on acquisitions on the technology side to enable us to expand our customer offering.
However, Nolato does not provide any earnings forecast because as a supplier, the company conducts operations that are highly dependent on its customers' internal decisions and commercial performance. Factors among customers that we cannot influence in the short term, such as postponed or cancelled projects, higher or lower sales volumes and longer or shorter product lifespan, are thus of great significance to Nolato's sales and profit.
The positions we have on the market and the investments we have implemented within each business area should enable us to continue to develop Nolato regardless of economic fluctuations. We will continue to grow by working even more closely with our customers to ensure we satisfy their demands and requirements.
An important aspect of Nolato's strategic planning is identifying potential risks in the organisation, assessing their likelihood and any consequences and minimising the negative impact that such risks could have on the Group. Financial risks are managed in accordance with a financial policy established annually by the Board of Directors.
The chart below shows our assessment of the probability of a risk occurring and – if it did – the anticipated impact on Nolato's operations and earnings.

| Operational risks | Risk exposure | Risk management |
|---|---|---|
| A Business cycle risk The risk that an economic downturn could have a significant impact on Nolato's perfor mance and earnings. |
Medical Solutions and Integrated Solutions' operations have a fairly low sensitivity to economic and business cycle fluctuations, while Industrial Solutions' business generally follows the Northern European industrial business cycle. |
Active monitoring of markets and efficient decision-making hi erarchy enable quick decisions to be taken to adapt resources at an early stage ahead of an anticipated economic downturn. |
| B Subcontractor risk The risk that changes at customers could have a significant negative impact on Nolato's performance and earnings. |
As a subcontractor, Nolato is highly dependent on customers' in ternal decisions and commercial performance. Factors among customers that we cannot influence include postponed or can celled projects, higher or lower sales volumes and longer or shorter product lifespans. |
By means of active and close contact with customers we endeavour to identify changes at an early stage and adapt our resources. Within mobile phone operations, which are characterised by rapid changes in project life cycles and volumes, all production takes place in Asia. This provides significant flexibility and good opportunities to manage this risk in a cost-effective way. |
| C Customer dependence The risk that changes at individual customers could have a significant negative impact on Nolato's performance and earnings. |
Dependence on individual customers is lowest in Industrial Solutions, whose market is made up of a large number of cus tomers. Medical Solutions also has good risk diversification across a large number of customers, while Integrated Solutions has fewer customers. |
We are endeavouring to broaden our customer base and offering within Integrated Solutions. |
| D Supplier dependence The risk of a supplier being unable to deliver to Nolato on time or at the right quality. |
If a significant, strategic supplier does not fulfil its undertakings we could face problems supplying on time and at the right quality to our customers. |
For input goods and machinery, this risk is limited by the fact that there are a number of alternative suppliers. In terms of components for system products, the choice of supplier is usu ally made in consultation with Nolato's customer. |
| E Raw material price risk The risk of an important raw material increasing in price and having a significant negative effect on various projects. In Nolato, this mainly applies to various plastic raw materials. |
Quantities of plastic raw material in our production vary from business area to business area. For Integrated Solutions, with its many thin-walled products, the plastic raw material only ac counts for around 5–15% of the selling price, while the corre sponding figure is around 20–25% for Medical Solutions and 25–30% for Industrial Solutions. |
We endeavour to include price adjustment clauses in supply agreements that cover an extended period of time. Product lifespan within Integrated Solutions is short, usually less than one year, which limits the risk in this business area. |
| F Energy cost risk The risk of the cost of energy rising and having a significant negative impact on profitability. Within Nolato this mainly applies to the pur chase of electricity. |
Nolato primarily uses electrical energy in production. In 2019, energy costs totalled SEK 158 million, of which 93% related to electricity. |
The risk of negative effects from rising electricity prices is ad dressed by the Group entering into fixed price agreements for 20–80% of electricity requirements for the next four to 12 quarters. |
| G Production risks The risk of significant supply delays and/or quality issues. |
As a subcontractor, the products and components that we man ufacture are supplied in accordance with customer specifications and quality requirements. Disruptions can mainly occur during the start-up of a project, but also during ongoing production. |
In order to counteract disruptions, the Group follows an advanced concept involving competent staff, quality assurance systems, vision monitoring systems and checklists. All production units apart from one are certified in accordance with ISO 9001. Most are also certified in accordance with industry-specific standards such as ISO/TS 16949 (automotive) and ISO 13485 (medical technology). |
| H Property damage and disruptions The risk of a negative impact on earnings and customer confidence as a result of a fire, explosion, natural disaster, damage to ma chinery, etc. |
Major property damage to a building or production equipment can lead to production losses that could impact the Group's profit. Our base technologies are in place at most of the Group's production units, making it possible to relocate production from one affected unit to another unit in the event of disruptions and consequently mitigate the effects of the damage. |
All units must follow Nolato's risk management manual to achieve the specified level of risk and thereby reduce the risk of significant damage and create strong security of supply. The risk manual also provides guidelines for the Group's property insurance. External risk engineers inspect the production units based on a rolling schedule to verify that risks are being man aged in line with the manual. |
| I Legal risks The risk of significant disputes with different external stakeholders. |
Legal risks can primarily arise in connection with the supply of products. This may concern issues relating to quality or liability and intellectual property rights. |
To prevent disputes Nolato works with external lawyers and consultants on legal issues, for example on agreements with customers and suppliers. The Group also has internal policies and regulations relating to which agreements senior executives are authorised to enter into. |
| J Product liability risk The risk of faults in a product manufactured by Nolato leading to significant financial claims on the Group. |
Design liability for products and components usually lies with customers. Nolato's risk is therefore limited solely to manufac turing faults. |
The Group follows an advanced concept involving competent staff, quality assurance systems and checklists. In many cases, in-line monitoring takes place using automated vision systems. All production units are certified in accordance with ISO 9001. Most are also certified in accordance with industry-specific standards such as ISO/TS 16949 (automotive) and ISO 13485 (medical technology). |
| Operational risks | Risk exposure | Risk management |
|---|---|---|
| K Sustainable development risks The risk of significant environmental damage, which could lead to costs or have a negative impact on Nolato's reputation. |
Nolato's operations do not involve any significant environmental impact through a risk of emissions to air, water and land. There are no known pollutants of land and groundwater at Nolato's plants. Hazardous substances (asbestos) are present in buildings and equipment to a very limited extent at a couple of plants. The risk to people and the environment is deemed to be very small. |
The production units have the necessary environmental permits and fulfil the requirements of other relevant environmental leg islation. All units apart from one are certified in accordance with ISO 14001. Regular risk assessments are carried out to identify new environmentally related risks and/or costs. Regular assess ments are carried out of the risk of ground contamination and other environmental damage in connection with company acquisitions. |
| The risk of climate change affecting the Group's operations. |
None of the Group's units are exposed to extreme weather con ditions or flooding. The units in Beijing are located in an area with limited access to water. |
The Group examines risk analyses relating to climate change conducted in the countries in which we operate. Climate-related risks are taken into account when carrying out acquisitions and supplier assessments. |
| The risk of lost business due to customers' interest in greater use of bio-based and recy cled polymer raw materials not being satis fied. The risk of lost business through society being more cautious about plastic products. |
Nolato makes polymer products that are primarily based on fos sil raw materials. The use of fossil raw materials contributes to climate change. Our range includes products with both long and short lifespans. There is a risk of products with short lifespans ending up littering the environment. |
Our range also includes a number of products that have an en vironmental benefit, for example through reduced weight and lower content of fossil raw materials. The Group is stepping up its efforts within environmentally sustainable product develop ment to reduce the risk of losing business, and to contribute to sustainable development. |
| The risk of the Group's costs increasing sig nificantly or of negative publicity owing to events relating to employees, respect for hu man rights, business ethics or other areas related to social responsibility. |
Nolato has large units active in Sweden, Hungary, the UK, Switzer land, the US and China. The majority of our employees are outside Sweden. The concentration in Asia brings a heightened risk in areas such as working conditions and business ethics (corruption). There is always a risk of failure to apply sound business principles, irrespective of where operations are pursued. The materiality analysis therefore gives business ethics a very high priority. |
All major units are wholly owned by Nolato, which facilitates the Group's management of sustainable development. Nolato has a significant focus on all units creating good working conditions for employees. Nolato has zero tolerance of bribery, corruption and cartel formation. Nolato's core values and Code of Conduct are continually communicated to staff. Whistleblowing is applied within the Group. Suppliers are regularly assessed via audits and questionnaires. |
| Financial risks* | Risk exposure | Risk management |
| L Customer credit risk The risk of a major customer becoming in solvent and being unable to pay for orders made. |
In terms of customers within Industrial Solutions and Medical Solutions, this risk is mitigated by sales taking place in a large number of countries to a large number of customers, which di versifies the risk. Integrated Solutions has fewer customers. If any of the Group's major customers were to suffer financial diffi culties, the Group could sustain significant bad debt losses. The Group's maximum exposure of accounts receivable amounted to SEK 1,051 million at year-end (all receivables from all customers). |
The Group's revenues are mostly derived from medium-sized and large global customer groups, which reduces the risk of credit losses but does not eliminate them. Nolato continually monitors the development of overdue receivables and the fi nancial position of large customers. |
| M Foreign exchange risk The risk that fluctuations between different currencies will have a significant negative impact on Nolato's performance and earnings. This risk consists of transaction exposure, which derives from buying and selling in dif ferent currencies, and translation exposure, which derives from the translation of foreign subsidiaries' assets, liabilities and earnings to Swedish kronor. |
Estimated net flows in foreign currency amounted to SEK 410 million at year-end, 48% of which was hedged. This means that SEK 214 million of estimated net flows were unhedged and a change in the value of the Swedish krona of +/–5% would have an impact of +/– SEK 10 million on Group profit. The Group has SEK 1,357 million in foreign net assets, mainly in China, Hungary and the UK. A 5% appreciation in the Swedish krona would have an impact of SEK 68 million on the net assets in the Group. |
Nolato carries out short-term currency hedging for part of the Group's estimated net exposure in foreign currencies in order to even out fluctuations in earnings. See tables under Note 30 on pages 80–81. |
| N Interest rate risk The risk that the Group's net interest ex pense will significantly increase in the event of changes to market interest rates. |
At 31 December, interest-bearing liabilities amounted to SEK 1,219 million. An increase in the interest rate of one percentage point would result in an increase of SEK 12 million in annual inter est expense. At 31 December, the Group's financial net assets amounted to SEK 143 million, including pension and lease liabilities. |
In order to limit interest rate risk, the portion of those interest bearing liabilities exceeding SEK 400 million must have a fixed interest term maturity structure as follows: Loans with a maturity of up to one year shall account for 35–65%. Loans with a maturity of over one year shall account for 35–65%. |
| O Financing and liquidity risk The risk of the Group having problems ac cessing capital. |
Total credit lines granted in the Group amount to SEK 1,260 million (1,232). Of this amount, SEK 527 million matures on 27/09/2021 and SEK 600 million on 24/04/2022. Other credit commitments of SEK 133 million (131) mature between 2020 and 2023. |
In order to maintain financial flexibility and meet the Group's capital requirements, loan facilities are continually agreed. |
| SEKm | Note | 2019 | 2018 |
|---|---|---|---|
| Net sales | 3, 4 | 7,919 | 8,102 |
| Cost of goods sold | 5, 6 | – 6,671 | – 6,845 |
| Gross profit | 1,248 | 1,257 | |
| Selling expenses | 6 | – 126 | – 119 |
| Administrative expenses | 6 | – 231 | – 217 |
| Other operating income and operating expenses, net | 7 | – 4 | 20 |
| – 361 | – 316 | ||
| Operating profit | 887 | 941 | |
| Financial income | 8 | 16 | 11 |
| Financial expenses | 8 | – 46 | – 31 |
| – 30 | – 20 | ||
| Profit after financial income and expenses | 857 | 921 | |
| Tax | 9 | – 154 | – 199 |
| Profit for the year attributable to Parent Company shareholders | 703 | 722 | |
| Basic earnings per share, (SEK) | 10 | 26.60 | 27.44 |
| SEKm | 2019 | 2018 |
|---|---|---|
| Profit for the year attributable to Parent Company shareholders | 703 | 722 |
| Other comprehensive income | ||
| Items that cannot be transferred to profit for the period | ||
| Revaluations of defined benefit pension schemes | – 66 | 3 |
| Tax attributable to items that cannot be reversed to profit for the period | 11 | – 1 |
| – 55 | 2 | |
| Items transferred or that could be transferred to profit for the period | ||
| Translation differences for the year on translation of foreign operations | 21 | 36 |
| Changes in the fair value of cash flow hedges for the year | 2 | – 1 |
| Tax attributable to changes in the fair value of cash flow hedges | — | — |
| 23 | 35 | |
| Total other comprehensive income, net | – 32 | 37 |
| Comprehensive income for the year attributable to Parent Company shareholders | 671 | 759 |
Net sales for the Group in 2019 saw a decline of 2% to SEK 7,919 million (8,102). Adjusted for currency and Group structure, sales decreased by 7%.
Medical Solutions sales totalled SEK 2,484 million (2,270). Adjusted for currency, sales increased by 5%. Sales increased in both Medical Devices and Pharma Packaging, and most product areas experienced good growth. Growth in the second half of the year was affected by strong comparative figures, which contained very high development sales and billing of production equipment.
Integrated Solutions sales amounted to SEK 3,292 million (3,720); adjusted for currency, sales decreased by 18%. Following inventory adjustments in vaporiser heating products (VHP) towards the end of the previous year and in the first quarter of 2019, the inventory situation normalised. The first quarter consequently began with low volumes, but these grew sequentially over the remaining quarters of the year. Heating Devices started delivering new product variants in the third and fourth quarters, which made a positive contribution. Volumes in the EMC area were stable over the period, while mobile phones were initially weak but performed well in the second half of the year.
Industrial Solutions sales were SEK 2,159 million (2,119); adjusted for currency and Group structure, sales were unchanged. Inventory adjustments in the hygiene area in the first half of the year had a negative effect. New customer projects in general industry were started in the fourth quarter, boosting sales. A proportion of this invoicing is non-recurring. Volumes were stable during the year in most other product areas.
Gross profit totalled SEK 1,248 million (1,257). The cost of goods sold consists of production costs for materials and manufacturing salaries, as well as other production expenses. The gross margin was 15.8% (15.5). Total depreciation/amortisation increased and amounted to SEK 376 million (248). This consisted mainly of depreciation of non-current assets in production, which is included in the cost of goods sold in the income statement at SEK 366 million (236). Other depreciation/amortisation primarily relates to amortisation of intangible assets arising in connection with acquisitions. The increase in depreciation/amortisation is due to the investments made by the
Group over the past few years to expand production capacity, with higher investments than depreciation/amortisation. The Group has also applied an impairment to machinery and other technical facilities in the amount of SEK 18 million, as part of restructuring costs relating to the approved closure of a production facility at Nolato Jaycare in the UK.
Selling and administrative expenses saw a slight increase compared with 2018 and amounted to SEK 357 million (336). These expenses consist of personnel costs and other costs associated with the sales organisation, and administrative functions. Selling expenses also include costs for amortisation of intangible assets arising from acquisitions, which amounted to SEK 8 million (8). They comprise amortisation of so-called customer relationships that are assigned value in the acquisition analysis in connection with acquisitions.
The net amount was a cost of SEK 4 million in 2019 compared with income of SEK 20 million for 2018. It comprises changes in net currency effects with losses of SEK 3 million (gains of SEK 1 million), compensation received from Chinese authorities amounting to SEK 2 million (14) and acquisition expenses of SEK 3 million (0).
Operating profit totalled SEK 887 million (941). The decrease is partly due to restructuring costs within the British business unit Nolato Jaycare of SEK 22 million, along with lower earnings for Integrated Solutions, for which sales dropped by 18% adjusted for currency.
Net financial income/expenses amounted to SEK −30 million in 2019 (−20). The higher net cost is largely due to the introduction of IFRS 16 Leases as of 1 January 2019, which has contributed SEK −11 million in interest expenses on lease liabilities.
Profit after tax totalled SEK 703 million (722), with basic earnings per share of SEK 26.60 (27.44). The effective tax rate was 18.0% (21.6). Excluding non-recurring items and adjustment to a lower tax rate in Switzerland (one-off effect), the tax rate was 18.2% (22.1).



| SEKm | Note | 2019 | 2018 |
|---|---|---|---|
| Assets | |||
| Non-current assets | |||
| Non-current intangible assets | 11 | 852 | 780 |
| Property, plant and equipment | 12 | 1,565 | 1,518 |
| Rights of use | 13 | 274 | — |
| Non-current financial assets | 14 | 2 | 2 |
| Other non-current receivables | 1 | 1 | |
| Deferred tax assets | 9 | 58 | 111 |
| Total non-current assets | 2,752 | 2,412 | |
| Current assets | |||
| Inventories | 15 | 667 | 566 |
| Accounts receivable | 14 | 1,051 | 949 |
| Current tax assets | 47 | 39 | |
| Other current assets | 16 | 250 | 232 |
| Other current financial assets | 14 | 5 | 5 |
| Cash and cash equivalents | 14 | 1,362 | 953 |
| Total current assets | 3,382 | 2,744 | |
| Total assets | 6,134 | 5,156 | |
| Shareholders' equity and liabilities | |||
| Equity attributable to Parent Company shareholders | 17 | ||
| Share capital | 133 | 132 | |
| Other capital contributed | 298 | 228 | |
| Other reserves | 18 | 159 | 136 |
| Retained earnings, (incl. profit for the year) | 2,376 | 2,096 | |
| Total shareholders' equity | 2,966 | 2,592 | |
| Non-current liabilities | |||
| Provisions for pensions and similar obligations | 20 | 246 | 182 |
| Non-current financial liabilities | 13, 19 | 834 | 522 |
| Deferred tax liabilities | 9 | 110 | 116 |
| Other provisions | 21 | 99 | 91 |
| Total non-current liabilities | 1,289 | 911 | |
| Current liabilities | |||
| Accounts payable | 19 | 839 | 594 |
| Current tax liabilities | 31 | 123 | |
| Other current financial liabilities | 13, 19 | 140 | 94 |
| Other current liabilities | 22 | 869 | 842 |
| Total current liabilities | 1,879 | 1,653 | |
| Total liabilities | 3,168 | 2,564 | |
| Total liabilities and shareholders' equity | 6,134 | 5,156 |
Non-current assets increased primarily due to new accounting rules, in which leases are to be recognised in the balance sheet as rights of use as of 2019. Rights of use according to IFRS 16 Leases contributed net SEK 274 million. Furthermore, Nolato acquired Jabar in the US at the end of the year, which contributed intangible assets of SEK 50 million and property, plant and equipment of SEK 21 million. Net investments in property, plant and equipment amounted to SEK 286 million excluding acquisitions (479 excluding disposals). Total depreciation/amortisation increased and amounted to SEK 376 million (248). The increase in depreciation is due to the investments made by the Group over the past few years to expand production capacity, with higher investments than depreciation.
Current assets increased by SEK 638 million. The acquisition of Jabar in the US contributed SEK 35 million. The balance sheet item 'Inventories' increased by SEK 101 million, while accounts receivable saw a rise of SEK 102 million, both including acquisitions. The increase in inventories and accounts receivable was largely the effect of higher levels of activity towards the end of 2019. Cash and cash equivalents increased by SEK 409 million via the positive cash flow and amounted to SEK 1,362 million (953).
Shareholders' equity increased as a result of comprehensive income for 2019 of SEK 671 million, which consists of profit after tax and
currency effects from translation differences and the revaluation of defined benefit pension schemes. Dividends to shareholders in the amount of SEK 368 million were paid, thereby reducing shareholders' equity. The return on shareholders' equity was 25.5% (30.4) and the decline was due to higher average equity.
Non-interest-bearing liabilities and provisions increased and amounted to SEK 1,949 million (1,770), largely owing to an increase in trade payables as a result of higher activity in the final quarter of 2019. The average total working capital requirement in relation to sales was 3.2% (3.8). The return on capital employed was 23.1% (29.7). Roughly two percentage points of the lower return is attributable to the introduction of IFRS 16 Leases, along with lower earnings combined with higher average capital employed. Interest-bearing liabilities and provisions increased and amounted to SEK 1,219 million (794); IFRS 16 Leases contributed SEK 277 million and there was an increase in pension liabilities of SEK 64 million. Interest-bearing assets amounted to SEK 1,362 million (953), and accordingly, net financial assets totalled SEK 143 million (159), including pension and lease liabilities. Nolato has long-term credit agreements totalling approximately SEK 1.1 billion. Short-term credit facilities of just over SEK 100 million are also available. The loan agreements' credit facilities mainly provide capacity for capital requirements in the event of future acquisitions.


| Attributable to Parent Company shareholders | ||||||
|---|---|---|---|---|---|---|
| Other capital | Translation | Total share | ||||
| SEKm | Share capital | contributed Hedging reserves | reserves Retained earnings | holders' equity | ||
| Opening balance, 1 January 2018 | 132 | 228 | — | 101 | 1,698 | 2,159 |
| Profit for the year | — | — | — | — | 722 | 722 |
| Other comprehensive income for the year | — | — | – 1 | 36 | 2 | 37 |
| Comprehensive income for the year | — | — | – 1 | 36 | 724 | 759 |
| Dividend for 2017 | — | — | — | — | – 329 | – 329 |
| Warrants included in incentive programme (Series 3) | — | — | — | — | 3 | 3 |
| Closing balance, 31 December 2018 | 132 | 228 | – 1 | 137 | 2,096 | 2,592 |
| Opening balance, 1 January 2019 | 132 | 228 | – 1 | 137 | 2,096 | 2,592 |
| Profit for the year | — | — | — | — | 703 | 703 |
| Other comprehensive income for the year | — | — | 2 | 21 | – 55 | – 32 |
| Comprehensive income for the year | — | — | 2 | 21 | 648 | 671 |
| Warrants exercised in incentive programme | 1 | 70 | — | — | — | 71 |
| Dividend for 2018 | — | — | — | — | – 368 | – 368 |
| Closing balance, 31 December 2019 | 133 | 298 | 1 | 158 | 2,376 | 2,966 |
| SEKm | Note | 2019 | 2018 |
|---|---|---|---|
| 25 | |||
| Operating activities | |||
| Operating profit | 887 | 941 | |
| Adjustments for items not included in cash flow: | |||
| Depreciation/amortisation and impairment | 376 | 248 | |
| Provisions | 7 | 3 | |
| Unrealised exchange rate differences | – 21 | – 5 | |
| Other items | 5 | 19 | |
| Pension payments | – 5 | – 5 | |
| Interest received | 16 | 11 | |
| Interest paid | – 35 | – 23 | |
| Realised exchange rate differences | – 22 | – 25 | |
| Income tax paid | – 203 | – 204 | |
| Cash flow from operating activities | |||
| before changes in working capital | 1,005 | 960 | |
| Cash flow from changes in working capital | |||
| Changes in inventories | – 75 | – 25 | |
| Changes in accounts receivable | – 71 | 206 | |
| Changes in accounts payable | 306 | – 119 | |
| Other changes in working capital | – 5 | 23 | |
| 155 | 85 | ||
| Cash flow from operating activities | 1,160 | 1,045 | |
| Investing activities | |||
| Acquisition of non-current intangible assets | – 5 | – 8 | |
| Acquisition of property, plant and equipment | – 355 | – 446 | |
| Business combinations, excluding cash and cash equivalents | – 93 | — | |
| Sale of property, plant and equipment | — | 2 | |
| Sale of business, net of cash and cash equivalents | — | 54 | |
| Cash flow from investing activities | – 453 | – 398 | |
| Cash flow before financing activities | 707 | 647 | |
| Financing activities | |||
| Borrowings | 25 | 89 | 5 |
| Repayment of loans | 25 | – 107 | – 72 |
| Warrants paid for in incentive programme | — | 3 | |
| Warrants exercised in incentive programme | 71 | — | |
| Dividend paid | – 368 | – 329 | |
| Cash flow from financing activities | – 315 | – 393 | |
| Cash flow for the year | 392 | 254 | |
| Cash and cash equivalents, opening balance | 953 | 669 | |
| Exchange rate difference in cash and cash equivalents | 17 | 30 | |
| Cash and cash equivalents, closing balance | 1,362 | 953 |
61
Cash flow before investments rose to SEK 1,160 million (1,045). Changes in working capital had a positive impact of SEK 155 million (85) on cash flow.
Net investments affecting cash flow totalled SEK 360 million excluding acquisitions (452 excluding disposals). Investments in property, plant and equipment largely comprised machinery and equipment as well as construction in progress, but also to a lesser extent investments in buildings and land in connection with new construction and extensions to factories. Net investments affecting cash flow excluding acquisitions and disposals are allocated between the Group's business areas as SEK 183 million (248) for Medical Solutions, SEK 20 million (18) for Integrated Solutions and SEK 159 million (187) for Industrial Solutions. For Medical Solutions, investments chiefly consisted of additional machinery capacity, primarily for new customer projects to facilitate growth. Integrated Solutions investments consisted mainly of technology initiatives, expansion of EMC production and investments in the replacement of machinery
in China. Industrial Solutions has made investments in additional machinery capacity.
| Investments (net) | 2019 | 2018 |
|---|---|---|
| Non-current intangible assets | 5 | 8 |
| Buildings and land | 11 | 56 |
| Machinery and equipment | 118 | 121 |
| Construction in progress | 226 | 267 |
| Total investments | 360 | 452 |
Affecting cash flow, excluding acquisitions and disposals
Cash flow after investments amounted to SEK 800 million excluding business acquisitions (593 excluding sales of subsidiaries). Including business acquisitions, cash flow was SEK 707 million (647 including disposals of subsidiaries).
Financing activities describe the Group's financing and dividends to shareholders, and totalled a net amount of SEK –315 million (–393). This consists of net amortised borrowings of SEK –18 million (–67), dividends paid totalling SEK –368 million (–329) and warrants exercised under the incentive programme of SEK 71 million (0).



Nolato is a high-tech developer and manufacturer of polymer product systems for leading customers in medical technology, pharmaceuticals, consumer electronics, telecom, automotive products, hygiene and other selected industrial sectors.
The Parent Company Nolato AB, company registration number 556080-4592, is a limited company with its registered office in Torekov, Sweden. Its head office address is Nolato AB, 269 04 Torekov, Sweden.
Nolato's B shares are listed on Nasdaq Stockholm Exchange in the Large Cap segment, where they are included in the Industrials sector.
The consolidated accounts have been prepared in accordance with International Financial Reporting Standards (IFRS) issued by the International Accounting Standards Board (IASB) as adopted by the EU, and interpretations from the International Financial Reporting Interpretations Committee (IFRIC). The Swedish Financial Accounting Standards Council's recommendation RFR 1 Supplementary Rules for Consolidated Financial Statements has also been applied.
The Parent Company applies the same accounting policies as the Group, except in those cases specified in the section 'Parent Company's accounting policies'.
Apart from those exceptions described in further detail, the following accounting policies have been applied consistently to all periods presented in the Group's financial statements. The accounting policies have been applied consistently by the Group's companies. In addition, comparison figures have been reclassified in those cases where the policies have been changed in order to correspond with the figures presented in this year's financial statements, as described below.
In order to make the text clearer and easier to read, accounting policies and estimates and judgements have been moved to the beginning of each note. Any accounting policies that do not relate to a specific note can be found in this note.
IFRS 16 Leases replaces IAS 17 as of 1 January 2019. The standard removes the requirement for the lessee to classify leases as either operating or finance leases, and instead introduces a collective model for recognition of all leases. In this model the lessee must recognise (a) assets and liabilities for all leases with a lease term of more than 12 months, with the exception of assets with a low value; and (b) depreciation of leased assets separately from debt interest on leases in the income statement. The Group provides details of its leasing commitments in Note 13, which also gives further information regarding the transition to IFRS 16.
IASB and IFRIC have issued new standards and statements which come into force for financial years beginning on 1 January 2020 or later. There are no plans for the early application of new or amended standards for future application.
None of the standards or interpretations published by IASB are expected to have a material impact on the Group or Parent Company's financial statements.
The functional currency of the Parent Company is the Swedish krona (SEK), which is also the reporting currency for the Parent Company and the Group. This means that the financial statements are presented in Swedish kronor. All amounts are presented in millions of kronor unless otherwise indicated.
Assets and liabilities are reported at their historical acquisition cost, except for certain financial assets and liabilities, which are measured at fair value. In Nolato, these consist of currency derivatives measured at fair value. Non-current assets and non-current liabilities consist in all significant respects only of amounts which are expected to be recovered or paid after more than 12 months from the balance sheet date. Current assets and current liabilities consist in all significant respects only of amounts which are expected to be recovered or paid within 12 months of the balance sheet date. Offsetting of receivables and liabilities and of income and expenses is done only if this is required or expressly permitted.
Preparing the financial statements in accordance with IFRS requires Group management to make judgements, estimates and assumptions that affect the application of accounting policies and the recognised amounts of assets, liabilities, income and expenses. Estimates and assumptions are based on historical experience and a number of other factors which seem reasonable given current conditions. The actual outcome may deviate from these estimates and assumptions. The estimates and assumptions are reviewed regularly. Changes to estimates are reported during the period when the change is made if the change only affects that period, or during the period when the change is made and future periods if the change affects both the current period and future periods.
Subsidiaries are companies in which Nolato AB has a controlling interest. A controlling interest exists if Nolato AB has influence over the investment object, is exposed or entitled to variable return from its exposure and can use its interest in the investment to influence the return. When determining whether a controlling interest exists, account is taken of potential voting shares and whether or not there is de facto control.
For all of the Group's subsidiaries, control exists via 100% ownership. The consolidated financial statements have been prepared in accordance with IFRS 3 Business Combinations and by applying the acquisition method. This method means that shareholders' equity in the Group includes shareholders' equity in the Parent Company and the portion of shareholders' equity in subsidiaries that has accumulated since the acquisition. The difference between the acquisition cost of shares in a subsidiary and that company's shareholders' equity at the time of acquisition, adjusted in accordance with consolidated accounting policies, has been allocated among the assets and liabilities measured at fair value that were taken over on acquisition. Transaction costs on acquisitions are recognised under profit for the year in accordance with IFRS 3 for the Group. Amounts which cannot be allocated are reported as goodwill. Intra-group transactions and balance sheet items and unrealised gains/losses on transactions between Group companies are eliminated. The accounting policies for subsidiaries have been changed, where applicable, to ensure the consistent application of consolidated accounting policies.
Items included in the financial statements for the various units in the Group are measured in the currency used in the economic environment in which each company primarily operates. The Swedish krona (SEK), which is the Parent Company's functional currency and reporting currency, is used in the consolidated accounts. For subsidiaries, the local currency of their respective countries is used as the reporting currency, and this is considered to constitute the functional currency.
Transactions in foreign currencies are translated into the functional currency at the rate in effect on the transaction date. Exchange rate gains and losses arising from the payment of such transactions and from the revaluation of monetary assets and liabilities denominated in foreign currencies at the rate on the balance sheet date are recognised in profit for the year.
The earnings and financial position of all Group companies are translated into the Group's reporting currency as follows:
Each operating segment is defined as business activities from which income can be generated or expenses incurred, whose operating earnings are regularly monitored by the Group's Chief Operating Decision Maker (CODM) and for which separate financial information is available. In Nolato's case, CODM is defined as Group management, which determines how resources are to be allocated between the different segments and that also makes regular assessments of earnings. The Group's internal reporting covers three segments: Medical Solutions, Integrated Solutions and Industrial Solutions.
Directly attributable items and items which could be distributed among the segments in a reasonable and reliable manner have been included in the segments' profit, assets and liabilities. The recognised items in the operating segments are measured in accordance with the earnings, assets and liabilities monitored by Group management.
Internal pricing between the Group's various segments is set according to the arm's length principle, i.e. between parties which are independent of each other, well-informed and have an interest in the transactions being carried out.
The assets in each business area consist of all operating assets used by the operating segment, primarily non-current intangible assets arising through business combinations, property, plant and equipment, inventories and accounts receivable. Liabilities assigned to operating segments include all operating liabilities, mainly accounts payable and accrued expenses.
Unallocated items in the balance sheet consist primarily of non-current financial assets, interest-bearing receivables and liabilities, provisions and deferred tax assets/liabilities.
Unallocated items in the income statement are attributable to Parent Company costs, financial income, financial expenses and tax expenses.
The segments' investments in non-current assets include all investments other than investments in expendable equipment and low-value equipment. All segments are established in accordance with Group accounting policies.
Medical Solutions develops and manufactures complex product systems and components within medical technology, as well as advanced packaging solutions for pharmaceuticals and dietary supplements. The market consists of large, global customers, featuring demanding development work, long product lifespans and stringent requirements in terms of quality, traceability and safety. Medical Solutions holds a strong position in the Nordic region and Europe, and a growing position in China and the US. Development and production are carried out in Sweden, Hungary, the US, the UK, Switzerland, Poland and China. A more detailed presentation of the business area can be found on pages 28–31.
Integrated Solutions business is divided into two sectors: consumer electronics and EMC & Thermal. Consumer electronics comprises selected electronics products where Nolato designs, develops and produces advanced components, subsystems and ready-packaged products. EMC & Thermal develops techniques and materials for shielding of electronics to achieve electromagnetic compatibility and heat dissipation of electronics. The market consists of a few large, global companies with high technological demands, extremely short development times and quick production start-ups. Integrated Solutions enjoys a strong position with selected customers. Development and production are conducted in China, Malaysia, Hungary, the US and Sweden. A more detailed presentation of the business area can be found on pages 32–35.
Industrial Solutions develops and manufactures components and product systems for customers in the automotive industry, hygiene, packaging, gardening/forestry, domestic appliances, furniture and other selected industrial segments. The market is fragmented and diversified, with a large number of customers and a large number of suppliers. Industrial Solutions has a strong position in the Nordic region and parts of Central Europe. Development and production are carried out in Sweden, Hungary, Romania, Switzerland and the US. A more detailed presentation of the business area can be found on pages 36–39.
| Group adjustment, | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Solutions | Integrated Solutions | Industrial Solutions | Parent Company | Total | ||||||||
| 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | |||
| External sales | 2,483 | 2,270 | 3,277 | 3,713 | 2,159 | 2,119 | — | — | 7,919 | 8,102 | ||
| Internal sales | 1 | — | 15 | 7 | — | — | – 16 | – 7 | — | — | ||
| Net sales | 2,484 | 2,270 | 3,292 | 3,720 | 2,159 | 2,119 | – 16 | – 7 | 7,919 | 8,102 | ||
| Profit | ||||||||||||
| Operating profit (EBITA) | 320 | 295 | 427 | 473 | 181 | 186 | – 33 | – 5 | 895 | 949 | ||
| Amort. of intang. assets arising from acq. | – 3 | – 4 | — | — | – 5 | – 4 | — | — | – 8 | – 8 | ||
| Operating profit | 317 | 291 | 427 | 473 | 176 | 182 | – 33 | – 5 | 887 | 941 | ||
| Financial income | 16 | 11 | ||||||||||
| Financial expenses | – 46 | – 31 | ||||||||||
| Tax expenses for the year | – 154 | – 199 | ||||||||||
| Profit for the year | 703 | 722 | ||||||||||
| Receivables and liabilities | ||||||||||||
| Segments' assets | 2,256 | 1,928 | 1,270 | 959 | 1,730 | 1,589 | – 558 | – 398 | 4,698 | 4,078 | ||
| Unallocated assets | 1,436 | 1,078 | ||||||||||
| Total assets | 2,256 | 1,928 | 1,270 | 959 | 1,730 | 1,589 | – 558 | – 398 | 6,134 | 5,156 | ||
| Segments' liabilities | 645 | 645 | 1,316 | 889 | 363 | 457 | – 584 | – 338 | 1,740 | 1,653 | ||
| Unallocated liabilities | 1,428 | 911 | ||||||||||
| Total liabilities | 645 | 645 | 1,316 | 889 | 363 | 457 | – 584 | – 338 | 3,168 | 2,564 | ||
| Other information | ||||||||||||
| Investments (capitalised) | 171 | 261 | 90 | 21 | 103 | 205 | — | 2 | 364 | 489 | ||
| Depreciation/amortisation and impairment | 160 | 113 | 78 | 41 | 131 | 103 | 19 | 1 | 388 | 258 | ||
| Significant items, other than depr./amort./impair ment with no offsetting payments, impairment |
||||||||||||
| and provisions | 54 | – 14 | 11 | – 1 | 2 | – 19 | — | — | 67 | – 34 |
| 2019 | 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Medical | Integrated | Industrial | Medical | Integrated | Industrial | |||||
| Solutions | Solutions | Solutions | Total | Solutions | Solutions | Solutions | Total | |||
| Cash flow from operations | ||||||||||
| before changes in working capital | 477 | 493 | 307 | 1,277 | 404 | 504 | 285 | 1,193 | ||
| Changes in working capital | – 124 | 428 | – 145 | 159 | – 21 | 28 | 70 | 77 | ||
| Cash flow from operating activities | 353 | 921 | 162 | 1,436 | 383 | 532 | 355 | 1,270 | ||
| Unallocated items1) | – 276 | – 225 | ||||||||
| Total cash flow from operations | 1,160 | 1,045 |
| 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Medical | Integrated | Industrial | Medical | Integrated | Industrial | |||
| Solutions | Solutions | Solutions | Total | Solutions | Solutions | Solutions | Total | |
| Acquisition of non-current assets2) | – 183 | – 20 | – 159 | – 362 | – 248 | – 19 | – 188 | – 455 |
| Business combinations, excl. cash and cash | ||||||||
| equivalents | — | – 93 | — | – 93 | — | — | — | — |
| Sale of non-current assets | — | — | — | — | — | 1 | 1 | 2 |
| Sale of business | — | 54 | ||||||
| Group elimination, Parent Company | 2 | 1 | ||||||
| Cash flow from investing activities | – 183 | – 113 | – 159 | – 453 | – 248 | – 18 | – 187 | – 398 |
1) For 2019, the Group's change in working capital was SEK 155 million and, allocated by business area according to the above, was SEK 159 million. The difference of SEK −4 million is included in the SEK −276 million. Other unallocated items consist chiefly of operating loss of SEK –33 million (with the Parent Company accounting for the majority), income tax paid at SEK –203 million and other items such as pension payments, other provisions paid, interest received/paid, including certain parts of the items not affecting cash flow.
2) Paid investments for the year in non-current assets, i.e. after adjustment for outstanding supplier invoices on the balance sheet date of SEK –67 million (34).
In the Nordic region, the rest of Europe, Asia and North America, the Group manufactures and sells products from all three business areas.
| Sweden | Other Nordic countries | Rest of Europe | North America | Asia | Other countries | Group | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | |
| External sales | 1,167 | 1,186 | 204 | 202 | 2,943 | 2,687 | 608 | 564 | 2,843 | 3,311 | 154 | 152 | 7,919 | 8,102 |
| Assets | 2,034 | 1,719 | — | — | 1,776 | 1,668 | 532 | 317 | 1,792 | 1,452 | — | — | 6,134 | 5,156 |
| Average no. of | ||||||||||||||
| employees | 1,135 | 1,055 | — | — | 1,362 | 1,336 | 281 | 233 | 3,163 | 3,825 | — | — | 5,941 | 6,449 |
| Investments | ||||||||||||||
| (capitalised) | 117 | 231 | — | — | 118 | 170 | 123 | 81 | 6 | 7 | — | — | 364 | 489 |
The Nolato Group's revenue is essentially derived from the sale of serially manufactured products and product systems within polymers such as plastic, TPE and silicone, which have been produced through development work and the creation of production equipment in partnership with our customers. Our customers maintain control over the products following delivery, which is when invoicing occurs with appropriate payment terms, see Note 14, with the average period of credit being 46 days. Jointly developed production equipment, which largely consists of tooling, is essentially owned by customers and invoiced to the customer in advance or over a period of time based on expenses incurred.
Nolato's customer contracts normally have entirely separate performance commitments with regard to delivery of serially manufactured products, which accounted for 93% of net sales in 2019, and development work and the creation of production equipment, which is considered to be a smaller separate performance commitment and is invoiced to the customer prior to the possible start of serial production. The products are primarily entirely customised and the design and drawings are owned by the customer.
Nolato normally assumes manufacturing responsibility, while the customer normally assumes design responsibility.
To give Nolato an idea of future production, customers often submit forecasts. These forecasts are often indicative and not binding for the customer. Nolato mainly uses the forecasts for planning with regard to input materials and machinery capacity, and begins production upon receipt of a purchase order from the client. Nolato invoices at the agreed price (transaction price) after delivery and once control has been transferred to the customer. The inventory turnover rate for completed products is very high. Agreed prices are continually adjusted, one reason being for Nolato to compensate for changes in the price of raw materials.
Nolato does not submit any information about outstanding performance commitments, as there are no unfulfilled performance commitments on completion of purchase orders received. Nolato has no significant contracts with an original anticipated term of more than one year, in which customers commit to buying more than continually placed purchase orders.
| 2019 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Medical Integrated Industrial |
Medical | Integrated | Industrial | |||||
| Total | Solutions | Solutions | Solutions | Total | Solutions | Solutions | Solutions | |
| Sweden | 1,173 | 157 | 35 | 981 | 1,189 | 140 | 51 | 998 |
| Rest of Europe | 3,148 | 1,620 | 548 | 980 | 2,889 | 1,492 | 473 | 924 |
| North America | 608 | 464 | 14 | 130 | 564 | 408 | 29 | 127 |
| Asia | 2,852 | 105 | 2,683 | 64 | 3,315 | 94 | 3,155 | 66 |
| Other countries | 154 | 138 | 12 | 4 | 152 | 136 | 12 | 4 |
| Elimination internal sale | – 16 | – 7 | ||||||
| Total revenue from contracts with customers | 7,919 | 2,484 | 3,292 | 2,159 | 8,102 | 2,270 | 3,720 | 2,119 |
The above table essentially covers products transferred following delivery. For 2019, the Group has an increased provision for anticipated credit losses on accounts receivable and contract assets, with SEK 12 million among the cost of goods sold.
| 2019 | 2018 |
|---|---|
| 1,051 | 949 |
| 107 | 120 |
| – 149 | – 178 |
| 145 | 181 |
| – 13 | – 16 |
| 90 | 107 |
| 298 | 316 |
| – 156 | – 179 |
| 146 | 170 |
| – 56 | – 20 |
| 7 | 11 |
| 239 | 298 |
The Group recognises development work and development of production tools per main product and customer as a net amount, either as a contract asset or contract liability.
| 2019 | 2018 | |
|---|---|---|
| Development expenditure for customer-specific | ||
| products | – 478 | – 604 |
The Group's development expenditure relates to developing customer-specific products in close collaboration with the customer. Product development costs are charged to the income statement under cost of goods sold. Nolato normally invoices the customer for these costs prior to serial production of the product and it is regarded as a lesser separate undertaking.
| 2019 | 2018 | |
|---|---|---|
| Material costs | – 3,499 | – 3,705 |
| Employee benefits | – 1,352 | – 1,291 |
| Social security contributions | – 280 | – 225 |
| Employee pensions | – 112 | – 99 |
| Energy costs | – 158 | – 137 |
| Other costs | – 1,257 | – 1,463 |
| Depreciation/amortisation/impairment | – 376 | – 248 |
| Total | – 7,034 | – 7,168 |
| Depreciation/amortisation/impairment is included | ||
| in operating expenses as follows: | 2019 | 2018 |
| Software | – 3 | – 2 |
| Customer relationships | – 8 | – 8 |
| Buildings and land improvements | – 104 | – 28 |
| Machinery and other technical facilities | – 228 | – 184 |
| Equipment, tools, fixtures and fittings | – 33 | – 26 |
| Total non-current assets | – 376 | – 248 |
| Accounts receivable | – 12 | – 10 |
| Total | – 388 | – 258 |
| Depreciation/amortisation/impairment has been | ||
| allocated as follows: | 2019 | 2018 |
| Cost of goods sold | – 378 | – 246 |
| Selling expenses | – 8 | – 10 |
| Administrative expenses | – 2 | – 2 |
| Total | – 388 | – 258 |
| Other operating income | 2019 | 2018 |
|---|---|---|
| Effect of exchange rate on operating receivables/liabilities | — | 1 |
| Compensation from bankruptcy payment | — | 20 |
| Other* | 2 | 16 |
| Total | 2 | 37 |
| Other operating expenses | ||
| Effect of exchange rate on operating receivables/liabilities | – 3 | — |
| Capital loss on sale of subsidiary | — | – 17 |
| Acquisition expenses | – 3 | — |
| Total | – 6 | – 17 |
| Other operating income and operating expenses, net | – 4 | 20 |
*SEK 2 million (14) concerns government grants received in Beijing, China.
Financial income consists of interest income on invested funds measured at amortised cost. Profit from the disposal of a financial instrument is recognised once the risks and benefits associated with ownership of the instrument have been transferred to the buyer and the Group no longer has control of the instrument. Financial expenses primarily consist of interest expenses on loans measured at amortised cost and other borrowing costs such as commitment fees and credit charges relating to the Group's credit agreements.
| Net financial income/expense | – 30 | – 20 |
|---|---|---|
| Financial expenses | – 46 | – 31 |
| Financial income | 16 | 11 |
| Recognised as: | ||
| Net financial income/expense | – 30 | – 20 |
| Other financial expenses | – 17 | – 16 |
| Foreign exchange gains and losses, net | – 11 | – 7 |
| Interest expenses | – 18 | – 8 |
| Interest income | 16 | 11 |
| 2019 | 2018 |
| 2019 | 2018 | |||||
|---|---|---|---|---|---|---|
| Interest | Interest | Foreign exchange gains/ |
Interest | Interest | Foreign exchange gains/ |
|
| income | expenses | losses, net | income | expenses | losses, net | |
| Derivatives used to hedge intra-group loans | — | — | — | — | — | – 3 |
| Bank deposits | 16 | — | — | 11 | — | — |
| PRI pension liability | — | – 3 | — | — | – 3 | — |
| Borrowings and lease liabilities | — | – 15 | — | — | – 5 | — |
| Supplier financial agreements | — | – 12 | — | — | – 13 | — |
| Other financial assets/liabilities | — | – 5 | – 11 | — | – 3 | – 4 |
| Total | 16 | – 35 | – 11 | 11 | – 24 | – 7 |
Income taxes consist of current tax and deferred tax. Income taxes are recognised in profit for the year, except where the underlying transaction is recognised in other comprehensive income, in which case the related tax effect is recognised in other comprehensive income.
All companies in the Group calculate income taxes in accordance with the tax rules and regulations that apply in the countries in which the profit is taxed.
Current tax is tax that is payable or receivable in relation to the current year, with the application of the tax rates that have been decided, or decided in practice, at the balance sheet date. Current tax also includes adjustments for current tax attributable to previous periods.
Provision has been made in the Group for taxes on subsidiaries' taxable profits for the financial year, which may be allocated to the Parent Company next year. Provision for any coupon tax for anticipated dividends is made in the Parent Company once the dividend is recognised as a receivable from a Group company. However, no provisions have been made for tax that may arise on allocation of the remaining distributable profits in foreign subsidiaries as these may be distributed tax-free, or because the Group does not intend to allocate any internal dividends in the foreseeable future.
Deferred tax is calculated using the balance sheet method, taking temporary differences between recognised and tax-related values of assets and liabilities as the starting point. Temporary differences are not taken into account in consolidated goodwill, or for any difference arising on initial recognition of assets and liabilities that are not business combinations which, at the time of the transaction, affect neither recognised nor taxable earnings. Temporary differences attributable to investments in subsidiaries that are not expected to be reversed within the foreseeable future are not taken into account either. The measurement of deferred tax is based on how underlying assets or liabilities are expected to be realised or settled. Deferred tax is calculated using the application of the tax rates and tax rules that have been decided, or decided in practice, at the balance sheet date.
Deferred tax assets in relation to deductible temporary differences and loss carryforwards are only recognised to the extent that it is likely that these will be utilised. The value of deferred tax assets is reduced once it is no longer deemed likely that they can be utilised.
Deferred tax assets and tax liabilities are offset when there is a legal right to offset current tax assets against current tax liabilities and when taxes are charged by one and the same tax authority, and when the Group intends to pay the current tax assets and liabilities at a net amount.
Management is required to make significant judgements when calculating tax liabilities and tax assets and for deferred tax for provisions and receivables. This process involves an assessment of the Group's exposure to current tax and the establishment of temporary differences created by various tax and accounting rules. Management looks in particular at the likelihood that deferred tax assets may be
offset against any surplus in future taxation.
Deferred tax assets are recognised to the extent that management deems it likely that sufficient taxable surplus will be available to permit recognition of such assets.
| 2019 | 2018 | |
|---|---|---|
| Current tax expenses | ||
| Tax expenses for the period | – 102 | – 246 |
| Adjustment for tax attributable to previous years | 2 | — |
| – 100 | – 246 | |
| Deferred tax income/expense | ||
| Deferred tax in relation to temporary differences | – 54 | 47 |
| Total recognised tax expense | – 154 | – 199 |
| Reconciliation of effective tax | ||
| 2019 | 2018 | |
| Profit before tax | 857 | 921 |
| Tax according to applicable Parent Company tax rate | – 183 | – 203 |
| Effect of other tax rates for foreign Group companies | 8 | 15 |
| Non-deductible expenses | – 6 | – 5 |
| Non-taxable income | 9 | 13 |
| Tax attributable to previous years | 2 | — |
| Effect of change in tax rates | 19 | – 9 |
| Effect of non-capitalised deficits arising | ||
| during the year | – 3 | – 10 |
| Recognised effective tax | – 154 | – 199 |
Swedish corporation tax amounted to 21.4% (22.0) and the effective tax rate was 18.0% (21.6).
| Deferred tax assets | Deferred tax liabilities | Net | ||||
|---|---|---|---|---|---|---|
| 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | |
| Non-current intangible assets | — | — | 23 | 19 | – 23 | – 19 |
| Property, plant and equipment | 25 | 31 | 79 | 80 | – 54 | – 49 |
| Inventories | 14 | 29 | 3 | 3 | 11 | 26 |
| Accounts receivable | 5 | 3 | — | — | 5 | 3 |
| Provisions for pensions | 41 | 32 | 2 | 1 | 39 | 31 |
| Tax allocation reserves | — | — | 50 | 44 | – 50 | – 44 |
| Other | 33 | 61 | 16 | 18 | 17 | 43 |
| Loss carry-forwards | 3 | 4 | — | — | 3 | 4 |
| Tax assets/liabilities | 121 | 160 | 173 | 165 | – 52 | – 5 |
| Offsetting | – 63 | – 49 | – 63 | – 49 | — | — |
| Tax assets/liabilities, net | 58 | 111 | 110 | 116 | – 52 | – 5 |
Deferred tax assets have not been recognised in the Group in relation to loss carryforwards totalling SEK 44 million (27). The loss carry-forwards relate to the business in India in the amount of SEK 28 million (27) and in China in the amount of SEK 16 million (0), and it is unlikely that it will be possible to use them against future taxable gains. The company in India is expected to be liquidated in 2020.
| Balance at 1 Jan. 2018 |
Recognised in profit for the year |
Recognised in other compre hensive income |
Business acquisitions |
Business disposals |
Balance at 31 Dec. 2018 |
|
|---|---|---|---|---|---|---|
| Non-current intangible assets | – 18 | – 1 | — | — | — | – 19 |
| Property, plant and equipment | – 53 | 4 | — | — | — | – 49 |
| Inventories | 9 | 17 | — | — | — | 26 |
| Accounts receivable | 1 | 2 | — | — | — | 3 |
| Provisions for pensions | 35 | – 3 | – 1 | — | — | 31 |
| Tax allocation reserves | – 44 | — | — | — | — | – 44 |
| Other | 18 | 25 | — | — | — | 43 |
| Loss carry-forwards | 1 | 3 | — | — | — | 4 |
| Total | – 51 | 47 | – 1 | — | — | – 5 |
| Total | – 5 | – 54 | 11 | – 4 | — | – 52 |
|---|---|---|---|---|---|---|
| Loss carry-forwards | 4 | – 1 | — | — | — | 3 |
| Other | 43 | – 26 | — | — | — | 17 |
| Tax allocation reserves | – 44 | – 6 | — | — | — | – 50 |
| Provisions for pensions | 31 | – 3 | 11 | — | — | 39 |
| Accounts receivable | 3 | 2 | — | — | — | 5 |
| Inventories | 26 | – 15 | — | — | — | 11 |
| Property, plant and equipment | – 49 | – 5 | — | — | — | – 54 |
| Non-current intangible assets | – 19 | — | — | – 4 | — | – 23 |
| Balance at 1 Jan. 2019 |
Recognised in profit for the year |
Recognised in other compre hensive income |
Business acquisitions |
Business disposals |
Balance at 31 Dec. 2019 |
| Total | 11 | – 1 |
|---|---|---|
| Deferred tax on currency forwards | — | — |
| provisions for pensions (PRI) | 11 | – 1 |
| Deferred tax attributable to | ||
| 2019 | 2018 | |
| 2019 | 2018 |
|---|---|
| 703 | 722 |
| 26,431,806 26,307,408 | |
| 26.60 | 27.44 |
| 16 | – 7 |
| 719 | 715 |
| 27.20 | 27.18 |
| 2019 | 2018 |
| — | 76,613 |
| 195 | — |
| — | — |
| 26,432,001 26,384,021 | |
| 26.60 | 27.37 |
| 27.20 | 27.10 |
* 2019: Non-recurring item for closure of production facility at Nolato Jaycare in the UK which had a negative effect on operating profit in the amount of SEK –22 million, and tax effects of SEK +6 million, which impacted post-tax profit in the amount of SEK –16 million. This non-recurring item has been recognised at Group level and has consequently not affected the profit of the business areas. 2018: Non-recurring items consist of a distribution from the previous bankruptcy of a customer in 2006 in the amount of SEK +20 million (0) and a capital loss on a divested business of SEK –17 million (0), net SEK +3 million (0) in operating profit. The tax effect on non-recurring items and adjustment to a lower tax rate in Sweden amounts to SEK +4 million (0). These non-recurring items were recognised at Group level and have consequently not affected the profit of the business areas.
Basic earnings per share are calculated by dividing profit for the year attributable to Parent Company shareholders by the average number of ordinary shares outstanding during the period.
When calculating diluted earnings per share, the average number of shares outstanding during the period is adjusted for all potential dilutive ordinary shares. Shares from incentive programmes are considered to be dilutive if the closing price was in the money at the end of the period, and the average closing price of Nolato's B share during the year has exceeded the exercise prices in the respective incentive programme.
The warrants in Series 2016/2019 (total 240,600) have been exercised to subscribe for shares in 2019.
The warrants in Series 2017/2020 (total 196,200) can be exercised to subscribe for shares as of 1 May 2020 up to and including 15 December 2020.
The warrants in Series 2018/2021 (total 193,500) can be exercised to subscribe for shares as of 1 May 2021 up to and including 15 December 2021.
The warrants in Series 2019/2022 (max. 266,000) have not been exercised to subscribe for shares in 2019.
The warrants in Series 2020/2023 (max. 266,000) can be exercised to subscribe for shares as of 1 May 2023 up to and including 15 December 2023.
The warrants in Series 2021/2024 (max. 266,000) can be exercised to subscribe for shares as of 1 May 2024 up to and including 15 December 2024.
Intangible assets are recognised at original cost less accumulated amortisation and impairment. Amortisation is applied on a straight-line basis over the useful lives of the assets and is initiated once the asset is put into use.
Useful life is based on historical experience of use of similar assets, area of use as well as other specific attributes of the asset.
Intangible assets acquired in a business acquisition which are recognised separately from goodwill consist of customer relationships.
Goodwill consists of the amount by which the consideration transferred exceeds the fair value of the Group's share of the identifiable net assets of the acquired subsidiary at the time of the acquisition. Goodwill from the acquisition of subsidiaries is recognised as an intangible asset. Goodwill is not amortised but impairment-tested annually, and is recognised at acquisition cost less accumulated impairment losses. Any gain or loss from the disposal of a unit includes the remaining carrying amount of the goodwill associated with the unit disposed of. Goodwill is allocated to cash-generating units in impairment tests.
Acquired intangible assets are recognised separately from goodwill if they fit the definition of an asset, are separable or arise from contractual or other legal rights and their fair values can be reliably measured.
Goodwill is impairment-tested annually and when there is an indication of impairment. The test is performed at the lowest cash-generating unit level, or groups of cashgenerating units on which these assets can be verified. For Medical Solutions and Industrial Solutions, impairment testing has been carried out at segment level. Nolato Jabar LLC is included in the Integrated Solutions business area and the acquisition took place at the end of the year. For Nolato Jabar LLC, impairment testing will be carried out as of 2020.
The Group's capitalised customer relationships relate to assets acquired through the acquisition of the Cerbo Group, Medical Rubber AB, Nolato Contour Inc. in the US, Nolato Jaycare Ltd in the UK, Nolato Stargard Sp.zo.o in Poland, Nolato Treff AG in Switzerland and Nolato Jabar LLC in the US. Straight-line depreciation is applied over the expected useful life, i.e. six to ten years.
An impairment is recognised if the carrying amount exceeds the recoverable amount. The recoverable amount is established based on calculations of useful life. A discounted cash flow model is used to estimate useful life. The estimate includes an important source of uncertainty because the estimates and assumptions used in the discounted cash flow model contain uncertainty about future events and market circumstances, so the actual outcome can differ significantly. The estimates and assumptions have, however, been reviewed by management and coincide with internal forecasts and future outlook for the operations.
The discounted cash flow model includes forecasting future cash flow from operations including estimates regarding income volumes, production costs and requirements in terms of capital employed. Several assumptions are made, the most significant being the growth rate of income, the discount rate and operating margin. Forecasts of future operating cash flows are based on the following:
Impairment-tested operations in the Group are mainly in Sweden, the UK, Switzerland and the US. These countries are deemed to have largely similar expected inflation, which is consistent with the goals of central banks and similar institutions. It is assumed that relevant markets will grow in line with general inflation.
Forecasts of future cash flow from operations are adjusted to present value with a suitable discount rate. As a starting point, the discount rate takes the Nolato Group's marginal borrowing rate adjusted for the risk premium in the country concerned, if applicable, and the systematic risk in the cash-generating unit at the time of measurement. Management bases the discount rate on the inherent risk in the business in question and in similar industries. The forecasts comply with historical experience and/or external sources of information.
In the impairment test in each segment, the discount rate has essentially been constructed segment by segment. The various legal companies in each segment are relatively similar in size, have the same type of customer segments with similar behaviour, and similar types of products. Thus the risk level for the legal companies has been assumed to be roughly the same.
Using these assumptions, the recoverable amount exceeds the carrying amount of all cash-generating units, and there is no impairment. Sensitivity analyses have been performed to evaluate whether reasonable unfavourable changes for the most relevant parameters would lead to impairment. The analyses focused on a deterioration in the average growth rate, reduced profitability and an increase in the discount rate. These analyses did not give rise to any impairment indications.
| Customer | Capitalised develop | |||||
|---|---|---|---|---|---|---|
| Software | Tenancy rights | relationships1) | ment expenditure | Goodwill1) | Total | |
| ACQUISITION COST | ||||||
| At 1 January 2018 | 21 | 3 | 194 | 3 | 754 | 975 |
| Investments | 7 | 1 | — | — | — | 8 |
| Divested subsidiary | — | — | – 20 | — | – 63 | – 83 |
| Translation effects | — | — | 6 | — | 28 | 34 |
| At 1 January 2019 | 28 | 4 | 180 | 3 | 719 | 934 |
| Investments | 5 | — | — | — | — | 5 |
| Acquisitions | — | — | 14 | — | 36 | 50 |
| Scrapping | — | — | — | – 3 | — | – 3 |
| Translation effects | — | — | 7 | — | 26 | 33 |
| At 31 December 2019 | 33 | 4 | 201 | — | 781 | 1,019 |
| ACCUMULATED DEPRECIATION/AMORTISATION | ||||||
| At 1 January 2018 | – 16 | – 3 | – 140 | – 3 | — | – 162 |
| Depreciation/amortisation for the year | – 2 | — | – 8 | — | — | – 10 |
| Divested subsidiary | — | — | 20 | — | — | 20 |
| Translation effects | — | — | – 2 | — | — | – 2 |
| At 1 January 2019 | – 18 | – 3 | – 130 | – 3 | — | – 154 |
| Depreciation/amortisation for the year | – 3 | — | – 8 | — | — | – 11 |
| Scrapping | — | — | — | 3 | — | 3 |
| Translation effects | – 1 | — | – 4 | — | — | – 5 |
| At 31 December 2019 | – 22 | – 3 | – 142 | — | — | – 167 |
| Carrying amount at 31 December 2018 | 10 | 1 | 50 | — | 719 | 780 |
| Carrying amount at 31 December 2019 | 11 | 1 | 59 | — | 781 | 852 |
1) Consists of acquired surplus values. Amortisation of customer relationships is included in Group selling expenses.
| Total | 781 | 719 |
|---|---|---|
| Nolato Jabar LLC | 36 | — |
| Integrated Solutions | ||
| Industrial Solutions | 224 | 214 |
| Medical Solutions | 521 | 505 |
| 2019 | 2018 | |
| Medical Solutions | Industrial Solutions | ||||
|---|---|---|---|---|---|
| 2019 | 2018 | 2019 | 2018 | ||
| Risk-free rate, % | 0.73 | 1.30 | 0.24 | 1.00 | |
| Tax rate, % | 17.8 | 19.3 | 17.8 | 17.9 | |
| Forecast period | 3 years | 3 years | 3 years | 3 years | |
| Growth after forecast period, % | 2.0 | 2.0 | 2.0 | 2.0 | |
| Applied discount rate before tax, % | 8.2 | 9.0 | 8.7 | 9.6 |
Property, plant and equipment are recognised within the Group at acquisition cost after accumulated depreciation according to plan and any impairment.
The principle of componentisation is applied for the depreciation of property, plant and equipment. This means that each component of an item of property, plant and equipment with a significant acquisition cost in relation to the asset's combined cost must be depreciated separately. Depreciation is applied on a straight-line basis and calculated based on the assets' original acquisition cost.
The carrying amount of an item of property, plant and equipment is removed from the balance sheet on scrapping or disposal, or when no future economic benefits are expected from using the asset. Any gain or loss arising from scrapping or disposing of an asset consists of the difference between the selling price and the carrying amount of the asset, with direct selling expenses deducted. Gains and losses are reported as other operating income/expense.
There is no depreciation of land. Other assets are depreciated on a straight-line basis over their expected useful life, taking into account the estimated residual value, as follows:
| Buildings | 25 years |
|---|---|
| Land improvements | 20–27 years |
| Injection moulding machines | 8–10 years |
| Automated assembly equipment | 3–5 years |
| Other machinery | 5–10 years |
| IT | 3 years |
| Other equipment, tools, fixtures and fittings | 5–10 years |
Useful life is based on the estimated period of time for which the asset generates income and is largely based on historical experience of the use of similar assets and technological development.
Property, plant and equipment is tested for impairment if an event occurs or circumstances change that indicate that it will not be possible to recover the carrying amount.
| Machinery and other | Equipment, tools, | Construction in progress | |||
|---|---|---|---|---|---|
| Buildings and land | technical facilities | fixtures and fittings | and advance payments | Total | |
| ACQUISITION COST | |||||
| At 1 January 2018 | 638 | 2,535 | 277 | 98 | 3,548 |
| Investments | 57 | 97 | 24 | 302 | 480 |
| Divested subsidiary | — | – 36 | – 10 | – 2 | – 48 |
| Sales/disposals | – 2 | – 39 | – 5 | — | – 46 |
| Reclassifications | 18 | 145 | 11 | – 174 | — |
| Translation effects | 19 | 57 | 6 | 4 | 86 |
| At 1 January 2019 | 730 | 2,759 | 303 | 228 | 4,020 |
| Investments | 11 | 103 | 15 | 159 | 288 |
| In new companies on acquisition | 19 | — | 2 | — | 21 |
| Sales/disposals | — | – 43 | – 2 | — | – 45 |
| Reclassifications | 88 | 223 | 12 | – 323 | — |
| Translation effects | 9 | 39 | 4 | 3 | 55 |
| At 31 December 2019 | 857 | 3,081 | 334 | 67 | 4,339 |
| ACCUMULTED DEPRECIATION AND IMPAIRMENT | |||||
| At 1 January 2018 | – 304 | – 1,793 | – 208 | — | – 2,305 |
| Depreciation/amortisation for the year | – 27 | – 184 | – 27 | — | – 238 |
| Divested subsidiary | — | 33 | 9 | — | 42 |
| Sales/disposals | 1 | 39 | 5 | — | 45 |
| Translation effects | – 5 | – 38 | – 3 | — | – 46 |
| At 1 January 2019 | – 335 | – 1,943 | – 224 | — | – 2,502 |
| Depreciation/amortisation for the year | – 33 | – 210 | – 29 | — | – 272 |
| Sales/disposals | — | 43 | — | — | 43 |
| Impairment losses due to restructuring | — | – 18 | — | — | – 18 |
| Translation effects | – 2 | – 22 | – 1 | — | – 25 |
| At 31 December 2019 | – 370 | – 2,150 | – 254 | — | – 2,774 |
| Carrying amount at 31 December 2018 | 395 | 816 | 79 | 228 | 1,518 |
| Carrying amount at 31 December 2019 | 487 | 931 | 80 | 67 | 1,565 |
In transitioning to IFRS 16 on 1 January 2019 the Group has used a modified retrospective method, meaning that the 2018 financial year is not recalculated. The lease liability is the sum of the net present value of all future lease payments for leases at the end of 2018. The simplification rule, that a right-of-use asset (prior to adjustments for any advance payments) should correspond to the lease liability, was applied at transition. All components, with the exception of property tax in Sweden, have been deemed to be a lease component. Exemptions to not recognise short-term leases and low-value assets have also been applied.
The discount rate is based on high-quality mortgage bond yields in Sweden, with reference to the term of leases, which for foreign companies are then adjusted for differences between 10-year government bond yields of Sweden and foreign countries. The largest asset class for leases is property, such as production plants and offices.
Leases consist mainly of rental contracts for production premises, primarily in China, the UK and Sweden. They are in some cases restricted by index clauses and/or such terms that may provide entitlement to extend or acquire the leased items.
| Buildings | Leasehold | Other equipment | Total | |
|---|---|---|---|---|
| ACQUISITION COST | ||||
| At 31 December 2018 | — | — | — | — |
| Transition to IFRS 16 Leases at 1 January 2019 | 336 | 15 | 11 | 362 |
| Revaluation of IFRS 16 lease liability due to restructuring in the UK | – 20 | — | — | – 20 |
| Other revaluations of IFRS 16 lease liabilities | – 3 | — | — | – 3 |
| Translation effects | 8 | — | — | 8 |
| At 31 December 2019 | 321 | 15 | 11 | 347 |
| ACCUMULATED DEPRECIATION/AMORTISATION | ||||
| At 31 December 2018 | — | — | — | — |
| Depreciation/amortisation for the year | – 71 | — | – 4 | – 75 |
| Other revaluations of IFRS 16 lease liabilities | 1 | — | — | 1 |
| Translation effects | 1 | — | — | 1 |
| At 31 December 2019 | – 69 | — | – 4 | – 73 |
| Carrying amount at 31 December 2018 | — | — | — | — |
| Carrying amount at 31 December 2019 | 252 | 15 | 7 | 274 |
for lease liabilities and changes during the year
| 2019 | |
|---|---|
| At 31 December 2018 | — |
| Transition to IFRS 16 Leases at 1 January 2019 | 362 |
| Revaluation of IFRS 16 lease liability due to restructuring in the UK | – 20 |
| Other revaluations of IFRS 16 lease liabilities | – 2 |
| Repayments | – 71 |
| Translation effects | 8 |
| At 31 December 2019 | 277 |
| Long-term financial lease liability | 207 |
| Short-term financial lease liability | 70 |
| Total financial lease liability | 277 |
| 2019 | |
|---|---|
| Matures 2020 | 70 |
| Matures 2021 | 57 |
| Matures 2022 | 47 |
| Matures 2023 | 24 |
| Matures 2024 and after | 79 |
| Total financial lease liability | 277 |
| Total in consolidated income statement | – 90 |
|---|---|
| Lease expenses for low-value assets | – 1 |
| Lease expenses for short-term leases | – 3 |
| Interest expenses on lease liabilities | – 11 |
| Amortisation of rights of use | – 75 |
| 2019 |
Financial assets are recognised in the balance sheet when the Group becomes a party to the commercial terms and conditions of the instrument. Financial instruments are initially recognised at fair value, which normally corresponds to the acquisition cost. Transaction costs are included in the initial valuation for financial assets not measured at fair value via profit or loss. Common purchases and sales of financial assets are recognised on the settlement date.
Accounts receivable are recognised at the first reporting date at their transaction price (according to the definition in IFRS 15) and subsequently at amortised cost. Recognition of expected credit losses is carried out at an amount corresponding to the expected credit losses for the remaining term. Term refers to the maximum contract period during which the Group is exposed to credit risk. For cash and cash
| 2019 | |
|---|---|
| Cost of goods sold | 80 |
| EBITDA (increase in performance indicator) | 80 |
| Amortisation in cost of goods sold | – 75 |
| EBITDA/EBIT (increase in performance indicator) | 5 |
| Interest expenses | – 11 |
| Profit after financial income and expenses | |
| (reduction in performance indicator) | – 6 |
| Tax | 1 |
| Profit after tax (reduction in performance indicator) | – 5 |
| Effect on basic earnings per share (SEK) | – 0.19 |
| 2019 | |
|---|---|
| Operating profit | 5 |
| Adjustments for items not included in cash flow: | |
| Depreciation/amortisation | 75 |
| Interest paid | – 11 |
| Cash flow from operating activities before changes | |
| in working capital | 69 |
| Other changes in working capital | 2 |
| Cash flow from operating activities | 71 |
| Cash flow from financing activities | – 71 |
| Cash flow for the period | — |
Recognised assets in the balance sheet attributable to leases amount to SEK 362 million at 1 January 2019. The commitment for leases in the 2018 annual report totalled SEK 213 million. The difference between the commitment for future lease payments and the opening lease liability at 1 January 2019 comprises discount effect, exercise of extension options, short-term contracts and leases relating to low-value assets.
equivalents, the carrying amount is considered to correspond to fair value. Cash and cash equivalents consist of cash assets and immediately available balances at banks and equivalent institutions, as well as short-term liquid investments maturing less than three months from the time of acquisition and which are exposed only to an insignificant risk of fluctuations in value.
Derivatives are categorised as held for trading, unless they are intended for hedge accounting, and are measured at fair value via profit or loss. Derivatives intended for hedge accounting are measured at fair value via other comprehensive income. The fair value of derivatives is based on listed market prices. Financial assets are removed from the balance sheet once the contractual rights to cash flows have ceased or been transferred, and when the risks and benefits associated with ownership of the financial asset have in all significant respects been transferred.
| Fair value via other com | Derivatives – identified | Derivatives at fair value | |||
|---|---|---|---|---|---|
| Amortised cost | prehensive income | for hedge accounting | via profit or loss | 2019 Total | |
| Non-current financial assets1) | 2 | 2 | |||
| Accounts receivable | 1,051 | 1,051 | |||
| Other current financial assets (see Note 30) | 2 | 3 | 5 | ||
| Cash and cash equivalents | 1,362 | 1,362 | |||
| Carrying amount | 2,413 | 2 | 2 | 3 | 2,420 |
| Fair value | 2,413 | 2 | 2 | 3 | 2,420 |
1) The holding concerns 20,000 shares in Arenabolaget i Ängelholm AB (Catena Arena). The value relates to the original transaction price (new share issue).
| Amortised | |
|---|---|
| cost | |
| Moody's: Aa3 | 18 |
| Standard & Poor's: AA+ | 57 |
| Standard & Poor's: AA- | 116 |
| Standard & Poor's: A+ | 844 |
| Standard & Poor's: A | 266 |
| Standard & Poor's: BBB+ | 40 |
| Standard & Poor's: BBB | 5 |
| No credit rating available for Acrevis Bank AG (Switzerland) | 11 |
| Other (credit rating not available) | 5 |
| 1,362 |
| Fair value via other | Derivatives | Derivatives at | |||
|---|---|---|---|---|---|
| comprehensive | – identified for | fair value via | |||
| Amortised cost | income | hedge accounting | profit or loss | 2018 Total | |
| Non-current financial assets1) | 2 | 2 | |||
| Accounts receivable | 949 | 949 | |||
| Other current financial assets (see Note 30) | 1 | 4 | 5 | ||
| Cash and cash equivalents | 953 | 953 | |||
| Carrying amount | 1,902 | 2 | 1 | 4 | 1,909 |
| Fair value | 1,902 | 2 | 1 | 4 | 1,909 |
1) The holding concerns 20,000 shares in Arenabolaget i Ängelholm AB (Lindab Arena). The value relates to the original transaction price (new share issue).
Financial assets categorised at amortised cost have determinable payments and are not listed on any marketplace. The category includes investments for which the Group expects to regain principally the entire initial investment, such as accounts receivable and bank deposits. The fair value of the currency forward contracts (derivatives) is set according to Level 2.
Level 1: In accordance with prices listed on an active market for the same instrument. Level 2: Based on directly or indirectly observable market data which is not included in Level 1. Level 3: Based on input data which is not observable in the market.
| Carrying amount | 1,051 | 949 |
|---|---|---|
| Deduction: Provision for expected credit losses | – 26 | – 14 |
| Accounts receivable | 1,077 | 963 |
| 2019 | 2018 |
The average period of credit in 2019 was 46 days (47). Accounts receivable as a percentage of sales amounted to 13.3% (11.7%). During the year, the Group reversed SEK 0 million (4) of provisions for expected credit losses at 1 January. Provisions for the year totalled SEK 12 million (14). The credit quality of accounts receivable not due and not impaired, and of other financial receivables is deemed to be good.
| Due | Due | Due | Due | |||
|---|---|---|---|---|---|---|
| Total | Not due | ≤ 15 days | 16–30 days | 31–60 days | > 60 days | |
| Expected gross amount | 1,077 | 922 | 98 | 28 | 11 | 18 |
| Expected credit losses | – 26 | – 25 | — | — | — | – 1 |
| 31 December 2019 | 1,051 | 897 | 98 | 28 | 11 | 17 |
| Expected gross amount | 963 | 828 | 78 | 16 | 25 | 16 |
| Expected credit losses | – 14 | – 10 | – 1 | – 2 | — | – 1 |
| 31 December 2018 | 949 | 818 | 77 | 14 | 25 | 15 |
Inventories are measured at the lower of the acquisition cost and the net market value. The acquisition cost of inventories is calculated by applying the first in, first out principle (FIFO), and includes expenditure arising on the acquisition of the inventory assets and on transporting them to their present location and condition. For finished goods and work in progress, the acquisition cost includes a reasonable proportion of indirect costs based on normal capacity.
The acquisition cost of inventories may need to be adjusted if the acquisition cost exceeds the net market value. The net market value is defined as the selling price after deductions for completion costs and selling expenses. The underlying assumptions used to establish the net market value of inventories can constitute an uncertainty factor. Since actual selling prices and selling expenses are not known at the time the assumption is made, management's assumption is based on current prices and cost levels. Adjustments to the net market value include assessments of technical and commercial obsolescence, which are conducted individually for each subsidiary. When assessing commercial obsolescence, risk factors include turnover rate and age.
| 2019 | 2018 | |
|---|---|---|
| Raw materials and supplies | 366 | 307 |
| Products in manufacturing | 74 | 54 |
| Finished goods and goods for resale | 227 | 205 |
| Total | 667 | 566 |
During the year, the Group impaired inventories by SEK 63 million (115). Impairment losses for the year are included in Cost of goods sold in the income statement.
During the year, reversed impairment losses recognised in Cost of goods sold totalled SEK 96 million (48). The reversal of previously impaired stocks is due to the fact that these items could be sold or were no longer deemed obsolete.
| Closing balance | 250 | 232 |
|---|---|---|
| development of production tools (see also Note 4) | 90 | 107 |
| Contract assets relating to development work and | ||
| Accrued income | 2 | 1 |
| Prepaid expenses | 44 | 34 |
| Other receivables | 114 | 90 |
| 2019 | 2018 | |
The Group aims to have a sound capital structure and financial stability. 'Capital' is defined as the Group's total reported shareholders' equity, i.e.:
| 2019 | 2018 | |
|---|---|---|
| Share capital | 133 | 132 |
| Other capital contributed | 298 | 228 |
| Translation reserve | 158 | 137 |
| Hedging reserves | 1 | – 1 |
| Retained earnings, incl. profit for the year | 2,376 | 2,096 |
| Total capital attributable to Parent Company | ||
| shareholders | 2,966 | 2,592 |
The Group has two Incentive Programmes: Incentive Programme 2016/2021 which may result in a dilution in the number of shares by 196,200 shares in 2020 and 193,500 shares in 2021, and Incentive Programme 2019/2024 which may result in a dilution of a maximum of 266,000 shares in 2023 and max. 266,000 shares in 2024. The maximum total number of dilutive shares consequently amounts to 921,700 shares. Further information can be found under Note 27.
73
The Board aims to maintain a good balance between a high return which can be achieved through higher borrowing and the advantages and security offered by a sound capital structure. The Board sets the Group's financial targets each year on the basis of this. These targets should be seen as average figures over the course of a business cycle. The extent to which these targets were achieved for 2019 is shown below.
| 2019 | 2018 | |||
|---|---|---|---|---|
| Financial | Financial | |||
| targets | Outcome | targets | Outcome | |
| EBITA margin | >10% | 11.3% | >10% | 11.7% |
| Cash conversion | >75% | 88.0% | >75% | 60.0% |
| Equity/assets ratio | >35% | 48.0% | >35% | 50.0% |
The Board's dividend proposal shall take into consideration Nolato's long-term development potential, financial position and investment needs. The Board's dividend policy means that the Board shall intend to propose a dividend which corresponds on average to at least 50% of profit after tax. For 2019, the Board proposes a dividend of SEK 14.50 per share (14.00), corresponding to SEK 385 million (368). The pay-out ratio is 55% (51).
| Hedging | Translation | ||
|---|---|---|---|
| reserves | reserve | Total | |
| Opening balance, 1 January 2018 | — | 101 | 101 |
| Cash flow hedges: | |||
| Loss from fair value measurement during the year | – 2 | — | – 2 |
| Tax from fair value measurement | 1 | — | 1 |
| Translation differences | — | 36 | 36 |
| Closing balance, 31 December 2018 | – 1 | 137 | 136 |
| Opening balance, 1 January 2019 | – 1 | 137 | 136 |
| Cash flow hedges: | |||
| Gain from fair value measurement during the year | 2 | — | 2 |
| Tax from fair value measurement | — | — | — |
| Translation differences | — | 21 | 21 |
| Closing balance, 31 December 2019 | 1 | 158 | 159 |
Hedging reserves include the effective portion of the accumulated net change in fair value of a cash flow hedging instrument attributable to hedged transactions regarding sales and costs of goods which have not yet occurred. Transfers to the income statement of cash flow hedges are recognised as other operating income/expenses.
The translation reserve includes all exchange rate differences arising on converting financial statements from foreign operations that have produced their financial statements in a currency other than that in which the Group's financial statements are produced. The Parent Company and the Group present their financial statements in Swedish kronor.
Financial liabilities are recognised in the balance sheet when the Group becomes a party to the commercial terms and conditions of the financial instrument. Financial liabilities are initially recognised at fair value, which normally corresponds to the acquisition cost. Transaction costs are included in the initial valuation for financial liabilities not measured at fair value via profit or loss. Derivatives are recognised at the trading date.
Loans and other financial liabilities, apart from derivatives, are measured at amortised cost, which is calculated using the effective interest method. For financial liabilities
that are hedging instruments used for hedge accounting, the carrying amount is adjusted for gains or losses attributable to the hedged risks.
Financial liabilities are removed from the balance sheet once they have been settled. Fair value has been provided as a disclosure for financial liabilities and with regard to non-current liabilities has been calculated using valuation techniques, primarily via discounted cash flows based on observable market information (Level 2). For current liabilities, carrying amount is deemed to be a good approximation of fair value.
| 2019 | 2018 | ||||
|---|---|---|---|---|---|
| Year of maturity | Carrying amount | Fair value | Carrying amount | Fair value | |
| Non-current financial liabilities | |||||
| Bank loan in CHF (fixed rate) | 2020 | — | — | 9 | 9 |
| Bank loan in CHF (fixed rate)* | 2021 | 527 | 508 | 501 | 473 |
| Bank loan in CHF (fixed rate) | 2022 | 5 | 5 | 5 | 5 |
| Bank loan in CHF (fixed rate) | 2023 | 7 | 7 | 7 | 7 |
| Bank loan in USD (variable rate) | 2022 | 88 | 88 | — | — |
| Lease liabilities (see Note 13) | 207 | 207 | — | — | |
| Subtotal of non-current financial liabilities | 834 | 815 | 522 | 494 | |
| Current financial liabilities | |||||
| Accounts payable | 2019–2020 | 839 | 839 | 594 | 594 |
| Bank loan in CHF (fixed rate) | < 12 months | 12 | 12 | 2 | 2 |
| Working capital finance USD (zero interest) | 57 | 57 | 88 | 88 | |
| Derivatives | — | — | 1 | 1 | |
| Derivatives identified for hedge accounting, at fair value via | |||||
| other comprehensive income (see Note 30) | 1 | 1 | 3 | 3 | |
| Lease liabilities (see Note 13) | 70 | 70 | — | — | |
| Subtotal of current financial liabilities | 979 | 979 | 688 | 688 | |
| Total | 1,813 | 1,794 | 1,210 | 1,182 |
*Comprises financing and also hedging instruments for hedging of net investment in foreign business, concerning Nolato Treff AG. This loan carries a fixed rate of interest until 27/09/2021 and is not being amortised. The fair value has been calculated using the current fixed interest rate and discounting has been applied for the remaining payment flows in CHF up until maturity on 27/09/2021. The discounted value in CHF has then been revalued according to the exchange rate at the balance sheet date.
At the end of the year, the Group's interest-bearing liabilities excluding pension liability and lease liabilities and including working capital finance amounted to SEK 696 million (612). The average interest rate was 0.7% (0.7). The average remaining fixed-interest term is 21 months (25).
Total credit lines granted in the Group amount to SEK 1,260 million (1,232). Of this amount, SEK 527 million matures on 27/09/2021 and SEK 600 million on 24/04/2022. Credit facilities totalling SEK 1,127 million are conditional upon normal covenants. These include requirements in terms of financial key ratios for the Group, including net debt in relation to operating profit before depreciation/amortisation (EBITDA). At 31 December, all loan conditions were met.
Other credit lines of SEK 133 million (131) mature between 2020 and 2023, according to the table above. Pledged assets for other credit facilities amount to SEK 86 million (97) and concern property mortgages in the Group's subsidiary in Switzerland. All loan agreements can be terminated by the other party in the event of any significant change in ownership control of the company.
The fair value of the currency forward contracts (derivatives) is set according to Level 2. Additional disclosures regarding financial risk management and hedge accounting are provided in Note 30 Financial risk management.
Level 1: In accordance with prices listed on an active market for the same instrument. Level 2: Based on directly or indirectly observable market data which is not included in Level 1. Level 3: Based on input data which is not observable in the market.
There are a number of both defined contribution and defined benefit pension schemes within the Group.
In defined contribution schemes, the company pays defined contributions to a separate legal entity and has no obligation to make further contributions. Expenses are charged to the consolidated profit as the benefits are earned.
In defined benefit schemes, remuneration to employees and former employees is payable based on their salary at the time they retired and the number of years earned. The Group bears the risk of ensuring that payments undertaken are made. Nolato's defined benefit schemes regarding PRI in Sweden are unfunded. These PRI obligations are recognised in the balance sheet as provisions.
For defined benefit schemes, the projected unit credit method is used to calculate the net present value of defined benefit obligations and costs regarding service during the financial year. Unless there have been significant changes to the most important assumptions in the calculation, such as discount rate and inflation, calculations are carried out on a quarterly basis. The schemes are always recalculated annually.
Independent actuaries are used for these calculations and the estimation of obligations and costs involving assumptions. The Group's undertakings are measured at the present value of expected future payments using a discount rate equal to the interest rate of top-rated housing bonds (Sweden) and corporate bonds (Switzerland) with a maturity equal to that of such undertakings.
Revaluations mainly arise in the event of changes to actuarial assumptions and experience-based adjustment, which is the difference between actuarial assumptions and actual outcome. They are recognised directly in other comprehensive income and never restated in profit or loss. For all defined benefit schemes, the actuarial cost, which is charged to earnings, comprises costs relating to service during the financial year, net interest expense and, where appropriate, the cost of service during previous periods, reductions and adjustments. Any cost relating to service during previous periods is recognised immediately. Net interest expenses are classified as financial expenses. Other costs are allocated to the businesses based on the employee's position in the organisation, within manufacturing, sales or administration.
The above-mentioned accounting policies for defined benefit schemes are only applied in the consolidated statements. Subsidiaries continue to use a local calculation for pension provisions and pension costs in their respective local annual accounts.
Commitments regarding retirement pensions and family pensions for salaried employees in Sweden are secured through a policy with Alecta. According to a statement issued by the Swedish Financial Reporting Board, UFR 10, this is a multiple-employer defined benefit scheme. For the 2019 financial year, the company had no access to any information that would enable it to recognise this scheme as a defined benefit scheme. The ITP pension scheme (supplementary pensions for salaried employees), which is insured by Alecta, is thus recognised as a defined contribution scheme.
The significant assumptions used to calculate the obligations and costs vary according to the economic factors that reflect conditions in the countries where the defined benefit schemes are located and are adjusted to reflect market conditions on the calculation date. However, changes in market and economic conditions may mean that the actual costs and obligations generated by the scheme differ substantially from the estimations.
Assumptions are made when estimating obligations and costs, and the most sensitive assumptions may vary between the schemes but primarily concern discount rate, pension indexing, future salary increases and assumptions regarding lifespan. These assumptions are determined separately for each scheme. The discount rate for schemes in Sweden is based on the return on housing bonds, which have maturities that are consistent with the maturity of the obligation. Correspondingly in Switzerland, the return on high quality AA-classified corporate bonds is used. Pension indexing is mainly relevant for retired members of the scheme and is attributable to changes linked primarily to inflation. Assumptions regarding salary increases are relevant for active members of the scheme and reflect previous experience of long-term changes, forecasts for future changes to terms and conditions and anticipated inflation. Assumptions about lifespan reflect the anticipated lifespan of members of the scheme and are determined based on the mortality table applicable to each scheme.
| Group | 2019 | 2018 |
|---|---|---|
| Net present value of defined benefit | ||
| pension schemes in Sweden | 155 | 131 |
| Net present value of pension scheme in Switzerland | 90 | 50 |
| Other pension schemes | 1 | 1 |
| Total | 246 | 182 |
In Sweden there is a defined benefit pension scheme (PRI) in which employees are entitled to remuneration after leaving their position based on their final salary and vesting period. In Switzerland, the Group has a defined benefit funded pension scheme in a Swiss pension fund. The fair value of the pension assets is established in accordance with Level 1: according to prices listed on an active market for the same instrument.
| 2019 | 2018 | |
|---|---|---|
| Balance on 1 January | 181 | 183 |
| Change in scheme provision in Switzerland | — | – 3 |
| Benefits vested during the period | 3 | 3 |
| Interest expenses | 3 | 3 |
| Benefits redeemed | — | — |
| Pension payments | – 5 | – 5 |
| Exchange rate effect | 3 | 4 |
| Actuarial gain (–)/loss (+) | 60 | – 4 |
| Total | 245 | 181 |
| Net debt, funded pension scheme* | 90 | 50 |
|---|---|---|
| Fair value of pension assets | – 293 | – 258 |
| pension scheme | 383 | 308 |
| Net present value of pension commitments, funded | ||
| 2019 | 2018 |
*The net present value of expected net debt for 2020 is SEK 94 million (balance sheet date rate at 31 Dec. 2019).
| 2019 | 2018 | |
|---|---|---|
| Cash and cash equivalents | 1.9% | 3.2% |
| Shares | 29.2% | 30.4% |
| Bonds | 43.8% | 44.1% |
| Property funds | 19.4% | 17.2% |
| Other investments | 5.6% | 5.1% |
The amounts recognised in the income statement during the year for pension schemes are as follows:
| Total pension expense | 112 | 99 |
|---|---|---|
| Expense for special employer's contribution | 11 | 9 |
| Expense for defined contribution schemes | 93 | 83 |
| schemes | 8 | 7 |
| Total expense for defined benefit pension | ||
| Expense for special employer's contribution | 2 | 1 |
| Interest expense | 3 | 3 |
| Expenses related to service during the financial year | 3 | 3 |
| 2019 | 2018 |
Costs relating to defined benefit pension schemes are recognised in the income statement as follows:
| Total | 8 | 7 |
|---|---|---|
| Interest expenses | 3 | 3 |
| Amounts charged to financial expenses: | ||
| Administrative expenses | 1 | 1 |
| Cost of goods sold | 4 | 3 |
| Amounts charged to operating profit: | ||
| 2019 | 2018 |
Costs relating to defined benefit pension schemes are recognised in other comprehensive income as follows:
| Total | – 55 | 2 |
|---|---|---|
| Deferred income tax | 11 | – 1 |
| Special employer's contribution | – 6 | – 1 |
| Actuarial gains (+)/losses (–) | – 60 | 4 |
| 2019 | 2018 | |
| 2019 | 2018 | |
|---|---|---|
| Discount rate | 1.40% | 2.30% |
| Inflation | 1.85% | 1.80% |
| Future annual salary increases | 2.75% | 2.75% |
| Employee turnover | 5.00% | 5.00% |
| Lifespan | DUS 14 | DUS 14 |
| Duration regarding pension commitments (years) | 18.0 | 17.0 |
| 2019 | 2018 |
|---|---|
| 0.20% | 0.85% |
| 1.00% | 1.00% |
| 0.50% | 0.50% |
| 1.00% | 1.00% |
| 0.00% | 0.00% |
| 17.8 | 17.3 |
| Sweden | Switzerland | |
|---|---|---|
| 2019 | 2019 | |
| Discount rate +0.5% | – 13 | – 29 |
| Discount rate –0.5% | 15 | 34 |
| Inflation +0.5% | 11 | 4 |
| Inflation –0.5% | – 10 | – 4 |
| Salary increase +0.5% | 5 | 5 |
| Salary increase –0.5% | – 3 | – 5 |
Charges for the year for pension insurance policies held with Alecta totalled SEK 7 million (6). Alecta's surplus can be allocated to policyholders and/or insured parties. At year-end 2019, Alecta's surplus, as expressed by the collective funding ratio, was a preliminary 148% (142). The collective funding ratio is determined by the fair value of Alecta's assets as a percentage of the pension commitments calculated according to Alecta's actuarial calculation assumptions, which do not comply with IAS 19.
In general, a provision is recognised when there is a commitment resulting from a past event, where it is likely that an outward flow of resources will be required to settle the commitment and a reliable estimation of the amount can be made. Provisions are made at an amount that is the best estimate of that required to settle the existing obligation at the balance sheet date, and the timing of the settlement is uncertain.
Provisions for product guarantees and customer claims represent management's best estimation of future cash flows required to settle the obligations.
Management is required to make significant judgements when establishing the need for and amount of provisions. Since there is a degree of uncertainty in estimates regarding future events that are outside the Group's control, the actual outcome may differ significantly. Provisions for product guarantees and customer claims are based on management's best estimation of the future cash flows required to settle obligations, even if the timing of the settlement is uncertain. Nolato does not normally take on full product responsibility, as we are largely a subcontractor of subcomponents for our customers. Nolato has manufacturing responsibility for subcomponents supplied and customer claims may arise over time.
| 2019 | 2018 | |
|---|---|---|
| Restoration of rental property | 15 | 10 |
| Special employer's contribution acc. to IAS 19 for | ||
| PRI pension liability | 16 | 11 |
| Special employer's contribution regarding | ||
| endowment insurance | 9 | 11 |
| Product guarantees and customer claims | 56 | 57 |
| Other | 3 | 2 |
| Amount at 31 December | 99 | 91 |
| 2019 | 2018 | |
|---|---|---|
| Customer advances, products | 1 | 1 |
| Contract liabilities relating to development work and | ||
| development of production tools (see also Note 4) | 239 | 298 |
| Other current liabilities | 76 | 57 |
| Accrued expenses and deferred income | ||
| Salary liabilities | 285 | 120 |
| Social security contributions | 58 | 52 |
| Deliveries of goods received, not invoiced | 31 | 59 |
| Energy costs | 21 | 18 |
| Rents | 4 | 29 |
| Claims | 67 | 98 |
| Maintenance | 22 | 36 |
| Tools | 4 | 2 |
| Machinery and spare parts | 13 | 19 |
| Other items | 48 | 53 |
| Subtotal of accrued expenses and deferred income | 553 | 486 |
| Total | 869 | 842 |
If an obligation fails to meet the criteria for recognition in the balance sheet, it may be treated as a contingent liability to disclose. Such obligations derive from past events and such events will only be confirmed by one or more uncertain future events that are not entirely within the Group's control occurring or not occurring. Contingent liabilities also include existing obligations where an outward flow of resources is unlikely, or where it is not possible to produce a sufficiently reliable estimation of the amount.
| 2019 | 2018 | |
|---|---|---|
| Property mortgages in Switzerland | 86 | 97 |
| Blocked bank deposits* | 13 | 37 |
*At 31 December 2018, SEK 24 million relates to bank deposits blocked until 11/11/2019 and SEK 13 million until 13/01/2020.
| 2019 | 2018 | |
|---|---|---|
| Guarantee commitments, FPG/PRI | 2 | 2 |
The Group's transactions with senior executives in the form of salaries and other remuneration, benefits, pensions and severance pay agreements with the Board and the President and CEO are detailed in Note 27.
There are no known transactions with related parties.
The following subcomponents are included in cash and cash equivalents:
| cash flow statement | 1,362 | 953 |
|---|---|---|
| Total cash and cash equivalents reported in the | ||
| Credit balance on Group account in Parent Company | 218 | 59 |
| Cash and bank balances | 1,144 | 894 |
| 2019 | 2018 | |
At the balance sheet date, unutilised credit within the Group stood at SEK 621 million (708).
In 2019, Nolato acquired US-based Ja-Bar Silicone Corporation. The purchase price transferred for the company was SEK 93 million and cash and cash equivalents acquired totalled SEK 0 million.
| 2019 | 2018 | |
|---|---|---|
| Opening balance for non-current and current | ||
| financial liabilities | 616 | 638 |
| Changes affecting cash flow | ||
| Borrowings | 89 | 5 |
| Repayment of loans | – 107 | – 72 |
| Changes not affecting cash flow | ||
| Translation effects | 35 | 41 |
| Transition to IFRS 16 Leases, see Note 13 | 340 | — |
| Derivatives | 1 | 4 |
| Closing balance for non-current and current | ||
| financial liabilities | 974 | 616 |
In January, Nolato announced that it plans to close a production unit in the UK in 2020. Costs relating to the closure have been accounted for in part in the fourth quarter of 2019 and are expected to impact the first quarter of 2020 as well. No other significant events have occurred since the end of the period, but Nolato is operating in an environment that at the time of the annual report's publication is affecting primarily our China-based operations in various ways due to the spread of COVID-19.
A director's fee is paid to the Chairman and members of the Board as decided by the annual general meeting. No director's fee is paid to employees of the Group or to employee representatives. Remuneration for the President and CEO and other senior executives is made up of a base salary, variable remuneration, other benefits and a pension. Senior executives are individuals who, together with the President and CEO, constitute Group management. In 2019, Group management comprised four individuals, in addition to the President and CEO. These are CFO Per-Ola Holmström, President of Medical Solutions Johan Iveberg, President of Integrated Solutions Jörgen Karlsson and President of Industrial Solutions Johan Arvidsson. For further information, see page 46.
Any assignment taken on by individual Board members on behalf of the company in addition to Board work is remunerated at market rates. Assignments should be documented in agreements specifying the type of assignment and agreed remuneration. Remuneration is paid in arrears on completion of the assignment.
The Board of Directors has appointed a Remuneration Committee, consisting of the Chairman of the Board and one other Board member. The committee has proposed, and the Board of Directors has approved, the current principles for variable remuneration. The committee has made decisions on all remuneration and benefits for the President and CEO, which have been presented to and approved by the Board. The committee has approved the remuneration of Group management.
Bonuses paid to the President and CEO and other senior executives are based on the outcome of profit and return on capital employed. The maximum outcome is 50% of base salary for the CEO and 40% for other senior executives. At the same time, the relevant profit centre must report positive earnings. In 2019, the outcome for the President and CEO was 41% of base salary (50) and for senior executives it was 16–32% of base salary (20–40).
Participants in Nolato's three incentive programmes are offered the opportunity to receive a bonus payment corresponding to half of the participant's warrant premiums and the income tax charged on such bonus payment, provided that the participant's employment at the company does not cease before three years have elapsed.
An extraordinary general meeting of 5 December 2016 approved the issue of up to 798,000 share warrants in three different series: Series 2016/2019, Series 2017/2020 and Series 2018/2021 with 266,000 warrants in each series, granting the right to subscribe for as many B shares. Each warrant thus entitles the holder to subscribe for one (1) new B share. The programme was offered to some twenty individuals within Nolato's management. The maximum dilution effect of the Incentive Programme's two remaining series is expected to amount to a total of approximately 1.5% of share capital and 0.8% of votes (calculated on the basis of the number of existing shares), assuming full exercise of all warrants.
Total subscribed warrants amounted to 240,600 and all have been exercised to subscribe for shares in 2019.
Total subscribed warrants amounted to 196,200 and the price per warrant was SEK 16.60. The issue price for a B share is SEK 485.10. The warrants can be exercised to subscribe for shares as of 1 May 2020 up to and including 15 December 2020.
Total subscribed warrants amounted to 193,500 and the price per warrant was SEK 17.80. The issue price for a B share is SEK 502.00. The warrants can be exercised to subscribe for shares as of 1 May 2021 up to and including 15 December 2021.
The ordinary general meeting of 8 May 2019 approved the issue of up to 798,000 share warrants in three different series: Series 2019/2022, Series 2020/2023 and Series 2021/2024 with 266,000 warrants in each series, granting the right to subscribe for as many B shares. Each warrant thus entitles the holder to subscribe for one (1) new B share. The programme was offered to some twenty individuals within Nolato's management. The maximum dilution effect of all of the Incentive Programmes' three series is expected to amount to a total of approximately 3% of share capital and 1.6% of votes (calculated based on the number of existing shares), assuming full subscription and full exercise of all warrants.
No warrants were subscribed for in this series.
The retirement age for the President and CEO and other senior executives is 65. The President and CEO's pension premium amounted to 25% (24) of pensionable salary, and follows a defined contribution pension scheme.
Other senior executives have defined contribution pension schemes. For 2019, the average pension premium was 22% of base salary (21). Variable remuneration does not qualify as pensionable income.
The President and CEO and other senior executives shall provide a notice period of six months. In the event of termination by the company, a notice period of 12–24 months applies. Any other income that is received during the notice period shall be deducted from the salary and other remuneration payable during the notice period. Both the President and CEO and other senior executives collect base salary and other benefits during the notice period. There is no remuneration after the notice period.
| 2019 | 2018 | ||||
|---|---|---|---|---|---|
| Men | Women | Men | Women | ||
| Parent Company Board including CEO | 8 | 3 | 8 | 3 | |
| Group management including CEO | 5 | — | 5 | — |
| Base salary/ | Other | Pension | Other | |||
|---|---|---|---|---|---|---|
| SEK thousand | Directors' fee1) | Bonus2) | benefits3) | premiums | remuneration4) 5) | Total |
| Remuneration and other benefits in 2019 | ||||||
| Chairman of the Board, Fredrik Arp5) | – 445 | — | — | — | – 150 | – 595 |
| Board member, Dag Andersson | – 215 | — | — | — | — | – 215 |
| Board member, Sven Boström-Svensson | – 215 | — | — | — | — | – 215 |
| Board member, Lovisa Hamrin | – 215 | — | — | — | — | – 215 |
| Board member, Åsa Hedin | – 215 | — | — | — | — | – 215 |
| Board member, Henrik Jorlén | – 262 | — | — | — | — | – 262 |
| Board member, Lars-Åke Rydh | – 285 | — | — | — | — | – 285 |
| Board member, Jenny Sjödahl | – 215 | — | — | — | — | – 215 |
| President and CEO, Christer Wahlquist | – 4,320 | – 2,376 | – 192 | – 1,060 | – 104 | – 8,052 |
| Other senior executives in Group management (four people) | – 12,453 | – 4,049 | – 446 | – 2,780 | – 228 | – 19,956 |
| Total | – 18,840 | – 6,425 | – 638 | – 3,840 | – 482 | – 30,225 |
| Remuneration and other benefits in 2018 | ||||||
| Chairman of the Board, Fredrik Arp5) | – 375 | — | — | — | – 150 | – 525 |
| Board member, Dag Andersson | – 200 | — | — | — | — | – 200 |
| Board member, Sven Boström-Svensson | – 200 | — | — | — | — | – 200 |
| Board member, Lovisa Hamrin | – 200 | — | — | — | — | – 200 |
| Board member, Åsa Hedin | – 200 | — | — | — | — | – 200 |
| Board member, Henrik Jorlén | – 243 | — | — | — | — | – 243 |
| Board member, Lars-Åke Rydh | – 265 | — | — | — | — | – 265 |
| Board member, Jenny Sjödahl | – 200 | — | — | — | — | – 200 |
| President and CEO, Christer Wahlquist | – 4,080 | – 2,461 | – 187 | – 986 | – 336 | – 8,050 |
| Other senior executives in Group management (four people) | – 12,096 | – 4,192 | – 414 | – 2,565 | – 166 | – 19,433 |
| Total | – 18,059 | – 6,653 | – 601 | – 3,551 | – 652 | – 29,516 |
1) Including remuneration for committee work. According to AGM decision regardless of payment period.
2) Bonus pertains to expensed remuneration for the financial year, payable in the following year.
3) 'Other benefits' primarily pertains to company cars.
4) 'Other remuneration' relates to the President and CEO and other senior executives regarding previous holiday entitlements paid, and other remuneration.
5) Fredrik Arp has invoiced SEK 150,000 for other agreed services. Remuneration received has been offset against for social security contributions.
| The company's auditing firm has received remuneration: | |
|---|---|
| -------------------------------------------------------- | -- |
| Total | – 5,090 | – 3,580 |
|---|---|---|
| Other assignments | – 227 | – 186 |
| Taxation assignments | – 314 | – 56 |
| Auditing | – 4,549 | – 3,338 |
| EY | ||
| SEK thousand | 2019 | 2018 |
Auditing relates to reviewing the annual report and accounts, as well as the administration of the Board of Directors and the President and CEO, other duties required of the company's auditor and providing advice or other assistance resulting from observations in relation to such review or carrying out such other duties.
Remuneration to other auditing firms for auditing assignments has amounted to SEK 854,000 (82,000).
| 2019 | 2018 | |||
|---|---|---|---|---|
| Number | Of which men | Number | Of which men | |
| Parent Company in Sweden | ||||
| Nolato AB, Torekov | 10 | 70% | 9 | 78% |
| Subsidiaries in Sweden | ||||
| Nolato Cerbo AB, Trollhättan | 142 | 70% | 136 | 68% |
| Nolato Gota AB, Götene | 256 | 67% | 245 | 80% |
| Nolato Hertila AB, Åstorp | — | — | 14 | 71% |
| Nolato Lövepac AB, Skånes Fagerhult | 46 | 59% | 47 | 60% |
| Nolato MediTech AB, Hörby | 293 | 70% | 256 | 67% |
| Nolato MediTor AB, Torekov | 85 | 52% | 77 | 55% |
| Nolato Plastteknik AB, Gothenburg | 137 | 69% | 122 | 70% |
| Nolato Polymer AB, Torekov | 88 | 81% | 74 | 77% |
| Nolato Silikonteknik AB, Hallsberg | 78 | 64% | 75 | 71% |
| 1,125 | 68% | 1,046 | 70% | |
| Subsidiaries abroad | ||||
| Cerbo France Sarl, France | 1 | 0% | 1 | 0% |
| Lövepac Converting Ltd, China | 153 | 35% | 253 | 42% |
| Lövepac Converting Private Ltd, India | — | — | 2 | 100% |
| Lövepac Technology (Shenzhen) Co., Ltd, China | 83 | 40% | 52 | 44% |
| Nolato Mobile Comm. Polymers (Beijing) Ltd, China | 2,431 | 48% | 3,053 | 51% |
| Nolato Contour, Inc., US | 281 | 59% | 233 | 55% |
| Nolato EMC Kft, Hungary | 12 | 83% | 9 | 56% |
| Nolato EMC Production Center SDN BHD, Malaysia | 136 | 46% | 131 | 55% |
| Nolato Hungary Kft, Hungary | 695 | 45% | 711 | 43% |
| Nolato Jaycare Ltd, UK | 249 | 75% | 250 | 74% |
| Nolato Medical Device Co. Ltd, China | 62 | 56% | 52 | 62% |
| Nolato Romania Srl, Romania | 56 | 41% | 56 | 41% |
| Nolato Silikonteknik (Beijing) Co., Ltd, China | 209 | 50% | 229 | 51% |
| Nolato Stargard Sp.zo.o., Poland | 121 | 24% | 113 | 24% |
| Nolato Technology (Suzhou) Co., Ltd, China | 89 | 43% | 53 | 43% |
| Nolato Treff AG, Switzerland | 228 | 72% | 196 | 72% |
| 4,806 | 50% | 5,394 | 51% | |
| 5,941 | 53% | 6,449 | 54% |
Operations are conducted on the basis of a financial policy established by the Board, which specifies rules and guidelines for how the various financial risks shall be dealt with. The following significant risks are identified in the financial policy: Foreign exchange risk, interest rate risk, financing risk, and credit and liquidity risk. Currency and fixed income derivatives are used as hedging instruments in accordance with the Board's guidelines.
As a borrower and through its extensive operations outside Sweden, the Nolato Group is exposed to various financial risks. Nolato's financial policy specifies guidelines for how these risks should be managed within the Group. This policy outlines the aim, organisation and allocation of responsibilities of the Group's financial operations, and is designed to manage the described risks. The CFO initiates and, if necessary, proposes updates to the financial policy, and issues internal instructions in order to ensure compliance with the policy within operating activities. The Board then evaluates and adopts the proposed changes to the financial policy on an annual basis or as necessary.
The Group's financial management is centralised within the Group's financial department, and acts as a staff service body. The Group staff is responsible for the Group companies' external banking relationships, liquidity management, net financial income/expense and interest-bearing liabilities and assets, as well as for the group-wide payment system, in the form of the internal bank. This centralisation involves significant economies of scale, a lower financing cost and better internal control and management of the Group's financial risks. Within the framework of the financial policy, there is the opportunity to utilise foreign exchange and fixed income instruments. During the year, trading was only carried out in currency derivatives.
The Group is exposed to exchange rate fluctuations in future payment flows attributable to both contracted and anticipated commercial undertakings, as well as loans and investments in foreign currency – transaction exposure. The Group's financial statements are also affected by translation effects when translating the earnings and net assets of foreign subsidiaries into Swedish kronor – translation exposure.
Transaction exposure derives from the Group's sales and purchases in various currencies. This foreign exchange risk consists of both the risk of fluctuations in the value of financial instruments, i.e. accounts receivable and accounts payable, and the foreign exchange risk in anticipated and contracted payment flows.
In 2019, Nolato's sales to countries outside Sweden accounted for 85% (86) of total sales. The largest flow currencies for the Swedish units were EUR and USD, with EUR being a net outward flow and USD being a net inward flow. The China-based operations had a net exposure largely in CNY/USD.
Nolato carries out short-term currency hedging for part of the Group's net exposure in foreign currencies. The aim of hedging the currency exposure is to even out fluctuations in earnings. According to this policy, Nolato shall hedge the net flow of the forecast inward and outward flow of currencies over a rolling 12-month period. In the event that the net flow in an individual currency is less than SEK 50 million, there is no hedging requirement. The hedging levels for the flows in each currency shall be within the following ranges:
| Range | Hedged flow |
|---|---|
| 1–3 months in the future | 60–80% |
| 4–6 months in the future | 40–60% |
| 7–9 months in the future | 20–40% |
| 10–12 months in the future | 0–20% |
Individual investments in machinery are hedged at 100% in the event that the currency flow has a countervalue exceeding SEK 3 million. The consolidated income statement includes exchange rate differences in a net amount of SEK –3 million (1) in operating profit.
Foreign exchange risks in financial flows relating to loans and investments in foreign currencies can be avoided by the Group's companies borrowing in local currencies or hedging these flows. According to this policy, any such hedging or risk-taking is decided on a case-by-case basis. Any hedging costs and any differences in interest
rate levels between countries are taken into consideration in decisions on any possible risk-taking in relation to financial flows. During the year, there were exchange rate differences of SEK –11 million (–7) in net financial income/expense.
At the end of 2019, the Group had the following currency hedges in relation to anticipated payment flows in CNY, EUR, GBP and USD for 2020. The derivatives used are forwards and currency swaps. The volume and scope of the contracts are stated below in nominal terms.
Currency forward contracts entered into but unutilised are detailed in the table below. The fair value at 31 December 2019 was SEK 4 million (1). The fair value of contracts identified as cash flow hedges that meet the conditions for hedge accounting was SEK 1 million (–2).
| Nominal value according to | Average rate | Reported in other | |||
|---|---|---|---|---|---|
| SEKm | contract | (SEK) | Fair value | Reported in profit/loss | comprehensive income |
| CNY (net sales) | 252 | 1.3263 | 1 | 2 | — |
| Q2-2020 | 252 | 1.3263 | |||
| EUR (net purchasing) | – 79 | 10.5577 | — | — | — |
| Q1-2020 | – 22 | 10.5577 | |||
| Q2-2020 | – 27 | 10.5577 | |||
| Q3-2020 | – 21 | 10.5577 | |||
| Q4-2020 | – 9 | 10.5577 | |||
| GBP (net sales) | 72 | 12.2861 | 1 | — | — |
| Q4-2020 | 72 | 12.2861 | |||
| USD (net sales) | 382 | 9.2971 | 2 | – 2 | 1 |
| Q1-2020 | 41 | 9.4174 | |||
| Q2-2020 | 37 | 9.4679 | |||
| Q3-2020 | 26 | 9.5477 | |||
| Q4-2020 | 278 | 9.2343 | |||
| Total | 627 | 4 | — | 1 | |
Gains and losses in other comprehensive income in relation to currency forward contracts at 31 December 2019 will be transferred to the income statement at various dates within one year of the balance sheet date.
| Total | 410 | 196 | 48% | |
|---|---|---|---|---|
| USD | 243 | 117 | 48% | 9.4542 |
| EUR | 167 | 79 | 47% | 10.5577 |
| SEKm | 12-month estimated net flows |
Total hedges | Percentage | Average rate |
The contracts are included at fair value in the balance sheet, and the change in value is recognised in other comprehensive income. When the contracts are realised, the accumulated change in value is booked to the income statement. In 2019, the effect of the currency derivatives on operating profit was SEK 1 million (–2).
| Total | 214 | +/– 10 | |
|---|---|---|---|
| USD | 126 | +/– 5% | +/– 6 |
| EUR | 88 | +/– 5% | +/– 4 |
| SEKm | 12-month unhedged estimated net flows |
Exchange rate change |
Impact on earnings |
At the end of the year, the Group had SEK 214 million in unhedged estimated currency flows, including effects from currency hedges. A change in the value of the Swedish krona of +/–5% would have an impact of SEK +/–10 million on profit.
Foreign exchange risks also exist in the translation of foreign subsidiaries' assets, liabilities and profit into the Parent Company's functional currency. This is known as translation exposure. Nolato's policy is that net investments in shareholders' equity in foreign currency are not normally currency-hedged, but may be in some cases following a separate decision. Translation differences reported in other comprehensive income are detailed in Note 18 Other reserves.
| 5% increase in | |||
|---|---|---|---|
| SEKm | Net assets | value of krona | |
| Nolato Romania, RON | 7 | — | |
| Nolato Holding USA, USD | 88 | – 4 | |
| Nolato Holdings UK, GBP | 138 | – 7 | |
| Nolato Automotive Components (Beijing), CNY | – 1 | — | |
| Nolato Medical Device (Beijing), CNY | – 23 | 1 | |
| Nolato Mobile Comm. Polymers (Beijing), CNY | 612 | – 31 | |
| Nolato Technology (Suzhou), CNY | 38 | – 2 | |
| Nolato Silikonteknik (Beijing), CNY | 19 | – 1 | |
| Lövepac Converting, CNY | 35 | – 2 | |
| Lövepac Converting India, INR | – 22 | 1 | |
| Lövepac Technology (Shenzhen), CNY | – 21 | 1 | |
| Nolato EMC Prod. Center, USD | 21 | – 1 | |
| Nolato Hungary, EUR | 455 | – 23 | |
| Nolato EMC Hungary, EUR | 1 | — | |
| Nolato Stargard, PLN | 10 | — | |
| Cerbo France, EUR | — | — | |
| Total | 1,357 | – 68 |
The Group has SEK 1,357 million in foreign net assets, mainly in China, Hungary and the UK. A five percentage point appreciation of the Swedish krona would have an impact of SEK –68 million on the net assets in the Group. The Group has no exposure in Nolato Treff AG's net assets, as any translation effects are evened out by a loan in CHF in the Parent Company.
Interest rate risk is the risk that the Group's net interest income/expense will be weakened in the event of changes to market interest rates. At 31 December, interest-bearing liabilities with credit institutions amounted to SEK 696 million (612). The fixed interest term on the Group's loans and investments determines how quickly interest rate changes affect earnings. In order to limit the Nolato Group's interest rate risk, the portion of those interest-bearing liabilities exceeding SEK 400 million must have a fixed interest maturity structure as follows:
– Up to one year: 35–65%
– More than one year: 35–65%
The target for investing excess liquidity is to achieve the best possible return with regard to credit risk and the liquidity of the investments. The policy stipulates that investments may only be carried out in interest-bearing securities or bank deposits. The term of the investments may not exceed three months.
Breakdown of interest-bearing liabilities by currency

Interest rate effect on interest-bearing liabilities at year-end

An increase in the interest rate of one percentage point based on the interest-bearing liabilities at the end of the year would result in additional interest expenses within the Group of SEK 12 million.
Liquidity risk, also known as financing risk, relates to the risk of the Group having problems accessing capital. In order to maintain financial flexibility and meet the Group's capital requirements, contractual credit facilities are in place with various contract lengths. This both enables the financing of fluctuations and organic growth, and provides the Group with capacity for large investments and acquisitions.
Nolato has credit lines granted of SEK 1,260 million, of which SEK 527 million matures on 27/09/2021, SEK 600 million matures on 24/04/2022 and SEK 133 million between 2020 and 2023.
| Outstanding | Future interest expense | Term out | Fixed interest | ||
|---|---|---|---|---|---|
| amount (SEKm) | during term outstanding | standing (mths) | period outst. (mths) | Average interest (%) | |
| Interest-bearing liabilities | |||||
| Bank loans, USD | – 88 | 5 | 28 | 28 | 2.5 |
| Bank loans, CHF | – 551 | 7 | 21 | 21 | 0.7 |
| Working capital finance, USD | – 57 | — | |||
| Lease liability, CHF | – 4 | 0.9 | |||
| Lease liability, CNY | – 101 | 4.4 | |||
| Lease liability, EUR | – 2 | 4.7 | |||
| Lease liability, GBP | – 24 | 2.2 | |||
| Lease liability, PLN | – 22 | 3.8 | |||
| Lease liability, RON | – 3 | 5.6 | |||
| Lease liability, SEK | – 119 | 2.3 | |||
| Lease liability, USD | – 2 | 5.0 | |||
| Pension liability, SEK | – 156 | 2.1 | |||
| Pension liability, CHF | – 90 | 3.8 | |||
| Total | – 1,219 | 12 | 1.8 | ||
| Interest-bearing assets | |||||
| Cash and cash equivalents | 1,362 | 1.6 | |||
| Net financial assets | 143 |
As part of the financing of the Group's subsidiaries, the Parent Company has issued internal loans in GBP to the UK and in USD to the US. The repayment of these loans has been hedged according to the table below. Hedge accounting is not applied for these currency swaps.
| Subsidiaries | Currency swap | Selling price | Maturity date |
|---|---|---|---|
| Nolato Holding USA Inc., US | USD 28 million | 9.2293 | 16 December 2020 |
| Nolato Holdings UK Ltd, UK | GBP 6 million | 12.2861 | 16 December 2020 |
At 31 December the Group's financial liabilities stood at SEK 2,059 million (1,392). Non-interest-bearing liabilities are attributable primarily to accounts payable, with the term outstanding shown in the table below.
| 1–3 | 4–12 | ||||
|---|---|---|---|---|---|
| Maturity | < 1 month | months | months | > 1 year | Total |
| Accounts payable | 483 | 319 | 36 | 1 | 839 |
Credit risk refers to an exposure to loss in the event that a counterparty to a financial instrument is unable to fulfil its commitments. Nolato is exposed to credit risk through its operational activities and some of its financial activities.
The Group's maximum credit risk exposure is SEK 2,420 million (1,909) at the balance sheet date. The exposure comprises the carrying amount of all financial assets.
| Total | 2,420 | 1,909 |
|---|---|---|
| Cash and cash equivalents | 1,362 | 953 |
| Derivatives | 5 | 5 |
| Other receivables | 2 | 2 |
| Contract assets relating to development work and development of production tools (see also Note 4) |
90 | 107 |
| Accounts receivable | 1,051 | 949 |
| 2019 | 2018 | |
Accounts receivable are continually analysed at operating level within the Group. Accounts receivable are subject to credit checks and approval procedures exist in all Group companies.
In accordance with the Group's financial policy on credit risk for financial activities, the Group only deals with well-established financial institutions. Transactions are undertaken within set limits and credit exposure per counterparty is continually analysed.
The Nolato Group has entered into ISDA contracts (International Swaps and Derivatives Association, Inc.) with essentially all of these financial institutions. An ISDA contract is classified as an enforceable netting arrangement. One function of an ISDA contract is that it allows the Nolato Group to calculate credit exposure on a net basis, i.e. the difference between the Group's claims and liabilities per counterparty. The agreement between the Group and the counterparty enables net payment of derivatives when both parties choose this method. In the event of failure to pay by either party, the counterparty is able to choose to pay net. Transactions are undertaken within set limits and credit exposure per counterparty is continually analysed. At the balance sheet date, the Group had derivative assets of SEK 5 million (5) and derivative liabilities of SEK 1 million (4) included in enforceable netting arrangements.
The Group applies hedging to reduce risks attributable to volatility in balance sheet items and future cash flows, which would otherwise affect profit or loss. A distinction is made between cash flow hedging, fair value hedging and hedging of net investments in foreign operations, based on the nature of the hedged item.
Derivatives that constitute effective financial hedges, but that either do not qualify for hedge accounting according to IFRS 9 or that the Group chooses not to apply hedge accounting for, are recognised in the same way as instruments held for trading. In such cases, changes to the fair value of financial hedges are recognised immediately in profit or loss as financial income or expense, or in operating profit depending on the nature of the hedged item.
Hedge accounting has been applied to derivative instruments that effectively counteract variations in the cash flow from forecast sales. Changes in the fair value of such derivative instruments identified as hedging instruments and that satisfy the criteria for hedging of future cash flows are recognised in hedging reserves in shareholders' equity via other comprehensive income.
Hedge accounting has been applied to financial instruments that effectively counteract the Group's exposure to effects arising on conversion of Nolato Treff AG's net assets into the Parent Company's functional currency. Gains and losses in hedging instruments that satisfy the requirements for hedging of net investments are recognised in the translation reserve in shareholders' equity via other comprehensive income.
At the balance sheet date, the Group hedged a nominal amount of CHF 55 million (55) of net investment in foreign operations against changes to the CHF/SEK exchange rate. A CHF loan in the amount of CHF 55 million (55) was used as a hedging instrument.
The result of the hedge amounted to SEK –26 million (–37) before tax for 2019 and was recognised directly in the translation reserve via other comprehensive income. During the year, no gains/losses from hedging reserves were reclassified via other comprehensive income to profit or loss to match the reclassification of the accumulated currency translation difference in the hedged subsidiary's equity.
Description of the company
Nolato has acquired US-based Ja-Bar Silicone Corporation. The company, which has annual sales equivalent to approximately SEK 150 million with good profitability, strengthens Nolato's offering in process- and materials-based electronics shielding solutions for electromagnetic compatibility or 'EMC'.
Nolato has acquired the business, consisting of net assets of Ja-Bar Silicone Corporation, controlling influence has been obtained and the company was consolidated into the Nolato Group as of 18 December. The acquisition was reported using the acquisition method, with the total purchase price being allocated among the assets acquired and liabilities assumed based on their fair values. Fair value of the net assets was determined using generally accepted principles and methods. The purchase price comprises a cash payment. The acquired business will be reported under the Integrated Solutions business area. If the company had been owned for the full year, the acquisition would have contributed SEK 157 million to the Nolato Group's sales in 2019. The transaction is expected to have a marginal positive effect on Nolato's earnings per share in 2020. The acquisition analysis is still preliminary as the value of the assets and liabilities assumed from the acquisition has not yet been finally established.
| Goodwill | 36 |
|---|---|
| Less fair value of acquired net assets (according to spec. below) | – 57 |
| Consideration transferred | 93 |
Goodwill arising in connection with the transaction consists of synergies that are expected to be achieved primarily as a result of increased sales volumes for the Nolato Group to customers in the Integrated Solutions business area. But also partly by means of lower costs through better purchasing terms from external suppliers, and other involvement at different levels in the Integrated Solutions business area. The goodwill is tax-deductible according to US tax rules.
| Balance sheet at | Adjustment to | Fair | |
|---|---|---|---|
| time of acquisition | fair value | value | |
| Non-current intangible assets | — | 14 | 14 |
| Property, plant and equipment | 21 | — | 21 |
| Current assets | 35 | — | 35 |
| Deferred tax liabilities | — | – 4 | – 4 |
| Current liabilities | – 9 | — | – 9 |
| Net assets acquired | 47 | 10 | 57 |
Non-current intangible assets in the form of customer relationships are estimated to amount to SEK 14 million and will be amortised for accounting purposes over a period of 10 years. Gross value, fair value and the value expected to be settled on for the balance sheet item 'Accounts receivable' are all SEK 14 million. Acquisition expenses of SEK 3 million were expensed as other operating expenses.
| – 93 |
|---|
| — |
| – 93 |
| 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|
| Performance indicators according to IFRS1) | |||||
| Operating profit (EBIT) (SEK million) | 887 | 941 | 749 | 443 | 556 |
| Basic earnings per share after tax (SEK)* | 26.60 | 27.44 | 21.74 | 12.77 | 15.97 |
| Performance indicators (alternative performance measures)1) | |||||
| Reversal of amortisation of intangible assets arising in connection with acquisitions | 8 | 8 | 14 | 14 | 14 |
| Operating profit (EBITA) (SEK million) | 895 | 949 | 763 | 457 | 570 |
| Performance indicators per share (alternative performance measures)1) | |||||
| Profit/loss after tax for the year (SEKm) | 703 | 722 | 572 | 336 | 420 |
| Reversal of amortisation of intangible assets arising in connection with acquisitions | 8 | 8 | 14 | 14 | 14 |
| Tax on reversal of amortisation of intangible assets arising in connection with acquisitions | – 2 | – 2 | – 3 | – 3 | – 4 |
| Adjusted profit/loss after tax (SEKm) | 709 | 728 | 583 | 347 | 430 |
| Average number of shares before dilution* | 26,431,806 | 26,307,408 | 26,307,408 | 26,307,408 | 26,307,408 |
| Adjusted basic earnings per share after tax (SEK)* | 26.82 | 27.67 | 22.16 | 13.19 | 16.35 |
| Sales and profit (alternative performance measures)1) | |||||
| Net sales (SEK million) | 7,919 | 8,102 | 6,720 | 4,447 | 4,726 |
| Sales growth (%) | – 2 | 21 | 51 | – 6 | 12 |
| Profit after financial income and expenses (SEK million) | 857 | 921 | 731 | 438 | 555 |
| Profit for the year (SEK million) | 703 | 722 | 572 | 336 | 420 |
| Cash flow (alternative performance measures)1) | |||||
| Cash flow from operations (SEK million) | 1,160 | 1,045 | 773 | 466 | 532 |
| Investing activities (SEK million) | – 453 | – 398 | – 277 | – 619 | – 244 |
| Cash flow after investing activities (SEK million) | 707 | 647 | 496 | – 153 | 288 |
| Cash flow from operating activities per share, before dilution (SEK)* | 43.81 | 39.72 | 29.38 | 17.71 | 20.22 |
| Cash flow after investing activities excluding acquisitions and disposals per share, | |||||
| before dilution, (SEK)* | 30.19 | 22.54 | 18.85 | 9.31 | 10.95 |
| Cash conversion (%) | 88 | 60 | 66 | 55 | 52 |
| Financial position (alternative performance measures)1) | |||||
| Total assets (SEK million) | 6,134 | 5,156 | 4,752 | 3,924 | 3,233 |
| Shareholders' equity (SEK million) | 2,966 | 2,592 | 2,159 | 1,850 | 1,759 |
| Interest-bearing liabilities and provisions (SEK million) | – 1,219 | – 794 | – 822 | – 819 | – 281 |
| Financial net assets (+)/net debt (–), excluding pension and lease liabilities (SEK million) | 666 | 341 | 31 | – 206 | 249 |
| KPIs (alternative performance measures)1) | |||||
| Return on total capital before tax (%) | 15.6 | 18.4 | 17.1 | 13.7 | 18.3 |
| Return on capital employed before tax (%) | 23.1 | 29.7 | 26.6 | 20.6 | 29.6 |
| Return on operating capital before tax (%) | 31.0 | 40.0 | 32.1 | 24.4 | 35.3 |
| Return on net shareholders' equity (%) | 25.5 | 30.4 | 29.4 | 19.0 | 25.3 |
| EBITA margin (%) | 11.3 | 11.7 | 11.4 | 10.3 | 12.1 |
| Profit margin (%) | 10.8 | 11.4 | 10.9 | 9.8 | 11.7 |
| Equity/assets ratio (%) | 48 | 50 | 45 | 47 | 54 |
| Debt/equity ratio (times) | 0.4 | 0.3 | 0.4 | 0.4 | 0.2 |
| Interest coverage ratio (times) | 25 | 40 | 56 | 67 | 78 |
| Average number of employees | 5,941 | 6,449 | 7,249 | 6,418 | 7,759 |
1) Nolato presents certain financial measures in this report that are not defined according to IFRS. Nolato considers that these measures provide valuable supplementary information for investors and company management, as they enable an assessment of trends and the company's performance. Since not all companies calculate financial measures in the same way, these are not always comparable to measures used by other companies. These financial measures should not therefore be regarded as substitutes for measures defined according to IFRS. For definitions of financial measures, see page 85.
* The Group has two Incentive Programmes: Incentive Programme 2016/2021 and Incentive Programme 2019/2024. For further information, see Note 27.
| SEKm unless otherwise specified | 2019 | 2018 |
|---|---|---|
| Operating profit (EBITDA) | 1,263 | 1,189 |
| Non-recurring items | 4 | – 3 |
| Adjusted operating profit (EBITDA) | 1,267 | 1,186 |
| Operating profit (EBIT) | 887 | 941 |
| Reversal of amortisation of intangible assets arising in connection with acquisitions | 8 | 8 |
| Operating profit (EBITA) | 895 | 949 |
| Non-recurring items | 22 | – 3 |
| Adjusted operating profit (EBITA) | 917 | 946 |
| EBITA margin (%) | 11.3 | 11.7 |
| Adjusted EBITA margin (%) | 11.6 | 11.7 |
| Profit after financial income and expenses | 857 | 921 |
| Non-recurring items | 22 | – 3 |
| Adjusted profit after financial income and expenses | 879 | 918 |
| Profit margin (%) | 10.8 | 11.4 |
| Adjusted profit margin (%) | 11.1 | 11.3 |
| Profit after tax | 703 | 722 |
| Non-recurring items | 22 | – 3 |
| Tax on non-recurring items | – 6 | – 4 |
| Adjusted profit/loss after tax | 719 | 715 |
| Cash flow after investment, excl. acquisitions and disposals | 800 | 593 |
| Non-recurring items (affecting cash flow) | — | – 29 |
| Adjusted cash flow after investments, excluding acquisitions and disposals | 800 | 564 |
| Operating profit (EBIT) | 887 | 941 |
| Non-recurring items | 22 | – 3 |
| Adjusted operating profit (EBIT) | 909 | 938 |
| Cash conversion (%) | 88 | 60 |
2019: Non-recurring item for closure of production facility at Nolato Jaycare in the UK which had a negative effect on operating profit in the amount of SEK –22 million, and tax effects of SEK +6 million, which impacted post-tax profit in the amount of SEK –16 million. This non-recurring item has been recognised at Group level and has consequently not affected the profit of the business areas. 2018: Non-recurring items consist of a distribution from the previous bankruptcy of a customer in 2006 and a capital loss on a divested business. The dividend in Q1 2018 had a positive effect on operating profit of SEK +20 million (0) within other operating income and the capital loss in Q3 2018 had a negative impact on operating profit of SEK –17 million (0) within other operating expenses. These non-recurring items were recognised at Group level and have consequently not affected the profit of the business areas.
| Q4 | Q3 | Q2 | Q1 | Q4 | Q3 | Q2 | Q1 | Q4 | |
|---|---|---|---|---|---|---|---|---|---|
| SEKm unless otherwise specified | 2019 | 2019 | 2019 | 2019 | 2018 | 2018 | 2018 | 2018 | 2017 |
| Profit after financial income and expenses, rolling 12 mths | 856 | 831 | 797 | 831 | 921 | ||||
| Financial expenses, rolling 12 mths | 36 | 30 | 29 | 26 | 24 | ||||
| Adjusted profit after financial exp., rolling 12 mths | 892 | 861 | 826 | 857 | 945 | ||||
| Total capital at end of period | 6,134 | 6,051 | 5,593 | 5,733 | 5,156 | 5,229 | 5,381 | 5,148 | 4,752 |
| Average total capital, past five quarters | 5,733 | 5,552 | 5,418 | 5,329 | 5,133 | ||||
| Return on total capital (%) | 15.6 | 15.5 | 15.2 | 16.1 | 18.4 | ||||
| Adjusted profit after financial exp., rolling 12 mths | 892 | 861 | 826 | 857 | 945 | ||||
| Capital employed at end of period | 4,184 | 4,022 | 3,771 | 3,982 | 3,387 | 3,225 | 3,131 | 3,188 | 2,980 |
| Average capital employed, past five quarters | 3,869 | 3,677 | 3,499 | 3,383 | 3,182 | ||||
| Return on capital employed (%) | 23.1 | 23.4 | 23.6 | 25.3 | 29.7 | ||||
| Operating profit (EBIT), rolling 12 mths | 887 | 855 | 821 | 853 | 941 | ||||
| Capital employed at end of period | 4,184 | 4,022 | 3,771 | 3,982 | 3,387 | 3,225 | 3,131 | 3,188 | 2,980 |
| Cash and bank balances at end of period | – 1,362 | – 851 | – 828 | 1,034 | 953 | 818 | 891 | 817 | 669 |
| Operating capital at end of period | 2,822 | 3,171 | 2,943 | 2,948 | 2,434 | 2,407 | 2,240 | 2,371 | 2,311 |
| Average operating capital, past five quarters | 2,864 | 2,781 | 2,594 | 2,480 | 2,353 | ||||
| Return on operating capital (%) | 31.0 | 30.7 | 31.6 | 34.4 | 40.0 | ||||
| Profit after tax, rolling 12 mths | 703 | 655 | 623 | 647 | 722 | ||||
| Shareholders' equity at end of period | 2,966 | 2,833 | 2,604 | 2,783 | 2,592 | 2,422 | 2,301 | 2,412 | 2,159 |
| Average shareholders' equity, past five quarters | 2,756 | 2,647 | 2,540 | 2,502 | 2,377 | ||||
| Return on shareholders' equity (%) | 25.5 | 24.7 | 24.5 | 25.9 | 30.4 |
Earnings for the period that are attributable to the Parent Company's owners divided by the average number of shares outstanding.
Operating profit (EBIT) Earnings before interest and taxes.
Nolato presents certain financial measures in this report that are not defined according to IFRS. Nolato considers that these measures provide valuable supplementary information for investors and company management, as they enable an assessment of trends and the company's performance. Since not all companies calculate financial measures in the same way, these are not always comparable to measures used by other companies. These financial measures should not therefore be regarded as substitutes for measures defined according to IFRS.
Profit after financial income and expenses, plus financial expenses, as a percentage of average total capital according to the balance sheet.
Profit after financial income and expenses, plus financial expenses, as a percentage of average capital employed. Capital employed consists of total capital less non-interestbearing liabilities and provisions.
Operating profit as a percentage of average operating capital. Operating capital consists of total capital less non-interestbearing liabilities and provisions, less interest-bearing assets.
Profit after tax in relation to average shareholders' equity.
Operating profit (EBITA) as a percentage of net sales.
The average basic number of shares comprises the Parent Company's weighted average number of shares outstanding during the period. After dilution, a weighted average of the shares that may be issued under the ongoing share warrant programme is added if they are in the money, but only insofar as the average listed share price for the period exceeds the subscription price of the warrants.
Profit after tax, excluding amortisation of intangible assets arising from acquisitions, divided by the average number of shares.
Cash flow from operating activities per share Cash flow from operating activities in relation to the average number of shares.
Cash flow before financing activities in relation to the average number of shares.
Cash flow after investments, excluding acquisitions and disposals, divided by operating profit (EBIT). Cash flow and operating profit have been adjusted to take account of any non-recurring items.
Profit after financial income and expenses, plus financial expenses, divided by financial expenses.
Earnings before interest, taxes, depreciation and amortisation.
Earnings before interest, taxes and amortisation of intangible assets arising from acquisitions.
Interest-bearing liabilities and provisions divided by shareholders' equity.
Shareholders' equity as a percentage of total capital according to the balance sheet.
Profit after financial income and expenses as a percentage of net sales.
Some of the items reported relate to future events and actual outcomes may differ materially. In addition to those factors explicitly commented on, other factors may also materially affect the actual outcome, such as economic conditions, exchange rates and interest rate levels, political risks, competition and pricing, product development, commercialisation and technical difficulties, supply problems and customer credit losses.
Materials such as plastic, silicone, rubber and thermoplastic elastomers (TPEs).
A method for the production of polymer components. The material is injected under high pressure into a mould in which the component is made .
Production technique whereby a container is first injectionmoulded and then inflated so that a receptacle is formed. Injection blow moulding is used by Nolato in the production of pharmaceutical packaging.
This is a method for continuously manufacturing products in strands, such as medical tubing.
Method used to manufacture breathing bags, ventilator bellows and catheter balloons from synthetic or natural latex rubber. Pre-heated formers are dipped into liquid latex and the products are shaped by the geometry of the formers.
Designing a surface so that a function or cosmetic effect can be felt.
A room with extremely strict requirements in terms of the absence of dust particles, in some cases even minimisation of bacteria, etc. Used by Nolato when producing medical technology components and mobile phone components.
Technology for shielding electronics from electromagnetic interference, both internally between different electronic components and from external interference. This is achieved using silicone gaskets containing silver or nickel particles. EMC stands for Electro Magnetic Compatibility, which is the purpose of the shielding.
| SEKm | Note | 2019 | 2018 |
|---|---|---|---|
| Net sales | 2 | 60 | 63 |
| Selling expenses | 6, 12 | – 7 | – 7 |
| Administrative expenses | 3, 6, 12 | – 48 | – 49 |
| Other operating income | 4 | 3 | 5 |
| Other operating expenses | 5 | – 48 | – 47 |
| 12 | – 100 | – 98 | |
| Operating profit | – 40 | – 35 | |
| Revenue from investments in Group companies | 7 | 468 | 495 |
| Financial income | 8 | 10 | 14 |
| Financial expenses | 9 | – 42 | – 60 |
| 436 | 449 | ||
| Profit after financial income and expenses | 396 | 414 | |
| Appropriations | 10 | 210 | 252 |
| Tax | 11 | – 43 | – 55 |
| Profit for the year | 563 | 611 |
| Comprehensive income for the year | 562 | 611 |
|---|---|---|
| overseas net investment | – 1 | — |
| Exchange rate difference on monetary item regarding | ||
| Items transferred or that could be transferred to profit for the period |
||
| Profit for the year | 563 | 611 |
| SEKm | 2019 | 2018 |
| SEKm | Note | 2019 | 2018 |
|---|---|---|---|
| Assets | |||
| Non-current assets | |||
| Non-current intangible assets | 1 | 1 | |
| Property, plant and equipment | 1 | 1 | |
| Total non-current assets | 2 | 2 | |
| Financial assets | |||
| Investments in Group companies | 13 | 1,411 | 1,231 |
| Receivables from Group companies | 16 | 441 | 442 |
| Other non-current receivables | 2 | 2 | |
| Total non-current financial assets | 1,854 | 1,675 | |
| Total non-current assets | 1,856 | 1,677 | |
| Current assets | |||
| Receivables from Group companies | 908 | 870 | |
| Other receivables | 40 | 30 | |
| Prepaid expenses and accrued income | 6 | 4 | |
| Total current assets | 954 | 904 | |
| Cash and bank balances | 218 | 59 | |
| Total assets | 3,028 | 2,640 | |
| Shareholders' equity and liabilities | |||
| Shareholders' equity | |||
| Restricted equity | |||
| Share capital (26,548,008 shares) | 14 | 133 | 132 |
| Statutory reserve | 298 | 228 | |
| Total restricted equity | 431 | 360 | |
| Unrestricted equity | |||
| Translation reserve | – 4 | – 3 | |
| Retained earnings | 852 | 609 | |
| Profit for the year | 563 | 611 | |
| Total unrestricted equity | 1,411 | 1,217 | |
| Total shareholders' equity | 1,842 | 1,577 | |
| Untaxed reserves | 19 | 229 | 199 |
| Provisions | |||
| Deferred tax liabilities | 11 | 5 | 6 |
| Other provisions | 17 | 11 | 12 |
| Total provisions | 16 | 18 | |
| Non-current liabilities | |||
| Liabilities to credit institutions | 15 | 615 | 501 |
| Liabilities to Group companies | 16 | 55 | 55 |
| Total non-current liabilities | 670 | 556 | |
| Current liabilities | |||
| Accounts payable | 5 | 3 | |
| Liabilities to Group companies | 235 | 258 | |
| Other liabilities | 12 | 12 | |
| Accrued expenses and deferred income | 18 | 19 | 17 |
| Total current liabilities | 271 | 290 | |
| Total liabilities and shareholders' equity | 3,028 | 2,640 |
| Restricted equity | Unrestricted equity | ||||
|---|---|---|---|---|---|
| SEKm | Share capital | Statutory reserve | Translation reserve | Retained earnings | Total shareholders' equity |
| Opening balance, 1 Jan. 2018 | 132 | 228 | – 3 | 938 | 1,295 |
| Profit for the year | — | 611 | 611 | ||
| Other comprehensive income for the year | — | — | — | ||
| Comprehensive income for the year | — | — | — | 611 | 611 |
| Dividend for 2017 | — | – 329 | – 329 | ||
| Closing balance, 31 Dec. 2018 | 132 | 228 | – 3 | 1,220 | 1,577 |
| Opening balance, 1 Jan. 2019 | 132 | 228 | – 3 | 1,220 | 1,577 |
| Profit for the year | — | 563 | 563 | ||
| Other comprehensive income for the year | – 1 | — | – 1 | ||
| Comprehensive income for the year | — | — | – 1 | 563 | 562 |
| Warrants exercised in incentive programme | 1 | 70 | — | — | 71 |
| Dividend for 2018 | — | — | — | – 368 | – 368 |
| Closing balance, 31 Dec. 2019 | 133 | 298 | – 4 | 1,415 | 1,842 |
| SEKm | Note | 2019 | 2018 |
|---|---|---|---|
| Operating activities | |||
| Operating profit | – 40 | – 35 | |
| Adjustments for items not included in cash flow | – 1 | — | |
| Dividends from subsidiaries | 182 | 131 | |
| Liquidation profit from subsidiaries | — | 6 | |
| Interest received | 10 | 14 | |
| Interest paid | – 6 | – 5 | |
| Realised exchange rate differences | – 23 | – 25 | |
| Income tax paid | – 52 | – 66 | |
| Cash flow from operating activities before | |||
| changes in working capital | 70 | 20 | |
| Changes in working capital | |||
| Changes in operating receivables and operating liabilities | 220 | 102 | |
| Cash flow from operating activities | 290 | 122 | |
| Investing activities | |||
| Acquisition of non-current intangible assets | — | – 2 | |
| Acquisition of non-current financial assets | – 26 | – 46 | |
| Shareholders' contribution | – 160 | — | |
| Sale of non-current intangible assets | — | 3 | |
| Sale of non-current financial assets | — | 55 | |
| Cash flow from investing activities | – 186 | 10 | |
| Cash flow before financing activities | 104 | 132 | |
| Financing activities | |||
| Borrowings | 15 | 88 | — |
| Repayment of loans | 15 | — | – 70 |
| Change in long-term intra-Group transactions | 13 | – 29 | |
| Dividend paid | – 368 | – 329 | |
| Group contribution received | 257 | 288 | |
| Group contribution paid | – 6 | – 6 | |
| Warrants exercised in incentive programme | 71 | — | |
| Cash flow from financing activities | 55 | – 146 | |
| Cash flow for the year | 159 | – 14 | |
| Cash and cash equivalents, opening balance | 59 | 73 | |
| Cash and cash equivalents, closing balance* | 218 | 59 |
*Credit balance on Group account in Parent Company
The Parent Company's annual accounts have been drawn up in accordance with the Swedish Annual Accounts Act (1995:1554) and the Swedish Financial Reporting Board's recommendation RFR 2, Accounting for Legal Entities. The Swedish Financial Reporting Board's statements relating to listed companies have also been applied. RFR 2 involves the Parent Company, in the annual accounts for the legal entity, applying all IFRS standards and statements adopted by the EU as far as possible within the framework of the Swedish Annual Accounts Act and the Swedish Law on Safeguarding Pension Obligations, and in view of the relationship between accounting and taxation. The recommendation details which exceptions from and additions to IFRS shall apply.
The accounting policies of the Parent Company otherwise comply with the accounting policies of the Group, with the following exceptions:
Investments in subsidiaries are recognised in the Parent Company in accordance with the cost method. Transaction charges attributable to the acquisition of shares in subsidiaries are included in the acquisition cost of investments in Group companies in the balance sheet. Impairment testing occurs annually by comparing the Parent Company's recorded acquisition costs with the subsidiaries' net worth, including their long-term earning capacity.
The income statement and balance sheet have been produced for the Parent Company in accordance with the Swedish Annual Accounts Act's format, while the comprehensive income statement, the statement of changes in shareholders' equity and the cash flow statement are based on IAS 1 Presentation of Financial Statements and IAS 7 Cash Flow Statements. The differences compared with the consolidated reports that are in the Parent Company's income statements and balance sheets consist primarily of reporting financial income and expenses and the classification of shareholders' equity.
IFRS 16 rules are not applied for legal entities, which are instead subject to the rules in RFR 2 p. 2–5. The Parent Company recognises lease payments as costs on a straight-line basis over the term of the lease. Expensed lease payments during the year amounted to SEK 754,000 (754,000). Over the next two years, lease payments will amount to a total of approx. SEK 578,000.
The Parent Company has the character of a holding company, in which expenses consist solely of invoicing for joint Group expenses, particularly personnel costs for Group staff and other joint Group overheads, such as insurance, licensing fees, etc. Invoicing is carried out when services are rendered or when other resources have been received by the counterparty.
Dividend income is recognised when the right to receive the dividend is established. Any anticipated dividend is recognised as receivables from Group companies and as revenue from investments in Group companies (see Note 7).
The Parent Company applies the section on IFRS 9 Financial Instruments in RFR 2 according to point 2. Outstanding derivative instruments at 31 December 2019 are described in Note 30 of the consolidated statements.
Defined benefit pension schemes are insured through a policy held with Alecta. According to RFR 2, the defined benefit pension schemes are classified and recognised as defined contribution schemes, which means that premiums paid are charged to the income statement. Charges for the year to Alecta totalled SEK 352,000 (286,000). Within the Parent Company, a different basis than that set out in IAS 19 is applied when calculating and valuing the defined benefit schemes. The Parent Company follows the provisions of the Swedish Law on Safeguarding Pension Obligations and the regulations of the Swedish Financial Supervisory Authority, since this is a requirement for tax deduction rights. The main differences compared with the rules of IAS 19 are the manner in which the discount rate is established, the fact that the defined benefit obligations are calculated based on current salary levels without taking assumptions regarding future salary increases into consideration, and the fact that all actuarial gains and losses are recognised in the income statement when they arise.
In the Parent Company, untaxed reserves are recognised gross as untaxed reserves in the balance sheet. Appropriations are recognised as gross amounts in the income statement.
Group contributions paid and received in the Parent Company are recognised as appropriations according to the alternative rule.
| 2019 | 2018 | |
|---|---|---|
| Sales of services to subsidiaries | 60 | 63 |
| Purchase of services from subsidiaries | – 8 | – 6 |
| Total | – 759 | – 855 |
|---|---|---|
| Other assignments | – 84 | — |
| Taxation assignments | – 110 | – 50 |
| Auditing | – 565 | – 805 |
| EY | ||
| SEK thousand | 2019 | 2018 |
Auditing relates to reviewing the annual accounts and financial statements, as well as the administration of the Board of Directors and the President and CEO, other duties required of the company's auditor and providing advice or other assistance resulting from observations in relation to such review or carrying out such other duties.
| 2019 | 2018 | |
|---|---|---|
| Effect of exchange rate on operating receivables/liabilities | 3 | 5 |
| 2019 | 2018 | |
|---|---|---|
| Effect of exchange rate on operating receivables/liabilities | – 12 | – 9 |
| Costs for personnel who are not employed by the | ||
| Parent Company and their overheads | – 36 | – 38 |
| Total | – 48 | – 47 |
| 2019 | 2018 | |||
|---|---|---|---|---|
| Number Of which men | Number Of which men | |||
| Nolato AB, Torekov | 10 | 70% | 9 | 78% |
| Total | – 38 | – 39 |
|---|---|---|
| Social security contributions | – 9 | – 9 |
| Pension expenses, defined contribution schemes | – 4 | – 4 |
| Salaries and remuneration | – 25 | – 26 |
| 2019 | 2018 |
There are 5 (5) senior executives at the Parent Company. Expensed remuneration and benefits for senior executives at the Parent Company during the year totalled SEK 28 million (27), of which SEK 6 million (7) relates to bonuses. Of the Parent Company's pension expenses, SEK 1 million (1) relates to the Board and the President and CEO. The company's outstanding pension liabilities and obligations in relation to the Board and the President and CEO stood at SEK 0 million (0).
| 2019 | 2018 | |||
|---|---|---|---|---|
| Men | Women | Men | Women | |
| Board members | 7 | 3 | 7 | 3 |
| President and CEO | 1 | — | 1 | — |
| Other senior | ||||
| executives | 4 | — | 4 | — |
| 2019 | 2018 | |
|---|---|---|
| Dividend received from Group companies | 182 | 131 |
| Anticipated dividend from Group companies | 293 | 344 |
| Capital gain on sale of subsidiary | — | 14 |
| Liquidation profit from Group companies | — | 6 |
| Impairment of investments in Group companies | – 7 | — |
| Total | 468 | 495 |
| Total | 10 | 14 |
|---|---|---|
| Interest income, Group companies | 10 | 14 |
| 2019 | 2018 |
All interest income is attributable to financial assets, which are measured at amortised cost.
| Total | – 42 | – 60 |
|---|---|---|
| Exchange rate differences | – 36 | – 45 |
| Insurance recourse1) | — | – 10 |
| Other financial expenses | – 1 | – 1 |
| Interest expenses, credit institutions | – 5 | – 4 |
| 2019 | 2018 |
1) Relates to a bankruptcy payment of a previously credit-insured customer.
All interest expenses are attributable to financial liabilities, which are measured at amortised cost.
| Total | 210 | 252 |
|---|---|---|
| Provision for tax allocation reserve | – 30 | – 46 |
| Reversal of tax allocation reserve | — | 47 |
| Group contributions paid | — | – 6 |
| Group contributions received | 240 | 257 |
| 2019 | 2018 | |
| Recognised in the income statement | |||
|---|---|---|---|
| ------------------------------------ | -- | -- | -- |
| Total recognised tax expense | – 43 | – 55 |
|---|---|---|
| Deferred tax in relation to temporary differences | — | – 11 |
| Deferred tax expense (–)/income (+) | ||
| – 43 | – 44 | |
| Tax expenses for the period | – 43 | – 44 |
| Current tax expense (–)/income (+) | ||
| 2019 | 2018 |
The tax rate applicable is 21.4% (22%).
| 2019 | 2018 | |
|---|---|---|
| Profit before tax | 606 | 666 |
| Tax according to applicable Parent Company tax rate | – 130 | – 147 |
| Coupon tax on anticipated dividends | – 15 | – 17 |
| Non-deductible expenses | – 1 | — |
| Non-taxable income | 103 | 109 |
| Recognised effective tax | – 43 | – 55 |
| Deferred tax recognised in the balance sheet | ||
| Other provisions | 2 | 2 |
| Other | – 7 | – 8 |
| Total | – 5 | – 6 |
| Recognised in | Recognised in | |||
|---|---|---|---|---|
| Balance at | profit for the | shareholders' | Balance at | |
| 1 Jan. 2018 | year | equity | 31 Dec. 2018 | |
| Other provisions | 3 | – 1 | — | 2 |
| Other | 2 | – 10 | — | – 8 |
| Total | 5 | – 11 | — | – 6 |
| Recognised in | Recognised in | |||
| Balance at | profit for the | shareholders' | Balance at | |
| 1 Jan. 2019 | year | equity | 31 Dec. 2019 | |
| Other provisions | 2 | — | — | 2 |
| Other | – 8 | 1 | — | – 7 |
| 2019 | 2018 | |
|---|---|---|
| Employee benefits expense | – 38 | – 39 |
| Consulting expenses | – 5 | – 5 |
| Travel expenses | – 3 | – 2 |
| Advertising and PR | – 4 | – 4 |
| Effect of exchange rate on operating receivables/ | ||
| liabilities, net | – 9 | – 4 |
| Costs for personnel who are not employed by the | ||
| Parent Company and their overheads | ||
| (charged on) | – 36 | – 38 |
| Other costs | – 5 | – 6 |
| Total | – 100 | – 98 |
| Carrying amount | 1,411 | 1,231 |
|---|---|---|
| Accumulated impairment losses at 31 December | – 367 | – 360 |
| Impairment losses for the year | – 7 | — |
| Accumulated impairment losses at 1 January | – 360 | – 360 |
| Accumulated acquisition cost at 31 December | 1,778 | 1,591 |
| Disposals | — | – 41 |
| Shareholders' contribution | 160 | — |
| Newly formed subsidiary | 27 | 46 |
| Acquisition cost at 1 January | 1,591 | 1,586 |
| 2019 | 2018 | |
| Participating interest | Carrying amount | ||||
|---|---|---|---|---|---|
| 2019 | 2018 | 2019 | 2018 | ||
| AB Cerbo Group, Trollhättan, Sweden | 100% | 100% | 268 | 117 | |
| Nolato Cerbo AB, Trollhättan, Sweden | 100% | 100% | |||
| Cerbo France Sarl, France | 100% | 100% | |||
| Lövepac Converting Ltd, China | 100% | 100% | 9 | 9 | |
| Lövepac Converting Private Ltd, India | 100% | 100% | — | — | |
| Lövepac Technology (Shenzhen) Co., Ltd, China | 100% | — | — | — | |
| Nolato Alpha AB, Kristianstad, Sweden | 100% | 100% | 12 | 12 | |
| Nolato Automotive Components (Beijing) Co., Ltd, China | 100% | 100% | 1 | 1 | |
| Nolato EMC Kft, Hungary | 100% | 100% | 9 | — | |
| Nolato EMC Production Center Sdn Bhd, Malaysia | 100% | 100% | 1 | 1 | |
| Nolato Holding USA Inc., US | 100% | 100% | — | — | |
| Nolato Contour Inc., US | 100% | 100% | |||
| Nolato Jabar LLC, US | 100% | — | |||
| Nolato Gota AB, Götene, Sweden | 100% | 100% | 129 | 129 | |
| Nolato Holdings UK Ltd, UK | 100% | 100% | 70 | 70 | |
| C A Portsmouth Ltd, UK | 100% | 100% | |||
| Nolato Jaycare Ltd, UK | 100% | 100% | |||
| Nolato Hungary Kft, Hungary | 100% | 100% | 46 | 46 | |
| Nolato Incentive AB, Torekov, Sweden | 100% | 100% | — | — | |
| Nolato Lövepac AB, Skånes Fagerhult, Sweden | 100% | 100% | 10 | 10 | |
| Nolato Medical Device (Beijing) Co. Ltd, China | 100% | 100% | — | — | |
| Nolato MediTech AB, Hörby, Sweden | 100% | 100% | 116 | 116 | |
| Nolato MediTor AB, Torekov, Sweden | 100% | 100% | 9 | 9 | |
| Nolato Mobile Comm. Polymers (Beijing) Ltd, China | 100% | 100% | 91 | 91 | |
| Nolato Plastteknik AB, Gothenburg, Sweden | 100% | 100% | 42 | 42 | |
| Nolato Polymer AB, Torekov, Sweden | 100% | 100% | 5 | 5 | |
| Nolato Produktions AB, Götene, Sweden | 100% | 100% | — | — | |
| Nolato Romania S.R.L., Romania | 100% | 100% | — | — | |
| Nolato Silikonteknik AB, Hallsberg, Sweden | 100% | 100% | 18 | 18 | |
| Nolato Silikonteknik (Beijing) Co. Ltd, China | 100% | — | 20 | — | |
| Nolato Stargard Sp.zo.o., Poland | 100% | 100% | 9 | 9 | |
| Nolato Technology (Suzhou) Co. Ltd, China | 100% | 100% | 46 | 46 | |
| Nolato Torekov AB, Torekov, Sweden | 100% | 100% | 12 | 12 | |
| Nolato Treff AG, Switzerland | 100% | 100% | 488 | 488 | |
| Carrying amount | 1,411 | 1,231 |
The share capital of Nolato AB totals SEK 133 million, divided into 26,548,008 shares. Of these, 2,759,400 are A shares and 23,788,608 are B shares. Each A share entitles the holder to ten votes, while a B share entitles the holder to one vote. All shares have equal rights to the assets and earnings of the company.
| Number of shares Quotient value | Share capital | |
|---|---|---|
| Share capital, 31 Dec. 2018 | 26,307,408 | SEK 5 SEK 131,537 k |
| Share capital, 31 Dec. 2019 | 26,548,008 | SEK 5 SEK 132,740 k |
| Maturity date | 2019 | 2018 | |
|---|---|---|---|
| Long-term bank loan in CHF (fixed rate) | 2021 | 527 | 501 |
| Long-term bank loan in USD (variable rate) | 2022 | 88 | — |
| Total | 615 | 501 |
| 2019 | 2018 | |
|---|---|---|
| Opening balance for non-current and current financial liabilities | 501 | 534 |
| Changes affecting cash flow | ||
| Borrowings | 88 | — |
| Repayment of loans | — | – 70 |
| Changes not affecting cash flow | ||
| Translation effects | 26 | 37 |
| Closing balance for non-current and current finan | ||
| cial liabilities | 615 | 501 |
| Receivables from Group companies | |
|---|---|
| At 1 January 2018 | 396 |
| Change | 46 |
| At 1 January 2019 | 442 |
| Change | – 1 |
| At 31 December 2019 | 441 |
| Liabilities to Group companies | |
| At 1 January 2018 | 55 |
| Change | — |
| At 1 January 2019 | 55 |
| Change | — |
| At 31 December 2019 | 55 |
All items relate to internal loans, for which interest is calculated on an ongoing basis in line with the market. There are no contractually regulated durations.
| Amount at 31 December | 11 | 12 |
|---|---|---|
| Amounts claimed | – 1 | – 2 |
| Provisions for the year | — | 1 |
| Amount at 1 January | 12 | 13 |
| 2019 | 2018 |
Relates to future salary tax for endowment insurance.
| Total | 19 | 17 |
|---|---|---|
| Other items | 2 | 2 |
| Social security contributions | 7 | 7 |
| Salary liabilities | 10 | 8 |
| 2019 | 2018 |
| 2019 | 2018 | |
|---|---|---|
| Provision for tax allocation reserve (taxation year 2016) | 69 | 69 |
| Provision for tax allocation reserve (taxation year 2017) | 84 | 84 |
| Provision for tax allocation reserve (taxation year 2018) | 46 | 46 |
| Provision for tax allocation reserve (taxation year 2019) | 30 | — |
| Total | 229 | 199 |
| 2019 | 2018 | |
|---|---|---|
| Guarantees on behalf of subsidiaries | 252 | 145 |
The Parent Company has controlling influence over the subsidiaries, in accordance with the structure described in Note 13.
When delivering goods and services between Group companies, business terms and conditions and market pricing are applied. The scope of internal invoicing for joint Group services amounts to SEK 60 million (63), as detailed in Note 2, and relates primarily to assigning costs for joint Group services and overheads. The Parent Company is an internal bank for the Group companies, whereby intra-group interest income of SEK 10 million (14) and interest expenses of SEK 0 million (0) have arisen in the Parent Company to the extent reported in Notes 8 and 9. Interest on loans receivable and liabilities is calculated on an ongoing basis in line with the market rate. There are no contractually regulated durations. Intra-group receivables at the Parent Company amount to SEK 441 million (442) and liabilities to Group companies amount to SEK 55 million (55).
During the year, the Parent Company received dividends from subsidiaries in the amount of SEK 475 million (475), of which SEK 293 million (344) refers to anticipated dividend.
| 1,411 | 1,217 | |
|---|---|---|
| To be carried forward | 1,026 | 849 |
| Dividend to the shareholders | 385 | 368 |
| be allocated as follows: | ||
| 1,411 | 1,217 | |
| Profit for the year | 563 | 611 |
| Retained earnings | 848 | 606 |
| The Board proposes that unappropriated funds: | ||
| 2019 | 2018 | |
These annual accounts have been prepared in accordance with IFRS international accounting standards as adopted by the EU and provide a true and fair presentation of the operations, financial position and earnings of the Group and the Parent Company, and describe the significant risks and uncertainties faced by the Parent Company and the companies included in the Group.
As indicated below, the annual accounts were approved for issue by the Board on 12 March 2020. The consolidated income statement and balance sheet and the Parent Company's income statement and balance sheet will be proposed for adoption at the annual general meeting on 4 May 2020.
Torekov, Sweden, 12 March 2020
Fredrik Arp
Chairman of the Board
Sven Boström-Svensson Henrik Jorlén Lovisa Hamrin Board member Board member Board member
Dag Andersson Åsa Hedin Lars-Åke Rydh Jenny Sjödahl Board member Board member Board member Board member
Christer Wahlquist Björn Jacobsson Håkan Svensson
President and CEO Employee representative Employee representative
Our auditor's report was submitted on 19 March 2020. Ernst & Young AB
Joakim Falck Authorised Public Accountant
To the general meeting of the shareholders of Nolato AB (publ), corporate identity number 556080-4592
We have audited the annual accounts and consolidated accounts of Nolato AB (publ) except for the statutory sustainability report on page 49 for the financial year 2019. The annual accounts and consolidated accounts of the company are included on pages 47–92 in this document.
In our opinion, the annual accounts have been prepared in accordance with the Annual Accounts Act and present fairly, in all material respects, the financial position of the parent company as of 31 December 2019 and its financial performance and cash flow for the year then ended in accordance with the Annual Accounts Act. The consolidated accounts have been prepared in accordance with the Annual Accounts Act and present fairly, in all material respects, the financial position of the group as of 31 December 2019 and their financial performance and cash flow for the year then ended in accordance with International Financial Reporting Standards (IFRS), as adopted by the EU, and the Annual Accounts Act. Our opinions do not cover the statutory sustainability report on page 49. The statutory administration report is consistent with the other parts of the annual accounts and consolidated accounts.
We therefore recommend that the general meeting of shareholders adopts the income statement and balance sheet for the parent company and the group.
Key audit matters of the audit are those matters that, in our professional judgment, were of most significance in our audit of the annual accounts and consolidated accounts of the current period. These matters were addressed in the context of our audit of, and in forming our opinion thereon, the annual accounts and consolidated accounts as a whole, but we do not provide a separate opinion on these matters. For each matter below, our description of how our audit addressed the matter is provided in that context.
Goodwill is recognised at SEK 781 million and investments in Group companies are recognised at SEK 1,411 million at 31 December 2019. Nolato conducts an annual review and in the event of an indication of impairment, to assure that the carrying amounts do not exceed the estimated recoverable amounts for these assets. Recoverable amounts are determined via a present value computation of future cash flows for each cash generating unit and are based on the anticipated outcome of several factors based on management's business plans and forecasts.
The impairment test for 2019 did not result in any impairment adjustments. As a result of the assessments and key assumptions required when calculating value in use, we have treated valuation of goodwill and investments in Group companies as an area of key audit matters in the audit. A description of the impairment test is detailed under Note 11.
This document also contains other information than the annual accounts and consolidated accounts and is found on pages 1–46. The Board of Directors and the Managing Director are responsible for this other information.
Our opinion on the annual accounts and consolidated accounts does not cover this other information and we do not express any form of assurance conclusion regarding this other information.
In connection with our audit of the annual accounts and consolidated accounts, our responsibility is to read the information identified above and consider whether the information is materially inconsistent with the annual accounts and consolidated accounts. In this procedure we also take into account our knowledge otherwise obtained in the audit and assess whether the information otherwise appears to be materially misstated.
If we, based on the work performed concerning this information, conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Our opinions in this report on the annual accounts and consolidated accounts are consistent with the content of the additional report that has been submitted to the parent company's audit committee in accordance with the Audit Regulation (537/2014) Article 11.
We conducted our audit in accordance with International Standards on Auditing (ISA) and generally accepted auditing standards in Sweden. Our responsibilities under those standards are further described in the Auditor's Responsibilities section. We are independent of the parent company and the group in accordance with professional ethics for accountants in Sweden and have otherwise fulfilled our ethical responsibilities in accordance with these requirements. This includes that, based on the best of our knowledge and belief, no prohibited services referred to in the Audit Regulation (537/2014) Article 5.1 have been provided to the audited company or, where applicable, its parent company or its controlled companies within the EU. We believe that the audit evidence we have obtained is sufficient and appropriate to
provide a basis for our opinions.
We have fulfilled the responsibilities described in the Auditor's responsibilities for the audit of the financial statements section of our report, including in relation to these matters. Accordingly, our audit included the performance of procedures designed to respond to our assessment of the risks of material misstatement of the financial statements. The results of our audit procedures, including the procedures performed to address the matters below, provide the basis for our audit opinion on the accompanying financial statements.
In our audit, we have evaluated and audited management's process to establish the impairment test, including by evaluating past accuracy of forecasts and assumptions. With the support of our valuation specialists we have audited the company's model and method for preparing the impairment test. We have evaluated the company's sensitivity analysis and also carried out our own sensitivity analysis of key assumptions and possible influencing factors. With the support of our valuation specialists we have also audited the reasonableness of assumptions regarding discount rates and long-term growth. We have also assessed whether the information disclosed in the financial statements is appropriate.
The Board of Directors and the Managing Director are responsible for the preparation of the annual accounts and consolidated accounts and that they give a fair presentation in accordance with the Annual Accounts Act and, concerning the consolidated accounts, in accordance with IFRS as adopted by the EU. The Board of Directors and the Managing Director are also responsible for such internal control as they determine is necessary to enable the preparation of annual accounts and consolidated accounts that are free from material misstatement, whether due to fraud or error.
In preparing the annual accounts and consolidated accounts, The Board of Directors and the Managing Director are responsible for the assessment of the company's and the group's ability to continue as a going concern. They disclose, as applicable, matters related to going concern and using the going concern basis of accounting. The going concern basis of accounting is however not applied if the Board of Directors and the Managing Director intends to liquidate the company, to cease operations, or has no realistic alternative but to do so.
The Audit Committee shall, without prejudice to the Board of Director's responsibilities and tasks in general, among other things oversee the company's financial reporting process.
Our objectives are to obtain reasonable assurance about whether the annual accounts and consolidated accounts as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinions. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and generally accepted auditing standards in Sweden will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these annual accounts and consolidated accounts.
As part of an audit in accordance with ISAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
In addition to our audit of the annual accounts and consolidated accounts, we have also audited the administration of the Board of Directors and the Managing Director of Nolato AB (publ) for the financial year 2019 and the proposed appropriations of the company's profit or loss.
We recommend to the general meeting of shareholders that the profit be appropriated in accordance with the proposal in the statutory administration report and that the members of the Board of Directors and the Managing Director be discharged from liability for the financial year.
We conducted the audit in accordance with generally accepted auditing standards in Sweden. Our responsibilities under those standards are further described in the Auditor's Responsibilities section. We are independent of the parent company and the group in accordance with professional ethics for accountants in Sweden and have otherwise fulfilled our ethical responsibilities in accordance with these requirements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinions.
The Board of Directors is responsible for the proposal for appropriations of the company's profit or loss. At the proposal of a dividend, this includes an assessment of whether the dividend is justifiable considering the requirements which the company's and the group's type of operations, size and risks place on the size of the parent company's and the group's equity, consolidation requirements, liquidity and position in general.
The Board of Directors is responsible for the company's organization and the administration of the company's affairs. This includes among other things continuous assessment of the company's and the group's financial situation and ensuring that the company's organization is designed so that the accounting, management of assets and the company's financial affairs otherwise are controlled in a reassuring manner. The Managing Director shall manage the ongoing administration according to the Board of Directors' guidelines and instructions and among other matters take measures that are necessary to fulfill the company's accounting in accordance with law and handle the management of assets in a reassuring manner.
Our objective concerning the audit of the administration, and thereby our opinion about discharge from liability, is to obtain audit evidence to assess with a reasonable degree of assurance whether any member of the Board of Directors or the Managing Director in any material respect:
on the company's and the group's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the annual accounts and consolidated accounts or, if such disclosures are inadequate, to modify our opinion about the annual accounts and consolidated accounts. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause a company and a group to cease to continue as a going concern.
We must inform the Board of Directors of, among other matters, the planned scope and timing of the audit. We must also inform of significant audit findings during our audit, including any significant deficiencies in internal control that we identified.
We must also provide the Board of Directors with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
From the matters communicated with the Board of Directors, we determine those matters that were of most significance in the audit of the annual accounts and consolidated accounts, including the most important assessed risks for material misstatement, and are therefore the key audit matters. We describe these matters in the auditor's report unless law or regulation precludes disclosure about the matter.
Our objective concerning the audit of the proposed appropriations of the company's profit or loss, and thereby our opinion about this, is to assess with reasonable degree of assurance whether the proposal is in accordance with the Companies Act.
Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with generally accepted auditing standards in Sweden will always detect actions or omissions that can give rise to liability to the company, or that the proposed appropriations of the company's profit or loss are not in accordance with the Companies Act.
As part of an audit in accordance with generally accepted auditing standards in Sweden, we exercise professional judgment and maintain professional skepticism throughout the audit. The examination of the administration and the proposed appropriations of the company's profit or loss is based primarily on the audit of the accounts. Additional audit procedures performed are based on our professional judgment with starting point in risk and materiality. This means that we focus the examination on such actions, areas and relationships that are material for the operations and where deviations and violations would have particular importance for the company's situation. We examine and test decisions undertaken, support for decisions, actions taken and other circumstances that are relevant to our opinion concerning discharge from liability. As a basis for our opinion on the Board of Directors' proposed appropriations of the company's profit or loss we examined the Board of Directors' reasoned statement and a selection of supporting evidence in order to be able to assess whether the proposal is in accordance with the Companies Act.
The Board of Directors is responsible for the statutory sustainability report on page 49, and that it is prepared in accordance with the Annual Accounts Act.
Our examination has been conducted in accordance with FAR's auditing standard RevR 12 The auditor´s opinion regarding the statutory sustainability report. This means that our examination of the statutory sustainability report is different and substantially less in scope than an audit conducted in accordance with International Standards on Auditing and generally accepted auditing standards in Sweden. We believe that the examination has provided us with sufficient basis for our opinion.
A statutory sustainability report has been prepared.
Ernst & Young AB, Box 7850 103 99 Stockholm, was appointed auditor of Nolato AB by the general meeting of the shareholders on the 8 May 2019 and has been the company's auditor since the 29 April 2015.
Torekov, Sweden, 19 March 2020
Ernst & Young AB
Joakim Falck Authorised Public Accountant
Nordiska Latexfabriken i Torekov is founded.
First medical device component is manufactured.
The Group changes its name to Nolato, a contraction of the original name.
Nolato shares are listed on the Stockholm Stock Exchange OTC list.
We are One Nolato
Nolato shares
Nolato was listed on the stock exchange in 1984 and its B shares, STO:NOLA B, are listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector.
One Nolato means customers benefit from end-to-end solutions using technologies and products that leverage the skills and resources of all three business areas.
The Investor Relations section of www.nolato.com provides information focused on investors and Nolato shares. The printed annual report is sent by post to those shareholders who have notified the company that they wish to receive a copy. It can also be ordered at www.nolato.com, where a digital version is also available. New shareholders are offered the opportunity in a welcome letter to receive future annual reports as long as they own shares in the company. The annual
www.nolato.com
"As a profitable, sustainable and innovative company
at the cutting edge of technology, we are well
positioned to take advantage of the many opportunities
that the future holds, with continued healthy
profitability and growth."
report is also available in Swedish.
Contents
Nolato in brief 3 2019 in brief 4 CEO's comments 6 Nolato's strategic focus 8 Operating environment 9 Vision 10 Values 11 Targets 12 Strategy 13 Mission and business model 14 Production technologies 16 Sustainable development 18 Nolato's three business areas 26 Shareholder information 40 Corporate governance 42 Board of Directors 44 Group management 46 Directors' report and financial statements* 47
Nolato aims to be the customer's
Nolato's offering One Nolato
Nolato's customer offering comprises most technologies in the field of polymers and spans the entire value chain, from solutions-oriented development to product delivery.
first choice of partner
*The information on pages 47–92 has been audited.
The Group achieves sales of SEK 650 million. Acquisition of companies in Lomma, Sunne, Hallsberg, Gothenburg and Ängelholm in Sweden.
Nolato doubles its sales through the acquisition of Ericsson's plastics factory in Kristianstad, Sweden (mobile phone division).
The first Group company achieves certification under the ISO 14001 environmental management system.
Production starts in Hungary through an acquisition.
Relocation of the mobile phone division to China begins.
Medical Solutions starts production in Hungary.
2006 Sweden-based Medical Rubber is acquired.
2007
Sweden-based Cerbo Group is acquired.
Medical Solutions starts production in China.
Medical Solutions starts production in the US through the acquisition of Contour Plastics.
Industrial Solutions starts production in Romania.
Medical Solutions starts production in the UK through the acquisition of Cope Allman Jaycare.
Sweden-based Nolato Sunne is sold.
Integrated Solutions establishes own production in Malaysia.
Treff AG in Switzerland and Grizzly Medical in Poland are acquired.
Sweden-based Hertila is sold.
Integrated Solutions acquires US-based Ja-Bar Silicone Corporation.

The Nolato Annual Report was produced by Bysted AB. Photography: Jüri Soomägi, Anders Eliasson and others. Illustrations: Björn Nilsson.
Repro & printing TMG Öresund. Translation by Hilltop Language Ltd. Production has been carried out in line with Nolato's corporate responsibility principles, with a sustainability focus, social responsibility and low environmental impact. The paper comes from responsible, certified sources and the printing process is FSC and environmentally certified.
SE-269 04 Torekov, Sweden Street address: Nolatovägen Phone: +46 431 442290 Email: [email protected]
402 Longsheng Industrial Park 7 Rong Chang Road East Beijing Development Area Beijing 100176, China Phone: +86 10 6787 2200
Suzhou, China Nolato Electronic Technology (Suzhou) Co. Ltd. Building E Pingqian Industrial Park No. 46 Chunxing Road Xiangcheng District Suzhou 215100, China Phone: +86 512 6939 0380
402 Longsheng Industrial Park 7 Rong Chang Road East Beijing Development Area Beijing 100176, China Phone: +86 10 6787 2200
Kristianstad, Sweden Krinova Incubator & Science Park Nolato AB 2022:210 Stridsvagnsvägen 14 SE-291 39 Kristianstad, Sweden Phone: +46 708-74 41 70
San Diego, USA 16208 Palomino Mesa Ct San Diego, CA 92127, USA Phone: +1 858 859 5270
Box 905, SE-461 29 Trollhättan, Sweden Street address: Verkmästarevägen 1–3 Phone: +46 520 409900
Paris, France 15 Rue Vignon FR-75008 Paris, France Phone: +33 1 47 975284
660 VandeBerg Street Baldwin, WI 54002, USA Phone: +1 715 684 4614
Box 29, SE-533 21 Götene, Sweden Street address: Alsborgsgatan 2 Phone: +46 511 342100
Jánossomorjai utca 3 HU-9200 Mosonmagyaróvár, Hungary Phone: +36 96 578770 Negoiesti, Romania DIBO Industrial Park, H13 Negoiesti, Prahova
Portsmouth, UK Walton Road, Farlington Portsmouth Hampshire, PO6 1TS UK
Phone: +44 2392 370102
Newcastle upon Tyne NE27 0QF UK
New York Way, New York Ind. Park
Phone: +44 191 296 0303
Beijing, China 4th Floor, Building 3, No. 21 Xingsheng Road BDA, Beijing, 100176, China Phone: +86 10 6780 5580
Lövepac technology (Shenzhen) Co., Ltd 1st. Floor, No. 3 building, No.1 Lirong Rd. Changyi Industrial Area, Xinshi Community, Dalang St. Longhua District Shenzhen 518109, China Phone: +86 755 8610 6065
Nolato EMC Production Center Plot 368, Lorong Perindustrian Bukit Minyak 21, Penang Science Park, 14100 Simpang Ampat Penang, Malaysia Phone: +604 50 57 830
Ringvägen 5 SE-286 73 Skånes Fagerhult, Sweden Phone: +46 433 32300
Box 93, SE-242 21 Hörby, Sweden Street address: Medicingatan 4 Phone: +46 415 19700
Lomma, Sweden Box 28, SE-234 21 Lomma, Sweden Street address: Koppargatan 13 Phone: +46 415 19700
SE-269 04 Torekov, Sweden Street address: Nolatovägen Phone: +46 431 442260
Box 4123, SE-422 04 Hisings Backa, Sweden Street address: Exportgatan 59 Phone: +46 31 588400
SE-269 04 Torekov, Sweden Street address: Nolatovägen Phone: +46 431 442200
Ängelholm, Sweden Framtidsgatan 6 SE-262 73 Ängelholm, Sweden Phone: +46 431 442200
Box 62, SE-694 22 Hallsberg, Sweden Street address: Bergsmansvägen 4 Phone: + 46 582 88900
Beijing, China Nolato Silikonteknik (Beijing) Co., Ltd Room 207, 2nd Floor, Building 208, 7# East Rongchang Road, Beijing Development Area Beijing 100176, China Phone: +86 10 6787 2200
Suzhou, China Nolato Electronic Technology Co., Ltd Plant E, No. 46 Chunxing Road Caohu Street, Xiangchen Suzhou 215100, China Phone: +86 51 2693 90380
Nolato Annual Report 2019
ANNUAL REPORT 2019
Global expansion
New Jersey, USA Nolato Jabar P.O. Box 1249 Andover, NJ 07821, USA Street address: 252 Brighton Road Phone: +1 973 786 5000
Penang, Malaysia Nolato EMC Production Center Sdn. Bhd. Plot 368, Lorong Perindustrian Bukit Minyak 21, Penang Science Park, 14100 Simpang Ampat Penang, Malaysia Phone: +604 50 57 830
Gyõr, Hungary Nolato EMC Production Center Limited Liability Company Bükkfa utca 10 HU-9027, Gyõr, Hungary
ul. Uslogowa 1 73-110 Stargard Poland Phone: +48 91 573 6362
Taastrasse 16, 9113 Degersheim Switzerland Phone: +41 71 372 55 55
www.nolato.com

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.